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Abstract
Two full-length cDNAs encoding putative glutamate receptor subunits denoted HG4 and 
HG5 have been isolated from the parasitic nematode Haemonchus contortus. The translated 
sequence for HG4 shared an 80.25% identity with the glutamate gated chloride channel beta 
subunit, GluCip, isolated from the free-living nematode Caenorhabditis elegans. This 
suggested that the HG4 receptor subunit was the parasitic orthologue of GluCip. Similarly, 
the translated sequence derived for HG5 was 56 % identical to the C. elegans inhibitory 
glutamate receptor subunit G luClal. This suggested that HG5 might be a-like in nature.
Co-expression of GluClal and -p in Xenopus oocytes forms avermectin sensitive receptors. 
It was postulated that HG4 was a component of an equivalent complex in H. contortus. The 
translated sequence of HG4 from an avermectin-resistant population of nematodes was 
found to be identical to the consensus sequence derived from a susceptible population. This 
confirmed that the switch from avermectin susceptible to resistant phenotypes did not result 
from a genetic mutation coded by the mRNA. Amplification of the 5’ end of HG5, encoding 
the predicted ligand-binding domain, from a resistant-population revealed that there was no 
difference in the sequence to that from susceptible worms.
HG4 expression was mapped in adult H. contortus using immunocytochemical techniques. 
Labelling was restricted to the commissures with a fainter staining observed in ventral and 
dorsal cords. Expression spanned from the mid-region of the pharynx to the mid-body 
region. These findings suggested that glutamate transmission occurs via HG4 associated 
receptors between the AVE interneurone and connecting motor neurones. Commissures 
within this region form branches that connect to the sublateral cords. Communication 
between these cords and surrounding muscle play a role in regulating the head movement of 
the worm. It was therefore predicted that exposure of H. contortus to avermectin result in the 
paralysis of somatic muscles in the anterior portion of the worm.
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This chapter provides an overview of parasitic nematodes, detailing the devastating affects 
incurred upon infection and hence the need to limit further spread. Nematodes causing 
disease specific to humans or livestock are described, with particular reference made to 
Haemonchus contortus, one of the most common worms infecting both sheep and goats on a 
global scale. Methods for controlling infection by this nematode are considered, with 
chemotherapy being the most popular approach taken by farmers. As with all anthelmintics 
so far administered to nematode infected livestock, H. contortus has developed drug resistant 
populations. Consequently there is concern that this particular measure will become 
inefficient in the future, with nematode populations becoming harder to control. Some of the 
most popular drugs used by farmers are discussed including details of known targets, 
mechanisms of action and the genetic changes, which produce resistance in certain 
nematode populations. To date nematode studies have concentrated on two species of 
nematode, Caenorhabditis elegans and Ascaris suum. Their popularity for genetic studies is 
discussed, including reasons for preferential use over nematodes such as H. contortus. 
Studies on these model systems corroborate findings that the majority of drug targets are 
localised within the nervous system of the nematode. A complete reconstruction of the C. 
elegans nervous system has been accomplished, the architecture of which is summarised in 
order to identify which neurones are targeted by which drugs. Target sites associated with 
neurones include a superfamily of ligand-gated ion channels of which both inhibitory and 
excitatory receptors are members. These are discussed to clarify the mechanisms of 
anthelmintic action and why drug resistance is triggered. This thesis details an attempt to 
isolate the avermectin target from the parasitic nematode H. contortus. Characterisation of 
this target has been combined with existing knowledge of model systems to develop an 
understanding of the drug mechanism in actual parasites.
1.1 Nematode Classification
Nematodes, also known as round worms or helminths, have cylindrical non-segmented 
bodies that possess bilateral symmetry. They are composed of two concentric tubes, the 
mesoderm (body wall) and the endoderm (gut), which are separated by a fluid-filled cavity 
known as the pseudocoelum as displayed in figure 1 (Wood, 1988). It has been estimated 
that four out of five animals on this planet are helminths (Platt, 1994). Free-living nematodes 
may feed entirely on micro-organisms present in decaying matter, or suck juices from plants. 
Other species have developed successful methods with which to parasitise animals. Most 
parasitic nematodes are dioecious, having male and female organs in separate individuals 
with fertilisation of eggs occurring in the female. Life cycles are highly conserved with the 
worm undergoing four moults, passing through four larval stages (L1-L4) before reaching 
maturity, at which stage females are generally larger than males (Wood, 1988).















OviductPharynx Uterus EggsOocytes Vulva
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Figure 1, Anatomy of Caenorhabditis elegans. a) male and b) hermaphrodite. The major anatomical features are highlighted with reference 
made to the mesoderm (body wall), endoderm (gut) and the pseudocoelum (fluid filled cavity).
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subclasses; subclass I (Adenophorea) and subclass II (Secernentea), depending on whether 
caudal sense glands (phasmids) were present. The Adenophorea lack phasmids and were 
of the order Enoplida. Nematodes of this order fell into one of two superfamilies: 
Trichuroidea or Dioctophymatoidea. The subclass Secernentea possessed phasmids and 
were classified in one of five orders- Order 1: Rhabditida, Order 2: Ascaridida, Order 3: 
Oxyurida, Order 4: Strongylida and Order 5: Spirurida. Strongylida were classified further 
into 4 superfamilies: Ancylostomatoidea (hookworms), Strongyloidea, Trichostrongyloidea, 
and Metastrongyloidea. The Spirurida were also classified into 6 different superfamilies: 
Filarioidea (filarial worms), Dracunculoidea, Gnathostomatoidea, Thelazoidea, 
Habronematoidea and Physaopteroidea. A summary of this classification is illustrated in 
Figure 2 with examples of some of the worms that fit into the various families listed.
1.2 Parasitic Infection
The majority of nematodes are free-living microbivores, however many species have adopted 
a parasitic lifestyle and can be found in host organs, tissues and cells. Colonisation of 
parasites within these structures can have severe effects, which may lead to death if not 
treated. In the following section examples of both human and livestock parasites are 
described. The cause of parasitic transmission, severity of host symptoms and the 
identification of high-risk host populations are included.
1.2.1 Human parasitic nematodes
In humans, both the whip worm Trichuris trichiura and the pin worm Enterobius vermicularis 
inhabit the gastro-intestinal tract, where they attach onto the gut wall and consume the hosts 
blood via the epithelial lining. Each of these species is distributed globally with the former 
most prevalent in humid tropical countries and the latter in temperate climates, infecting 
mainly children (Whitfield, 1993).
Parasites such as Ascaris lumbricoides and the hookworm Necator americanus journey 
through various organs whilst undergoing development, their ultimate destination being the 
alimentary canal. A female N. americanus can grow to 1.3 cm long whilst female A. 
lumbricoides can measure up to 35 cm in length (Jeffery & Leach, 1972). Both species are 
found globally, the latter prevalent in the Far East and tropical Africa and the former in the 
tropics and subtropics such as the Southeast states of the USA (Whitfield, 1993). Ascaris 
eggs, present in water or contaminated foodstuffs, are swallowed by the human host and 
pass into the duodenum where they hatch into L2 larvae. These burrow into the mucosa and 
migrate to the liver. From this point they can enter the lymphatic system or the veins which 
carry them to the heart. From here they journey to the lungs where they moult twice, 
ascending the trachea where they re-enter the digestive tract upon being swallowed.
Similarly, the hookworm follows the same route, but only does so if the L3 larvae penetrate 












































Figure 2, An Outline of the classification of the Phylum Nematoda: includes examples of free-living worms, human parasites and domesticated 
livestock/animal parasites
they travel directly to the gut where they develop to adulthood. The adults may also perforate 
the lining of the jejunum or duodenum inducing peritonitis.
Dracunculus medinensis, also known as the guinea worm, is the largest of the human 
parasitic nematodes, growing to lengths of up to one meter (Whitfield, 1993). They are 
ingested through drinking water contaminated with water-borne animals called cyclops 
containing L3 larvae. These penetrate the gut and develop into adults over a 12-week period 
at which stage they mate and then move through the body causing tremendous pain until 
they reach the ankle. Eight to ten months after the original infection the mature female, 
carrying about a million L1 larvae, induces a blister on the hosts skin. Worms emerge from 
these sites causing patients to suffer extreme pain accompanied by fever, nausea and 
vomiting. In the following months the patient can remain ill due to an increased susceptibility 
to super-infections. A global campaign was initiated in 1980 by the World Health 
Organisation (Reviewed by WHO, 1997) to eradicate dracunculsis as no drug or vaccine 
existed to treat the disease. Steps were made to prevent the completion of the parasites life 
cycle by the systematic filtering of all drinking water, disinfecting stagnant water holes and 
installation of water pumps. A press release by the WHO (1995) reported that guinea worm 
disease remained prevalent in India and Yemen, as well as in 16 countries in Africa south of 
the Sahara. It was estimated that 130 million people were at risk of infection, of which 99% 
lived in Africa.
A disease known as lymphatic filariasis is caused by infection of filarial nematodes such as 
Wuchereria bancrofti and Brugia malayi (Whitefield, 1993). Both adult worms and microfilaria 
(L1 larvae) settle within the lymphatic vessels of the human host, where they develop over a 
15 month period. Microfilariae are able to invade the blood stream, where they may remain 
as immature forms for up to 2 years. Transmission to other humans is achieved by the 
involvement of an intermediate host, the mosquito of genera Aedes, Mansonia, Culex or 
Anopheles. Microfilariae present in the blood meal of a mosquito invade the flight muscles 
via the hemocoel, moulting twice to give infective L3’s. These migrate to the proboscis where 
they are released into another human host when the mosquito takes another feed. L3 larvae 
then travel to the lymphatic system during which time they moult twice to give adults. Adult 
worms grow to several centimetres in length damaging lymphatic ducts. They are also 
extremely resilient, surviving attack by the host immune system by expressing epicuticular 
enzymes (glutathione peroxidase, catalase and superoxide dismutase) to disarm the oxygen 
radical attack of activated immune effector cells (Cookson et a!., 1993, Ou et al., 1995, Tang 
et al., 1994). A condition, called elephantiasis, develops after infection causing body parts 
such as the legs, arms, scrotum, vulva or breasts to become grossly swollen and covered 
with sores. Other symptoms of infection include acute fevers, inflammation of the lymphatic 
system and pulmonary eosinophilia. In 1996 more than 120 million people world-wide were 
estimated to be infected of which 106 million were infected with W. bancrofti and 12.5 million 
people with B. malayi and the closely related B. timori (WHO, 1996).
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The disease Onchocerciasis is caused by the infection of the filarial worm, Onchocerca 
volvulus and is most prevalent between the West African savanna and forest areas. Here 
nematodes are transmitted by the Simulium genus of black fly which breed in fast flowing 
freshwaters (reviewed by Whitfield, 1993). Unsheathed L3 larvae, released from the blackfly, 
penetrate human skin and mature to adults, growing up to 50 cm in length, in the 
subcutaneous tissue (Jeffery & Leech, 1975). Unlike W. bancrofti and B. malayi, microfilariae 
from O. volvulus do not travel around the blood system but rather localise under the skin 
where they cause the majority of side affects associated with the disease. Initial light 
infections induce itchy rashes, contrasting with subsequent long heavy infections leading to 
patchy pigmentation changes of the skin. Chronic infection also causes the skin to thicken, 
becoming coarse in texture whilst losing its elasticity. Elephantiasis of the genitals and river 
blindness are two symptoms commonly observed in infected individuals, the latter developing 
when microfilariae move through the skin to the eye impairing vision.
The whipworm Trichinella spiralis, a parasitic nematode that invades cells in the human host, 
causes the disease called trichinosis. The worm is globally distributed, in a range of 
carnivorous and omnivorous mammals, with larvae being transmitted when uncooked 
infected flesh is eaten. Adult parasites reside in the small intestine where they burrow into 
epithelial cells causing damage to the lining of the gut wall. However, the majority of harm is 
attributed to the larvae migrating to voluntary muscles forming cysts within muscle cells. 
Symptoms of heavy infections include vomiting, diarrhoea, high fever and muscular pain, with 
severe cases causing cardiac and central nervous system damage (Whitfield, 1993)
1.2.2 Livestock parasitic nematodes
Nematodes of veterinary importance include the gastro-intestinal parasites Haemonchus 
contortus infecting sheep & goats and Ostertagia ostertagi found in cattle (Granvold et al., 
1993). With both species of nematodes, L3-larvae are ingested whilst the ruminant is grazing 
and migrate to the stomach where they undergo two moults, transforming them into adults. 
Blood feeding starts when the adults attach onto the gut lining, using teeth present in the 
buccal cavity. Sheep infected with H. contortus can carry several thousand worms, each 
consuming 15 pi of blood per day (reviewed by Smyth, 1994). This action inevitably drains 
the sheep of blood. With O. ostertagi carrying out the same process in cattle, similar 
symptoms are induced.
The ascarid Ascaris suum, parasitises pigs, undergoing a similar life cycle and migrational 
path as that described for the human parasite, A. lumbricoides. Migrating A. suum larvae 
cause allergic reactions and respiratory problems such as bronchitis. High levels of worms 
can encourage migration out of the gut into the bile duct, pancreatic duct, oesophagus, mouth 
and sometimes the liver (Whitfield, 1993).
Other nematodes found in domesticated animals include the filarial parasite Onchocerca
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gutturosa present in the connective tissue of cattle. Adult Ascaridia galli inhabits the small 
intestine of chicken, and the strongylida Dictyocaulus viviparus resides in the lungs of cattle.
1.3 H. contortus
H. contortus is one of the most common nematodes to parasitise sheep and goats in Britain. 
An increased understanding of the genetic make-up of this parasite is required to optimise 
methods for controlling its transmission. Difficulties encountered in previous studies of the 
nematode are discussed. Two alternative helminths, Caenorhabditis elegans and Ascaris 
suum have however been successfully studied and are also reviewed. Findings for these 
systems are currently used to predict processes occurring in H. contortus.
I.3.1 Appearance and Life Cycle
The wireworm Haemonchus contortus is a highly pathogenic sheep parasite. It is also known 
as the barbers pole worm as the female has a characteristic red strip spiralling along its body 
(Figure 3a). This is due to the white ovaries twisting around the red intestine. Adult H. 
contortus reside in the true stomach or abomasum of sheep, cattle, goats and other small 
ruminants. Adult worms are dioecious, whereby both male and females worms are needed 
to reproduce. Adult males are 10-20 mm in length with a diameter of 0.4 mm whilst females 
are 18-30 mm in length with a 0.55 mm diameter (Jeffery & Leech, 1972). It is estimated that 
the females H. contortus can lay 20,000 eggs per day, each egg being approximately 66.5-79 
x 43.3-46.6 pm in size (Blaxter & Bird, 1987 and Anderson, 1992). These pass out of the 
sheep with the faeces and hatch to release first stage L1-larvae. These free-living L1 
microbivores are 340-350 pm in length having a valve termed the oesophageal bulb and a 
slender, sharply pointed tail. L1-larvae commence eating an hour after hatching and grow to 
a length of 400-450 pm over a period of 14-17 hours. At this stage they become lethargic 
and moult to give second stage L2-larvae, possessing prominent lateral alae, ridges which 
stretch the length of the cuticle. These resume feeding for a further 40 hours, at which point 
they undergo lethargy and a moult, but unlike the previous moults the cuticle is not shed. The 
resultant infective L3-larvae are therefore enclosed in two cuticles, the outermost of which is 
called the sheath. The ensheathed larvae are 754-756 pm in length still possessing lateral 
alae, yet the tail differs being less attenuated and conical in shape at the tip. L3-larvae climb 
up blades of grass and wait to be eaten by grazing sheep. Once ingested, ecdysis is 
triggered whereby larvae exsheath whilst en route to the abomasum, upon arrival they 
burrow into gastric pits between the villi and commence feeding. As the larvae reach a length 
of 655-840 pm they experience a third lethargic period followed by a moult giving way to 14- 
larvae. The L4-larva has a buccal cavity containing teeth allowing it to hook onto the 
mucosal layer accessing the host’s blood. After seven days of blood feeding activities, sexes 
can be clearly differentiated, males being 2.7-3.0 mm in length and females 3.7-4.0 mm.
Following a further 12 days including a final 24 hours of lethargy, a fourth moult is initiated, 
liberating adults. This cycle is depicted in Figure 3b.
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Figure 3a. A female adult Haemonchus contortus, photograph provided by Dr E. Munn.
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Figure 3b. The Life cycle of H. contortus. Drawn by Dr D. Cope
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1.3.2 Model Nematodes
H. contortus is difficult to study since no in vivo culturing technique has been developed to 
incorporate the nutrients and environmental cues experienced within the sheep gut 
(Stringfellow, 1986). The size of the worm also presents a problem when attempting 
electrophysiological studies. Use of two other closely related nematodes, Caenorhabditis 
elegans and Ascaris suum, as model systems have circumvented many of the problems 
posed by the experimental use of H. contortus. These systems and their uses are described 
next.
I.3.2.1 Caenorhabditis elegans
Caenorhabditis elegans, reviewed by Wood (1988), is an ideal experimental model system 
for studying nematodes. It is a small free-living soil nematode, an adult being 1.5 mm in 
length, feeding primarily on bacteria. Nematodes can therefore be easily maintained in the 
laboratory by growing on Escherichia coli coated agar plates at 20 °C. It is also possible to 
cultivate large numbers of worms by mass culture in liquid media (Lewis & Fleming, 1995). 
This species has two sexes, hermaphrodites and males, the former produce both oocytes 
and sperm allowing them to reproduce by self-fertilisation, also known as selfing. 
Hermaphrodite/male crossing can produce over 1000 progeny compared to the 300 eggs laid 
during selfing. Under optimal conditions a C. elegans life-cycle typically spans over three 
days from fertilisation to adulthood, during which time it undergoes 4 successive moults. 
Adults are then able to live for a further 17 days, hermaphrodites living slightly longer than 
males. This short life-cycle is therefore well suited to the ease of cultivation within a 
laboratory.
The transparency of the body is also advantageous as it allows features such as cell 
numbers and their positions to be observed during the worm’s development. C. elegans 
anatomy is also simple and the consistency of structures observed between individuals 
remains constant. With the aid of electron microscopy, the complete nematode anatomy has 
been reconstructed with adult hermaphrodites having a total of 959 somatic nuclei and adult 
males having 1031 (Sulston et al., 1983). Information on locations and characteristics of 
these somatic cells and cell lineage has been established. Details of the latter include timing, 
locations and ancestral relationships of all the cell divisions during development. A technique 
called laser microsurgery has proved a useful tool, whereby cells undergo laser ablation 
within the living organism allowing the resulting phenotype to be examined (Mclntire et al., 
1993b).
The simplicity of the nematode is also a valuable factor, having an estimated genome size of
100 x 106 base pairs, organised into six chromosomes (Hodgkin et al., 1995).
Hermaphrodites have 2 sex-linked X-chromosomes whilst males possess a single X-
chromosome, remaining chromosomes are autosomal in nature. The genome is 1730th the
size of the human genome and 20 times the size of the Escherichia coli genome. It is 36 %
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GC rich with coding sequences having a high GC content and non-coding regions 
possessing a high AT content (Sulston & Brenner, 1974). The complete genomic sequence 
will be available by the end of 1998 (Hodgkin et al., 1995). Detailed genetic mapping is also 
in progress and can be accessed by the C. elegans database, AceDB (Hodgkin et al., 1995). 
This involves the cloning and analysis of mutationally defined genes such as a group of 
uncoordinated worms, defined as the unc mutants. This has led to the production of a 
physical map of the entire genome, which is nearing completion. One limitation with the C. 
elegans model is that electrophysiology, although possible (Raizen & Avery, 1994), is not 
easy due to the small size of the neurones, muscle cells and pharynx. The pig parasite 
Ascaris suum is a more suitable nematode for such studies, possessing large cells that are 
more amenable to the electrode attachment required for electrophysiological recordings 
(Martin, 1993).
1.3.2.2 Ascaris suum
Ascaris suum is a large parasitic nematode, 30 cm in length, ultimately residing in the pig’s 
intestine. Worms can be collected from abattoirs and then preserved in a warm saline 
solution for about five days (Martin et al., 1996). The large size of its muscles and nerve cells 
makes it an attractive system to study the electrophysiological action of exposure to a variety 
of chemicals including neurotransmitters and anthelmintics. This technique has yielded 
information on the nervous system of A. suum, which corresponds closely with data collected 
on C. elegans.
1.4 Controlling infection
H. contortus pathogenicity is attributed to its blood feeding activities. Feeding initiates 
haemorrhaging of the abomasum wall. Blood plasma and proteins are lost in addition to the 
haemoglobin and iron from red blood cells. A loss of these components can cause anaemia 
and hypoalbuminaemin (Crompton & Joyner, 1980). Consequently, production of milk, wool 
and meat becomes reduced, and in severe cases the sheep can die. A variety of methods 
can be used and prevent H. contortus transmission. It should be noted that these measures 
are also used to control a range of other nematode infections. It is currently believed that a 
combination of these control measures may prove more successful than the use of single 
methods (Strong & Wall, 1990).
The most popular method chosen by farmers however is chemotherapy. In the short term, 
this method has proven most effective however incorrect usage is rendering it less efficient. 
This will therefore become a problem in the long run as more anthelmintic resistant nematode 
populations evolve. The most commonly used drugs including the avermectins are 
described, with details of modes of action. Avermectins are the most recent class of 
anthelmintics to be discovered and are the most potent drugs on the market. Even though 
avermectins possess activity against a broad spectrum of nematodes there are however a 
number of species that remain resilient to the drug and are referred to below.
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1.4.1 Physical control
Nematode infection of livestock can be effectively reduced through management activities 
(Strong & Wall, 1990). Pasture resting counteracts the possibility of transmission by rotating 
livestock to clean pastures and by alternating grazing between various species. Allowing 
animals to graze in larger fields to lower livestock density also reduces infection. A cramped 
condition where grass is scarce encourages animals to feed closer to faeces elevating the 
risk of infection. Dung removal is also recommended, involving either sweeping or 
vacuuming infected dung from the fields. It is also advantageous to expose young animals to 
minor larval infection thus stimulating some degree of immunity to the parasite for later life.
1.4.2 Biological control
An alternative approach to controlling parasitic spread of nematodes by ruminants is to kill 
the helminths whilst they are undergoing the free-living stages of their life cycle. Searches 
for parasitic predators have resulted in the discovery of a family of nematophagous fungi. 
This family can be split into three categories; the nematode trapping fungi, such as 
Arthrobotrys oligospora and Duddingtonia flagrans, endoparasitic fungi of which 
Harposporium anguillae is a member and fungal parasites such as Verticillium 
chlamydosporium (Waller, 1993 & Gronvold et al., 1993).
The nematode trapping fungus A. oligospora grows saprophytically, developing vegetative 
mycelium, which in the presence of nematodes grow trapping organs. Moreover, induction is 
most effective when highly motile larvae are present, resulting in the formation of constricting 
(active) or non-constricting (passive) rings, sticky hyphae, adhesive networks or knobs 
(Nansen et al., 1988). Fungi in this class may also secrete chemo-attractants and/or 
chemotoxic substances to nematodes. For example, following an hour of entrapment by A. 
oligospora, the nematode cuticle is penetrated by the fungus, which then secretes a 
nematotoxin that either kills or paralyses the trapped helminth (Balan et al., 1974). This is 
followed by the formation of an infectious bulb within the nematode from which trophic 
hyphae grow out causing internal destruction.
In contrast, endoparasitic fungi possess trapping nets anchoring the nematode near spore 
containing fungal structures called conidia. Upon entrapment, released spores are 
consumed by the nematode, lodging in the muscle tissue of the oesophagus and developing 
into an infectious thallus that absorbs the body contents. (Granvold et al., 1993)
A reduction in levels of larvae was observed when nematode trapping fungi such as D. 
flagrans were added directly onto the dung infected with O. ostertagl and Dictyocaulus 
viviparus (Granvold et al., 1993). A disadvantage of this approach is that it is highly 
dependent on climatic conditions. An alternative to covering dung with large quantities of 
fungi is to feed nematode infected cattle with endoparasitic fungi. Calves infected with O. 
ostertagi were fed with the fungus D. flagrans and the levels of eggs in the faecal deposits
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were then monitored to ascertain the level of the fungus through the digestive tract. The 
fungus appeared to survive its journey through the animal as cow pats after treatment 
contained reduced levels of larvae. There is the possibility that alternative predators such as 
bacteria, protozoa or viruses may offer a means of biological control (Waller, 1992).
1.4.3 Vaccines
A naturally occurring immune response occurs when ruminants are infected with gastro­
intestinal nematodes thus providing a degree of protection. This was demonstrated when 
ferrets were successively infected with third-stage larvae of the canine heartworm Dirofilaria 
immitis (Blair & Campbell, 1981). The anthelmintic drug, avermectin, was administered two 
months post-infection of 30 larvae thus flushing the nematodes out of the ferrets. Three 
months following this, the ferrets were re-exposed to an equal number of larvae followed by 
termination after a further two months using avermectin. Three months following the second 
administration of drug ferrets were challenged with 30 larvae. The 4 ferrets surviving this 
treatment were necropsied after 6 months. Two were free of infection whilst the other two 
were each infected with a single worm.
Vaccination is a way of elevating levels of immunity to antigens following infection producing 
a response higher than that obtained naturally. This approach to control is a relatively new 
field of research with some vaccines presently undergoing clinical trials. In 1987, a vaccine 
enriched with a concealed antigen called contortin, a protein associated with the luminal 
surface of the intestinal epithelium of H. contortus, was tested (Munn et al., 1987). In this 
case, it is only when the worm feeds on the host’s blood that the antigen is recognised by 
antibodies and other effector components present in the meal. Sheep administered with this 
vaccine displayed a significant reduction in worm burden and egg counts.
More recently, it has been demonstrated that a natural immune response was associated 
with the humoral recognition of excretory-secretory (ES) products from H. contortus of 
molecular weights ranging from 10 to greater than 100 KDa. Infected Texel sheep raised 
significantly high levels of IgG to two low molecular weight antigens of 15 and 24 kDa in size 
(Schallig et al., 1994). These two proteins were partially purified by gel filtration using total 
adult ES products to monitor their ability to induce protective immunity against H. contortus in 
sheep (Schallig & Leeuwen, 1997). Five sheep were challenged with 20,000 H. contortus 13- 
larvae 5 weeks post-vaccination of the 15/24 kDa ES immunogen. After ten weeks post­
primary vaccination, one of the sheep had not developed protection against the parasite, 
however for the remaining four sheep, a mean reduction of faecal egg counts by 99.9% was 
observed as well as a 97.6 % mean reduction in abomasal worm burden. Discrepancies in 
degrees of protection may be genetically linked, causing variation in the ability of individuals 
to respond to parasites.
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1.4.4 Chemotherapeutics
Chemical control is the most successful short-term treatment employed by farmers. There 
are over 200 chemical compounds currently available to farmers to treat livestock parasites 
(Strong & Wall, 1990).
Highly toxic chemicals based on arsenic, mercury, tar and petroleum were some of the 
original treatments administered to animals experiencing parasitic infestations. However, 
these compounds more often than not poisoned livestock. A second class of compounds 
called the organochlorines, such as DDT, where developed aiming to reduce toxicity to hosts. 
Unfortunately, DDT’s unforeseen persistence, spreading up the food chain led to the ban on 
its use in many countries.
Since the 1940’s the rate of discovery of novel drugs has been approximately one every 5 
years, with potency towards the parasite increasing with each new discovery (McKellar & 
Benchaoui, 1996). Consequently, doses to hosts tend to be reduced by half with each 
succeeding novel compound. Gutteridge has reviewed these novel anthelmintic drugs in 
1993; details of these are described below with corresponding structures presented in figure
4.
Anthelmintics available to control gastro-intestinal nematode infestations include the 
organophosphates Haloxon (for horses), Dichlorvos (for pigs) and Naphthalophos (for 
sheep). Each of these drugs acts as a potent inhibitor of acetylcholine esterases present at 
synapses in the nematode's nervous system. This enzyme breaks acetylcholine down into 
acetic acid and choline, the former of which is taken up presynaptically. Degradation by 
esterases is very efficient, inactivating the neurotransmitter. Inhibition of this break down 
would thus prolong exposure of acetylcholine at synaptic junctions leading to longer 
depolarisation times causing muscle paralysis.
Another drug that targets the helminth’s nervous system is piperazine and is often used to 
treat infected small animals. The compound selectively opens GABA gated chloride 
channels present at neuromuscular junctions; hyperpolarisation produced by an influx of 
chloride ions into muscle cells leads to flaccid paralysis. It has subsequently been found that 
piperazine binds reversibly to the channel, simply immobilising the worm rather than killing it. 
Immobilisation enabled the natural expulsion of the nematodes by bowel movement.
Benzimidazoles were discovered in 1964 to have a broad-spectrum activity against gastro­
intestinal parasites. This class of compounds has limited solubility leading to poor absorption 
when ingested thus making them ideal candidates for treatment of intestinal helminth 
infections. The mode of action of these drugs involves an interaction with the cytoskeletal 
protein, tubulin, inhibiting its polymerisation into microtubules by binding to the nucleotide 
GTP-binding site (Kwa et al., 1995). Benzimidazole selectively binds to helminth tubulins 
since the rate of dissociation of the drug to mammalian tubulin is much higher than for its
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Figure 4, Anthelmintic drugs used to control parasitic nematode infection.
parasitic counterpart (Lacey & Gill, 1994).
Levamisole, morantel and pyrantel were also introduced in the 1960s and target nicotinic 
acetylcholine receptors located in the helminth nervous system (Lewis et al., 1980). This 
group of drugs act as agonists, mimicking the effect of acetylcholine at the excitatory 
receptor, opening the channel for cation influx depolarising cells (Coles et al., 1975). 
Continued depolarisation leads to muscular paralysis thus preventing movement by the 
nematode.
In 1981, a new class of compounds known as the avermectins was introduced as a novel 
anthelmintic treatment. Avermectins are macrocyclic lactones produced by the filamentous 
bacterium Streptomyces avermitilis (Burg et al., 1979). The synthetic derivative of the natural 
occurring avermectin 1B is called ivermectin. This possesses a single bond rather than a 
double bond between carbon 22 and 23 (Sutherland & Campbell, 1990). The potency of 
ivermectin is 25 fold higher than contemporary products, thus requiring nanomolar doses for 
administration to infected livestock (McKeller & Benchaoui, 1996). Avermectins target 
inhibitory ion channels present in the nervous system of the worm inducing an irreversible 
influx of Cl' ions through inhibitory glutamate-gated receptors resulting in paralysis. This was 
confirmed by injecting mRNA isolated from the free-living nematode Caenorhabditis elegans 
into Xenopus oocytes. Pharmacological studies on these revealed the activation and 
potentiation of glutamate gated chloride currents by avermectin and a series of analogues 
(Arena etal., 1995).
Ivermectin was initially used to treat livestock and by 1986, it had captured 16 % of the world­
wide anti-parasitic sales. Approximately 800 million cattle had been treated with ivermectin 
by the year 1990 and awareness that the drug could be used in the control of insects and 
human parasites was developing. The human filarial disease, onchocerciasis, has since 
been successfully treated with ivermectin (Plaisier etal., 1995).
In Haemonchus contortus, avermectin affects three different structures: the gut lining, the 
pharynx, and somatic muscle (Geary et al., 1993). At concentrations greater than 
approximately 10-8 M, ivermectin reduces the motility of the worm. The observed drug 
induced paralysis was confined to the mid-body region of the parasite, contrasting with the 
head and tail regions where normal motility action was maintained. This observation was 
believed to be a result of the drug binding to GABA receptors which are known to bind 
avermectin at pM concentrations (Holden-Dye et al., 1988 and Martin & Pennington, 1989). 
At avermectin concentrations of 10'10 M, a reduction in ingestion by H. contortus was 
visualised by detection of FITC-labelled Escherichia coli. It was also discovered that the drug 
paralysed the pharynx when present at concentrations greater then 10'10 M, preventing the 
influx of nutrients into the digestive tract (Geary et al., 1993).
Temporary paralysis of the pharynx has been induced by immersion of first stage C. elegans
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larvae into 0.15 5 1-phenoxyl-2-propanol. The subsequent addition of ivermectin triggered 
coiling and prolonged immobilisation of the larvae at final concentrations of 50 mg/ml (Smith 
& Campbell, 1996). These findings indicate that avermectin uptake is not solely dependent 
on the ingestion by pharyngeal pumping.
From these findings it was evident that avermectin inhibits pharyngeal pumping more potently 
than motility, however it is not yet known whether the drug kills the worm by terminating its 
feeding abilities thus leading to arrested development and starvation. Death by starvation is 
likely to occur over a period of time, as adult parasites possess ample supplies of glycogen 
and would therefore not, as is the case, cause a rapid expulsion of worms out of the host. It 
has been suggested that avermectin may kill worms by preventing pharyngeal related 
functions, such as the regulation of internal pressure through which it maintains its rigid body 
shape (Laughton et al., 1997a & Wolstenholme, 1997). It is also possible that the levels of 
drug administered to the host are sufficient to promote paralysis of the somatic muscle 
causing a rapid reduction in motility as is the case seen with piperazine (Del Castillo et al., 
1964).
Electrophysiological recordings on the model system, Ascaris suum, support the findings that 
avermectin paralyses worms without causing hypercontraction or flaccid paralysis. In 
particular, avermectin B1a appears to block transmission between the interneurones along 
the nerve cords and excitatory motor neurones (Kass et al., 1980). The drug has little or no 
effect on excitatory neuromuscular transmission however it is able to inhibit transmission 
between inhibitory motor neurones and muscles. Blockage of interneurone stimulation of 
excitatory motor neurones by 5 pg/ml of avermectin B1a was reversed by subsequent 
addition of 10 pg/ml picrotoxin. This compound however, has no effect on avermectin 
blocked inhibitory motor neuronal synapses. Both picrotoxin and ivermectin inhibit the 
positive allosteric modulator (35S)-TPBS binding to locust GABA receptors at nM 
concentrations (Bermudez et al., 1991). This suggests that the blocking effect of avermectin 
may act near the picrotoxin-binding site. Avermectin effects were mimicked by two 
GABAergic agonists, muscimol and piperazine, inferring the drug contributes to a GABAergic 
mechanism (Kass et al., 1984). These results suggest the presence of 2 distinct sites of 
action in A. suum.
Contrasting with the efficacy of avermectin on H. contortus, control of other nematode 
species is not so straightforward. Ivermectin given as a single dose acts as an effective 
microfilariacide for Onchocerca volvulus. However, adult filariae appear to remain unscathed 
by single doses of drug (Awadzi et al., 1986). Following administration, embryos within the 
female continue to develop into microfilariae. The drug prevents expulsion of these, causing 
an accumulation of large numbers of microfilariae in the uterus. These gradually degrade in 
utero and resorb back into the female (Albiez et al., 1988). After exposure to the drug, the 
adult worm slowly resumed production and release of microfilariae. It has been suggested
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that the mass of decomposing tissue may block the passage to the uterus, preventing sperm 
to reach the seminal receptacles. This would deter any likelihood of fertilisation hindering the 
adult’s ability to reproduce (Duke et al., 1990).
Repeated dosage to infected patients with ivermectin gives no statistically significant 
differences to those observed in control patients. However a general trend of increased 
levels of moribund and dead females was observed in ivermectin treated patients. The 
average number of males per nodule, and hence the ratio of male to female worms, was 
reduced in ivermectin treated groups (Duke et al., 1991a,b). The lack of efficacy of 
ivermectin in adults of the related filarial nematode, O. ochengi, was found not to be a result 
of failure to penetrate host nodules (Cross et al., 1997). This was established by monitoring 
the distribution of subcutaneously injected ivermectin in infected cattle using high-pressure 
liquid chromatography.
The heartworm, Dirofilaria immitis, is a filarial nematode that parasitises ferrets and dogs. 
Avermectins action towards this nematode is similar to that observed for O. volvulus in that it 
causes the rapid removal of microfilariae from the blood (Blair & Campbell, 1979). Further 
studies have shown that maturation of nematode larvae can be prevented in dogs if 
ivermectin is administered 31 to 60 days after infection. If however, the drug is given 90 days 
following infection, maturation into adults occurs in 3 out of 5 dogs (Blair & Campbell, 1980).
Filarial nematodes are not the only class of helminths that respond in different ways to 
ivermectin. Variation in sensitivity to this drug also exists for members of the 
Ancylostomatoidea superfamily of hookworms. Ancylostoma ceylanlcun and Necator 
americanus both infect hamsters. The latter is insensitive to ivermectin whilst the former is 
300 times more sensitive in relation (Rajasekeriah et al., 1989; Behnke et al., 1993). In vitro 
comparison of these two hookworms demonstrated that the difference in drug sensitivity was 
neither attributed to the host-parasite relationship or variation in drug uptake via the cuticle 
(Richards et al., 1995). This suggests variation in drug target site and therefore 
characterisation of the target from each of the described models may reveal the molecular 
action of the drug.
Prospective anthelmintics include paraherquamide, PF1022A, dioxapyrrolomycin and 
clonstachydiol. Paraherquamide is isolated from the fungus Penicillum charlesii and has 
successfully treated experimental infections of Haemonchus contortus in sheep 
(Blanchflower et al., 1991). Its mode of action is believed to be different to benzimidazole 
and avermectin targets since nematode isolates, resistant to the latter two drugs, are 
eradicated by paraherquamide (Shoop et al., 1990). The fungal compound, PF1022A 
paralyses worms by stimulating inhibitory GABA receptors on muscles while simultaneously 
inhibiting the cholinergic mechanism synergistically (Terada, 1992). The drug was first 
discovered in a screening using chickens infected with Ascaridia galli (Sasaki et al., 1992).
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The compound was also shown to be effective against H. contortus infection in cattle. 
Binding assays on Ascaris suum somatic muscle preparations revealed binding to GABAa 
type receptors with affinity, Kj of 7.41+/- 8.5 nM, 10 fold higher than piperazine, having a Kj of 
856+/- 69.7 nM (Chen et al., 1996). Effective control of H. contortus in in vitro experiments 
using Dioxapyrrolomycin, a metabolite from Streptomyces species, has been successful 
however the mode of action has yet to be identified (Conder et al., 1992). A similar 
achievement was demonstrated with the use of a fungal metabolite, clonstachydiol isolated 
from Clonostachys cylindrospora (Grabley et al., 1993).
1.5 Resistance
As previously discussed, chemotherapy is the most frequently used method of control to treat 
the main groups of nematode infected farm animals, sheep, goats, cattle, pigs and horses. 
However, this type of therapy is becoming increasingly ineffective since drug resistance has 
developed throughout the nematode population (Conder & Campbell, 1995). The most 
affected areas where nematodes are resistant to broad-spectrum drugs are South Africa, 
Australia and South America. The absence of drugs to combat multi-resistant populations 
has forced many farmers in South Africa to stop rearing sheep. Surveys carried out in 
countries such as Uruguay, Argentina, Paraguay, and Brazil reveal a prevalence of 
nematode resistant populations of 40-90% for benzimidazole, 22-84% for levamisole and up 
to 73 % for ivermectin (Geerts et al., 1997). In comparison, resistance in Europe has not yet 
reached equivalent levels of severity. In this section the reasons for spread of resistance are 
discussed, as well as the molecular mechanisms responsible for this change in phenotype. 
Hopefully understanding these effects will help to minimise the spread of anthelmintic 
resistance across nematode populations as well as limiting the occurrence of further resistant 
traits.
Conder and Campbell (1995) have reviewed a number of factors contributing to the ability of 
nematodes to survive drug therapy. Under dosing encourages resistance and is frequently 
carried out by farmers who underestimate the animals weight. Farmers also tend to treat 
their livestock with reduced doses in order to cut costs. Sub-therapeutic doses allow survival 
of marginally resistant heterozygous individuals, which are then able to contribute resistant 
genes to subsequent generations. An error commonly made is for farmers to allow infected 
sheep and goats to graze together. Farmers often treat their goats with the same amount of 
drug as they would to their sheep; this under-dosing in goats will therefore encourage 
resistant populations that can then spread to sheep sharing the same pastureland. Some 
drugs, with the exception of avermectins, do not possess persistent activity in animals, 
allowing rapid re-infection after treatment. This can lead to frequent dosing and resistance. 
Another error that farmers tend to make is the frequent administration of a single drug until it 
no longer works (Reinemeyer et al., 1992). A more successful result is observed when the 
animal is exposed to a variety of drug classes. Computer models predict that resistance can
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be inhibited when two drugs are used simultaneously, while annual rotation is less effective 
(Barnes etal., 1995).
Climatic conditions play a role in the development of resistant populations. A good example 
of this was found on a Greek island where sheep and goats became heavily infected with 
resistant worms (Coles et al., 1995). The animals on this island suffered from an extended 
drought, preventing the survival of the majority of helminths outside the host. However, the 
worms that did survive became extremely resilient displaying a resistance to anthelmintics. 
In this particular case a resistant population was present after two drug doses had been 
administered. In more humid tropics 10 to 15 treatments per year have been necessary to 
prevent re-infection of H. contortus in sheep (Geerts et al., 1997).
So far, each class of chemicals used to combat nematode infection has resulted in the 
development of resistant populations of nematodes (Conder & Campbell, 1995). Resistance 
towards a drug is believed to be a consequence of either decreased drug uptake, an increase 
in drug metabolism, or an alteration at the drug-receptor site. Studies to date suggest that it 
is the latter event which is the key factor contributing to resistance rather than the former two 
suggestions. Mechanisms for resistance towards the three broad-spectrum drugs, 
benzimidazole, levamisole and avermectin are under examination as a means of improving 
control.
1.5.1 Benzimidazole
A survey was completed in 1992 to determine the presence of benzimidazole resistant 
parasitic nematodes on sheep and goat farms around England (Hong & Coles, 1996). Out of 
the tested sheep farms in the south-west, 44 % had sheep that were infected with resistant 
worms compared to 15 % in the north east. Similarly 65 % of the non-dairy goat farms tested 
in England and Wales each had benzimidazole resistant populations. Close inspection of the 
nematodes confirmed that the main species found in sheep was Ostertagia circumcincta and 
Haemonchus contortus in goats.
Resistance developed towards benzimidazole is associated with a point mutation of Phe200 
to Tyr200 in the (3-tubulin isotype 1 gene near the GTP-binding domain II in C. elegans 
(Driscoll et al., 1989). A similar point mutation is observed in the p-tubulin isotype 1 gene of 
several species of fungi whereby Gln198 is mutated to a Lys or Gly when comparing resistant 
and susceptible populations (Wheeler et al., 1995) providing further proof that this alteration 
is a causative mutation. The tub-1 gene coding for p-tubulin isotype 1 was isolated from H. 
contortus genomic DNA and transformed into C. elegans by injection (Kwa et al., 1995). This 
model nematode had previously undergone gamma irradiation so that its own p-tubulin locus 
ben-1 had been deleted. Expression of the tub-1 gene restored benzimidazoles mode of 
action, however injection of a mutated tub-1 gene carrying a tyrosine at position 200 instead 




Levamisole resistance has been observed in the trichostrongylid nematodes, Ostertagia 
circumcinta and Trichostrongylus colubriformis. In Australia, resistance of these nematodes 
to levamisole is present on up to 90% of sheep raising properties. This level of resistance is 
similar in other countries, however it is lower in Europe where levamisole resistance in H. 
contortus is rare (Overend et al., 1994 & Waller et al., 1995). Ligand binding studies suggest 
that levamisole binds to two populations of acetylcholine receptor in H. contortus. Two 
different binding sites have been detected, one of high affinity with a Kd of 2.9x10*9 M and 
Bmax of 4x1 O'9 mol/mg of protein and the other of lower affinity of Kd 2-10 pM (Sangster, 1996 
& Sangster et al., 1991). The affinity of the first population of levamisole receptors remained 
the same in susceptible and resistant isolates, however the Kd and Bmax of the lower affinity 
receptors increased. This suggested that levamisole resistance in H. contortus resulted from 
increased levels of low affinity levamisole receptors. Interestingly, in C. elegans, mutations in 
the unc-50 gene, which does not encode a receptor subunit causes a decrease in levamisole 
binding. It has been suggested that this protein plays a role in receptor gene transcription or 
receptor assembly (Lewis et al., 1987).
Comparison of a levamisole receptor subunit denoted Hca1 from levamisole-susceptible and 
-resistant H. contortus revealed levels of 98.5-100% homology at the amino acid level upon 
examination of 4-5 individual clones taken from each of the two populations (Hoekstra et al., 
1997). From these results it was concluded that any polymorphisms that were detected in 
the clones were not consistent and were thus not associated with levamisole resistance.
1.5.3 Avermectin
The mechanism for resistance towards avermectins is still unknown. The most common
resistance developed in C. elegans isolates allows worms to survive exposure to low levels of
drug (Novak & Vanek, 1992). Comparison of resistant and susceptible populations revealed
a series of recessive mutations that map to more than 20 loci. Two genes, avr-1 and avr-5,
are allelic to the previously known loci che-3 and osm-3 respectively, each displaying
phenotypes defective in dye-filling (Perkins et al., 1986 & Stravich et al., 1995). This term
reflects the ability of chemosensory receptors, known as the amphids and phasmids, to take
up a dye. The ability to visualise pores on the surface of the nematode by filling with dye has
been utilised as a marker to identify nematodes that possess amphids and phasmids with
those that don’t thus facilitating the classification of different species. Wild-type C. elegans
have both amphids and phasmids, however the che-3 and osm-3 animals lack the ability to
take up dye though their chemosensory receptors. Cloning of the avr-1 gene identified a
cytoplasmic dynein protein, believed to play a role in the amphidial neuronal transport
process. It has been postulated that C. elegans takes up the drug via the amphids, allowing
it to reach its target (Blaxter & Bird, 1997). In contrast, avermectin resistant nematodes are
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thought to prevent avermectin uptake as a result of defective proteins present at the 
amphids.
It is also possible that resistance has developed as a result of an alteration at the drug- 
receptor site. As already mentioned, avermectin binds irreversibly to glutamate-gated 
chloride channels in avermectin susceptible-worms (Arena et al., 1992). Resistance 
therefore may result from a mutation in the DNA coding for the receptor thus blocking 
avermectin binding. This would in effect prevent the irreversible opening of the channel to 
chloride ions. Studies using ivermectin-susceptible and -resistant isolates of H. contortus L3 
larvae reveal high affinity ivermectin binding sites with a K<j of 0.13 nM and a Bmax of 0.4 
pmol/mg for both isolates (Rohrer et al., 1994). In this particular case, both isolates possess 
the same avermectin binding properties, suggesting that a modification at the target site is 
not involved in the development of resistance. There is some debate as to whether these 
results represent a true model for resistance, as nematodes were laboratory derived rather 
than field isolates.
Contrasting with the latter findings the avr-15 gene was found to confer ivermectin sensitivity 
on C. elegans. Dent and co-workers (1997) discovered that this gene encoded two 
alternatively spliced channel subunits, GluCla2-A and -B , both of which being components of 
the glutamate gated chloride channel. Comparison of the two spliced products, from 
avermectin-susceptible and -resistant worm pools, revealed a guanine to alanine transition at 
the third position of the W271 codon of GluCla2A, thus creating an opal stop codon. A 
Northern blot confirmed that levels of both transcripts were reduced for both GluCla2-A and - 
B at least two fold and four fold respectively. This was accounted for by the ability of 
C.elegans to degrade mRNAs containing nonsense mutations such as the opal stop codon in 
resistant worms at position 271.
1.6 Nematode anatomy
The majority of anthemintics used so far target the nematode’s nervous system. It is 
however also apparent that nematodes are becoming resistant to the majority of these drugs. 
This will inevitably cause a problem for farmers in the future. One approach to overcome this 
is to study the worm’s nervous system in hope of determining the underlying principles for the 
development of resistance. This approach may also yield novel targets for mechanism based 
screening programmes. Locomotion and feeding by nematodes is mediated by the nervous 
system. In this section the neural anatomy of C. elegans is described so that an 
understanding of how anthelmintics interact with specific neurones can be obtained. A 
similar connectivity network is seen in A. suum. This neuronal map is therefore believed to 
be a good model for other nematodes including H. contortus.
1.6.1 Locomotion
Nematodes achieve locomotion by alternate contraction and relaxation of dorsal and ventral
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muscles dictated by the nervous system. This gives rise to a sinusoidal wave propagation 
along the length of their bodies (Wharton, 1986). Forward motion is achieved by waves of 
contraction initiated at the anterior of the worm passing down to the posterior. Likewise, 
backward movement is accomplished by wave propagation in a posterior to anterior direction. 
A consequence of this specific movement is that the worm is forced to lie on its side. The 
efficiency with which nematodes move improves with the amount of friction they experience 
with their environment. The presence of longitudinal lateral ridges (alae) of cuticle spanning 
the length of their bodies helps increase the level of friction. The head region of the 
nematode has a greater degree of freedom moving in both a lateral and dorso-ventral 
direction. This is a direct result of innervating lateral muscles as well as dorsal and ventral 
muscles in the head, permitting the worm to detect environmental cues.
1.6.2 Nervous system
The most characterised nematode nervous system is that of the free-living worm, 
Caenorhabditis elegans, reconstructed from electron micrographs of 50 nm thick serial 
sections (White et al., 1986). The hermaphrodite nervous system is composed of 302 
neurones, of which at least 12 are sexually specialised involving egg laying. In contrast, 
males have 381 neurones, 87 of which are sexual, most of which are present in the tail 
innervating the copulatory bursa. The following descriptions have been summarised from the 
work of White et al. (1986) unless otherwise stated.
1.6.2.1 Sensory cells
Nematodes monitor environmental cues using a combination of sensory organs or sensilla 
receptive to chemicals, pressure, touch and temperature. Each sensillium is composed of a 
socket cell, a glial-like cell known as a sheath cell and one or more nerve endings. Papillae, 
receptive to chemical stimuli, have an internal channel, which is formed by the sheath and 
socket cells, and opens up through the cuticle to the outside. Nerve endings reach out onto 
the surface of the channel allowing exposure to the external environment. Mechanosensory 
organs are different in that they do not have a channel that opens up to the exterior. Rather, 
their nerve endings penetrate the sheath cell instead of being exposed on the cuticular lining.
Specialised sensilla are abundant in the head of the nematode and are most concentrated
around the mouth or buccal cavity. At the entrance of the buccal cavity there are 6 cephalic
lips, a finger-like projection or bristle stems from each of these forming a circle of inner labial
papillae. Surrounding the inner circle is an outer circle of a further 6 papillae and exterior to
this, is a cephalic circlet of 4 papillae. The 6 inner labial sensilla are chemosensory organs,
whilst the outer circle of papillae and the cephalic circlet are mechanoreceptors. Each papilla
contains one or more nerve endings, which are supplied by sub-dorsal, lateral or sub-ventral
cords extending from the papillary ganglia. These ganglia link directly to the anterior side of
the nerve ring. Amphids are the main chemoreceptive organs in the nematode and are
located one in each lateral quadrant, in line with the cephalic circlet. A total of 8 sensory
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neurones have dendritic nerve endings that come into direct contact with the external 
environment via the open channel, and a further 4 are associated with the sheath cell. These 
neurones originate from nerve fibres that run down to laterally positioned amphid ganglia, 
found posterior to the nerve ring. Similar structures to the amphids are present in the tail and 
are called the phasmids. These differ in that they expose only 2 neuronal endings, as 
opposed to the amphids 8, to the external environment. Neuronal architecture of the sensory 
neurones is mapped out in figure 5a.













Figure 5a, Sensory neurones in the head. Labial and amphid process bundles are 
displayed running from the nerve ring to the labia and amphids respectively lining the buccal 
cavity of C. elegans . Adapted from White et al., 1986.
Other sensilla include the 2 pairs of lateral receptors called the deirids or cervical papillae. 
These mechanosensory sensilla, having no external access, are situated in the lateral 
quadrants of the nematode, one pair posterior to the excretory pore and the other in the 
posterior portion of the body approaching the tail. They are believed to be responsible for 
determining whether the worms can pass through restricted gaps.
1.6.2.2 Central Nervous System (Nerve Ring)
The central nervous system surrounds the midpoint, or isthmus, of the pharynx and consists 
of ganglionated nerve tissue linked together by a circumoesphangeal commissure termed the 
nerve ring. This ring sits at an oblique angle with the dorsal side raised at a more anterior 
site than the oppositely located ventral side.
1.6.2.3 Peripheral Nervous system
Nerve processes connected to the cephalic sensillia, run in longitudinal tracts down to the
front of the nerve ring where their cell bodies associate to form the anterior ganglion.
Posterior to the nerve ring, ganglia are split by the basement membrane into four groups: a
ventral ganglion, a small dorsal ganglion and two lateral ganglia. Nerve bundles connected
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to amphids, run adjacent to laterally positioned tracts, bypassing the nerve ring completely 
and assembling their cell bodies in lateral ganglia. Amphid associated neurones are bipolar, 
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Figure 5b, The peripheral nervous system. Both left- and right-hand sections of the C. 
elegans body are displayed. Note that no detail of the head is given. Adapted from White et 
al.. 1986._________________________________________________________________________
Ventral, dorsal and lateral nerve tracts project out of the respective ganglion and associate 
with longitudinal hypodermal ridges, extending posteriorly to the tail. The four tracts, shielded 
from the pseudocoelum by a layer of basal laminae, section the body symmetrically into 
quadrants. The ventral ganglion is separated into two groups by the presence of the 
excretory duct, cell bodies posterior to the duct overlap with the retrovesicular ganglion, but 
each ganglion remains an individual entity due to separation by the basal lamina. Nerve 
processes made up of interneurones and motor neurones, emerge from both ventral and 
retrovesicular ganglia forming a ventral cord (figure 5b). A single row of motor neurone cell 
bodies span the length of this cord before it terminates at the pre-anal ganglion in the tail. 
Seven main classes of motor neurones are present in the ventral cord of C. elegans denoted 
VAn, VBn and VDn innervating ventral muscle and DAn, DBn, ASn and DDn innervating 
dorsal muscle. These groups of motor neurone receive synaptic input from five types of 
interneurone denoted AVA, AVB, AVD, AVE and PVC. The cell bodies from the former 4 
classes are situated in the lateral ganglia whilst PVC interneurones have cell bodies located 
in the lumbar ganglia, in the tail. Processes from AVA, AVB and AVD span the whole length 
of the ventral cord whereas the AVE set of neurones terminates in the mid-body region. 
Innervation of VAn, DAn, VBn, ASn and DBn results in the release of the excitatory 
neurotransmitter acetylcholine at neuromuscular junctions thus causing contraction of muscle
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cells. Contraction of muscle groups in one quadrant coincides with the relaxation of the 
opposite quadrant. This is achieved by the release of GABA from VDn and DDn motor 
neurones, defined as VI and VD motor neurones in Ascaris, at neuromuscular junctions on to 
muscle (Johnson & Stretton, 1987).
The dorsal quadrant of C. elegans contains a dorsal ganglion and two small subdorsal 
ganglia. These are in close proximity to the nerve ring, and each comprises of two neuronal 
cell bodies. Dorsal cords extending from these ganglia contain no cell bodies but are 
predominantly made up of motor neurone axons that originate from the ventral cord. 
Connection of cords is achieved by motor neurones branching from the ventral cord to form 
commissures. These run around the circumference in contact with the hypodermis, to the 
dorsal cord (figure 5b).
Each lateral quadrant contains a lateral ganglion composed of cell bodies from interneurones, 
motor neurones and amphid associated sensory neurones. Processes from these neurones 
emanate from the ganglia forming lateral nerve cords, which terminate in the lumbar ganglia 
in the tail (figure 5b). As previously mentioned bipolar sensory neuronal processes branch 
away from each lateral cord, forming a commissure that connects to the ventral cord. Also 
spanning the lengths of the lateral cords are sensory neurones receptive to touch and are 
thus known as dendritic touch receptors.
1.6.2.4 Commissures
In whole mount preparations of the nematode, the hemizonid is identified as a biconcave, 
highly refractive band consisting of a tight bundle of axon processes. It is located in the 
vicinity of the excretory pore, its exact position depending on the species of nematode 
examined. In C. elegans it is located anterior to the pore whereas in L3 infective larvae of 
Haemonchus contortus it lies posterior to the pore (Rogers, 1968). This belt of nerve fibres 
extends from deirids in lateral fields, where present, around the circumference of the 
nematode to the ventral cord thus appearing semicircular in shape (figure 5c). Nerve 
endings from this structure are separated from the cuticle by a very narrow layer of 
hypodermal tissue. The cuticle directly above this structure appears to be modified in H. 
contortus having tightly packed annular striations in this area. It had originally been proposed 
that the hemizonid was a sensory receptor triggering the synthesis of neurosecretory 
granules. It had been hypothesised that these neurosecretions stimulated the production of 
enzymes present in the exsheathing fluid, thus initiating moulting (McLaren, 1976). A more 
recent report however has proposed that the hemizonid is more likely to be the amphid 
commissure (Bird & Bird, 1991). In 1986, White et al. identified a total of 44 nerve axons 
present in the C. elegans amphid commissure.
Directly neighbouring the amphid commissure is a sublateral commissure consisting of 10 
axons, which run adjacent to the hypodermis until they reach sublateral lines. They then turn
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to form longitudinal cords stretching down to the vulva. It is in this region that they merge 
with lateral cords (figure 5c). The deirid commissure is situated slightly further down stream 
from amphid and sublateral commissure and consists if 11 axon fibres (figure 5c). 
Commissures derived from motor neurones have cell bodies that are present in the ventral 
cord but have axons that branch out, crossing lateral lines and connecting to the dorsal nerve 
cord (figure 5c).
left hand right hand
Figure 5c, Commissures. This diagrams features the existing commissures mapped out in 
the C. elegans nervous system. Adapted from White et al., 1986.
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1.6.2.5 Neuromuscular organisation
Nematode somatic muscle cells are unusual in that they send out processes that form 
neuromuscular junctions with neurones in the nerve cord rather than neurones sending out 
processes that synapse on to muscles. Each somatic muscle cell has a longitudinal 
contractile region, known as the spindle, made of regularly arranged, thick myosin filaments 
and thin actin containing filaments aligned at an angle of 10° to the z-line (White et al., 1986). 
This obliquely striated organisation runs beneath the epidermis of the worm. Each spindle is 
connected to a non-contractile muscle cell body containing a nucleus, cytoplasmic organelles 
including high levels of mitochondria, and glycogen. This bulbous bag-like structure projects 






Figure 5d, The muscle cell structure and its neuromuscular junction.
the arm that emanates from the cell body to either dorsal or ventral nerve cords. The arm 
terminates in a structure called the syncytium which has a number of fine finger-like 
projections extending from its surface forming neuromuscular junctions on to a motor 
neurone axon (figure 5d).
The ventral, dorsal and lateral hypodermal ridges divide the body into four symmetric 
domains. C. elegans has a total of 95 somatic muscle cells, 24 cells lining each domain with 
the exception of the left ventral quadrant which contains 23 muscle cells. Cells from each 
quadrant are arranged in 2 parallel rows and are classified into three groups depending on 
the source of their synaptic input. An anterior group is located above the nerve ring 
containing 4 muscle cells per quadrant, a total of 16 cells, all sending arms that synapse on 
to the inside surface of the nerve ring. The next 16 cells, 4 in each quadrant are dually 
innervated by motor neurones present in the nerve ring and the ventral cord. Foraging 
movements made by the head results from the differential activation of muscle cells in 
adjacent quadrants as well as in adjacent rows creating lateral waves of muscle contraction
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as well as dorso-ventral waves. The remaining muscle cells connect to motor neurones, 
which originate from the ventral cord and span both dorsal and ventral midlines. Stimulation 
of these muscles provokes sinusoidal waves that propagate along the length of the body.
1.6.3 Pharynx
Nematodes ingest nutrients via the buccal cavity, from where the nutrients are propelled by 
the pharynx into the intestine. Omission of this pumping action induced by blocking 
pharyngeal muscle action causes starvation. The pharynx of C. elegans, reviewed by 
Albertson & Thomson (1975), is a self contained, tubular organ having its own musculature 
and nervous system, with the exception of two interneurones, originating from the worm’s 
central nervous system. These neurones, denoted RIP cells, are believed to mediate the 
overall control of pharyngeal pumping. The pharynx is separated from the rest of the 
nematode by a basement membrane and is composed of 34 muscle cells, 9 marginal cell, 9 
epithelial cells, 5 gland cells and 20 neurones. The organ has three compartments: the 
corpus, isthmus and the terminal bulb (figure 6a). The corpus is located most anterior and 
functions to filter food from the buccal cavity. This compartment is subdivided into the 
procorpus and the metacorpus. Neighbouring this is the isthmus, which delivers food to the 
terminal bulb, where grinding takes place. Two types of motions induced by the muscle cells 
propel food through the pharynx by creating a pumping action. The first is a near 
simultaneous contraction of the corpus, anterior isthmus and terminal bulb, followed 200ms 
later by relaxation of parts. The second motion induces peristalsis whereby the isthmus 
drives a posteriorly directed wave of contraction, thus sending food towards the terminal bulb 
(Raizen & Avery, 1994). The lumen of both the buccal cavity and the pharynx are lined with 
cuticle that is continuous with the external body cuticle. Eight muscle types, denoted pm1 to 
pm8, line the pharynx and are innervated by motor neurones, M1 to M5 (figure 6b).
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Figure 6a, Anatomy of the C. elegans pharynx. The three compartments 1) the corpus, 
which is split into procorpus and metacorpus chambers, 2) the isthmus and 3) the terminal 
bulb. These structures are composed of muscle cells as indicated. Key: i) pharyngeal muscle, 
pm1, ii) pm2, iii) pm3, iv) pm4, v) pm5, vi) pm6, vii) pm7 and viii) pm8. Adapted from
Albertson & Thomson, 1976.________________________________________________________
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Figure 6b, Organisation of the pharyngeal motor neurones. The pm cells are innervated 
by 5 different motor neurones, M1-M5. Positions of these motor neurones are displayed, i) 
motor neurone M1, ii) M2, iii) M3, iv) M4, and v) M5. Adapted from Albertson & Thomson, 
1976.____________________________________________________________________________
1.7 Nematode Fast Ion Channel Receptors, TGIC
This section details the superfamily of channels, localised to the nervous system, that are 
believed to be drug target sites. Knowledge of the function and mechanism by which drugs 
bind to these sites should help in the search for more effective drugs.
Sequence similarity between the polypeptide chains, coding nicotinic acetylcholine-, GABA-, 
glycine- and glutamate gated chloride-channels, forms a basis for classifying them as 
superfamily of transmitter-gated ion channels (TGICs). The following considers each of 
these channels and details on the known subunits that associate to form the receptor types. 
This includes the glutamate-gated chloride channels, denoted GluCIRs that are targeted by
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avermectin. Pharmacological properties of associated subunits are described as well as their 
localisation within the nematode’s nervous system.
Identification of neurones that express GABA receptors in C. elegans is discussed as well as 
phenotypic observations form worms that no longer express them. These findings highlight 
the importance of a fully functional class of receptors that enable locomotion characteristic of 
wild type nematodes. The most characterised members of the ligand-gated ion channel 
superfamily are the nicotinic acetylcholine receptors (nAChRs). Topology of these receptors 
is outlined since this has provided a model for related receptors such as the GluCIRs. 
Predicted binding sites for neurotransmitters such as GABA and glutamate are detailed along 
with possible sites for avermectin to bind to. These regions can be compared in subunits 
isolated from avermectin susceptible and resistant populations of nematodes including H. 
contortus. The current status of GluCIR subunits isolated from the parasitic nematode 
Haemonchus contortus is discussed along with aims to further categorise this drug target.
1.7.1 Glutamate-gated chloride channels
The inhibitory glutamate receptor (GluCIR) is a member of the ligand gated ion channel 
superfamily possessing a pharmalogical profile distict from glutamate gated cation channels, 
GABA and glycine gated channels (Cully et al., 1994). As yet, no evidence supports their 
presence in vertebrates however they seem to be a common feature of invertebrates and 
have been described as H-receptors due to the hyperpolarising response induced by 
glutamate (Cully et al., 1996a). The first report, identifying the existance of GluCIRs or H- 
receptors, was by Cull-Candy & Usherwood on Schistocerca gregaria (locust) leg muscle, the 
extensor tibiae, in 1973. This was followed by their detection in insects, crustaceans and 
molluscs.
Studies into the mechanism of action of the anthelmintic drug avermectin on nematodes have 
led to the recognition of GluCIRs as being their target (Arena et al., 1991, 1992). This 
discovery has encouraged much study into the inhibitory class of glutamate receptors. 
Initially poly (A)+ RNA from the free-living nematode C. elegans was injected into Xenopus 
laevis oocytes. Exposure of these ooctyes to the synthetic avermectin derivative, ivermectin 
4-O-phosphate (IVMP04), evoked inward membrane currents resulting from an influx of 
chloride into the cell having a dissociation constant Kd of 90 nM and a Hill coefficient of 1.1 
(Arena et al., 1991). Further work identified glutamate to be responsible for activating inward 
membrane currents, which were inhibited by the chloride channel blockers: picrotoxin and 
flufenamate. Co-application of avermectin with glutamate provided evidence of a glutamate 
receptor that was potentiated by avermectin shifting the glutamate dose response curve to 
the left, slowing receptor desensitisation (Arena et al., 1992). A reduction in the Hill 
coefficient from approximately 2 to 1.0 was recorded, implying that in the presence of 
avermectin only one molecule of glutamate needs to bind in order to open the channel (Arena 
etal., 1994).
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The two insect species, Drosophila melangastor and the locust Schistocerca americana are 
also believed to possess a similar target. D. melangastor heads and the metathoracic 
ganglia from locusts are enriched with high affinity avermectin binding sites. A photoaffinity 
probe of (125l)-arylazido-avermectin identified a 45 kDa protein from both sources of neuronal 
membranes (Rohrer et al., 1995).
1.7.1.1 GluCIR Subunits
To date, each of the GluCIR subunits sequenced are typical of ligand gated ion channels with 
topology based on that observed for the nicotinic acetylcholine receptor (Unwin, 1993). They 
have long N-terminal extracellular domains coding one or more N-linked glycosylation sites 
and two highly conserved cysteine residues that form the characteristic cys-loop. In addition 
to these residues, a further 2 cysteines are located between the cys-loop and the first 
transmembrane region (TM1) that are also characteristic of vertebrate glycine gated chloride 
channels. Following the N-domain are four transmembrane domains, denoted TM1 to TM4. 
TM3 and TM4 are connected by a long intracellular loop of variable length containing 
consensus sites for phosphorylation such as those recognised by protein kinase C (Cully et 
al., 1994).
The first two glutamate-gated chloride channel subunits to be isolated in nematodes were the 
GluCI-a and -p subunits from Caenorhabditis elegans (Cully et al., 1994). The two subunits 
were expressed as homomeric channels following injection into Xenopus oocytes. GluCI-p 
channels were reversibly responsive to glutamate at a 1mM concentration whereas GluCI-a 
channels responded irreversibly to 1 pM of ivermectin. Co-expression of a and p subunits, 
resulted in the formation of heteromeric channels, responding to glutamate at pM 
concentrations and potentiated by 5 nM IVMP04. Simultaneous expression of the two 
subunits resulted in a shift in the EC50 value for glutamate from 380+/-20 (for the homomeric 
p channels) to 1.360+/-50 pM (for heteromeric channels). The Hill coefficient for GluCI-a and 
-p channels was calculated as 1.7+/-0.1 suggesting that more than one glutamate molecule 
was necessary to gate the channels. The GluCIa sequence consisted of 1,383 bp coding for 
a 461 amino acid polypeptide, likewise GluClp was 1,302 bp in size coding a polypeptide of 
434 amino acids. Pharmacological properties differ in ooctyes injected with GluCI a  and p to 
those injected with poly (A)+ RNA indicating that additional subunits are required to form the 
wild type channel. Subsequent to these findings the GluCIa sequence has been mapped to 
chromosome V (Dent et al., 1997) and GluClp to chromosome I (Laughton et al., 1995).
Phylogenetic analysis has been aided by gene structure comparison (Vassilatis et al., 1997).
Several introns, specific to GluCIRs, are absent in other ligand-gated ion channels, giving
them a distinct evolutionary position. GluCIa and GluClp are thought to form a monophyletic
sub-branch in the TGIC superfamily being most related to the vertebrate glycine receptors.
In light of a  and p sequence properties it has been suggested that these subunits may even
represent genes orthologous to vertebrate glycine receptors. GluCIRs share the feature of 2
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conserved cys-cys pairs with the glycine receptors compared to GABA receptors, which only 
possess one of these pairs. A tyrosine residue at position 182 of GluClp is conserved in both 
GABA and GluCI receptors. Glycine channels however, incorporate a phenylalanine at this 
site. Mutation of this residue alone was sufficient to change a glycine receptor into a GABA 
receptor (Schmieden et al., 1993). This finding suggests that the tyrosine residue is 
responsible for the absence of glycine sensitivity among GluCIRs and supports the possibility 
of these receptors being the othologues of the vertebrate glycine receptors.
Two further glutamate-gated chloride channel a subunits have been isolated from C. elegans, 
as a result the GluCIa subunit isolated by Cully et al. (1994) will therefore now be described 
as GluClal. The two novel subunits are products from the differentially spliced GluCla2 
gene, which was found to map to the same position as the avr-15 gene on chromosome I 
(Dent et al., 1997). Worms possessing mutant avr genes confer resistance to avermectin. 
The two resulting alternatively spliced sequences differ only at the 5’ extremity of the N- 
terminal extracellular domain with one variant coding 23 unshared amino acids (GluCla2A) 
and the second variant having an extra 202 amino acid chain (GluCla2B). Each stretch of 
amino acids is then followed by shared exons encoding a putative ligand binding domain and 
transmembrane spanning regions. Mature GluCla2A of 459 amino acids was 85 % identical 
to GluClal at the amino acid level followed by having a 45 % amino acid identity with GluClp. 
The mRNA levels of GluCla2A (1.7 kbp) was twice that detected for GluCla2B (2.2 kbp). 
Expression of GluCla2A homomeric channels in Xenopus oocytes were activated by both 
ivermectin and glutamate.
A second set of alternatively spliced products, share the same 237 amino acid N-terminal 
extracellular sequence followed by different, though closely related, C-terminals (Laughton et 
al., 1997b). These were denoted GBR-2A and GBR-2B, whose mRNA was 2.15 kbp long 
(coding a polypeptide of 416 amino acids) and 1250 bp (coding a 430 amino acid sequence) 
respectively. These putative sequences were most closely related to the GluClal subunit 
sharing an amino acid identity of about 55 %. This percentage is believed to be too low to 
qualify GBR-2A and -2B as alpha subunits, it has therefore been suggested that they form a 
third class of inhibitory glutamate gated receptor subunits of y type.
Upon examination of the amino acid sequence for GBR-2A and -2B, variance occurs along 
the intracellular loop located between TM3 and TM4. Comparison reveals the presence of 
differing numbers of phosphorylation motifs with GBR-2A possessing 2 consensus sites for 
phosphorylation by protein kinase C contrasting with GBR-2B having 3 consensus sites for 
phosphorylation by protein kinase C, 2 for cAMP-dependent protein kinase and 2 for casein 
kinase 2. These differences infer that the two subunit-proteins are regulated by different 
mechanisms.
Additional partial sequences have been isolated from the filarial nematodes Onchocera
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volvul$us and Dirofilaria immitis and are both called GluCIX, sequence obtained for the 
former codes for 330 amino acid residues (accession number U59745) whilst the translated 
sequence for the latter codes 141 residues (accession number U59744). These two filarial 
clones are believed to be orthologues of GBR-2. It is however uncertain as to whether the 
filarial forms of GBR-2 are the products of alternative splicing. The predicted sequences, 
C27H5.5 and ZC317.7, have been identified by the C. elegans genome sequencing project 
and are also predicted to be members of this family of inhibitory receptors.
Another GluCIR subunit, denoted Dros GluCI-a (accession number U58776), has been 
isolated from Drosophila melangastor, by probing a cDNA library (Cully et al., 1996b). This 
456 amino acid protein was coded by a 3958 bp mRNA transcript and shares a 48 % amino 
acid identity with the C. elegans GluCI-a subunit. Responses were measured to gating by 
glutamate (EC50 of 23 pM, Hill coefficient of 2.0) and irreversible gating by avermectin when 
expressed as homomeric channels in Xenopus oocytes. Despite avermectins ability to bind 
to the channel it is unable to induce any potentiation.
1.7.1.2 Localisation of subunits in nematodes
To date only two receptor subunits have localised to specific cells in the nematode C. 
elegans. These are GluClp (Laughton et al., 1997a) and GluCla2A (Dent et al., 1997) whose 
spatial expression was deciphered by using reporter gene constructs. Laughton et al. 
(1997a) designed a construct that encoded the GluClp gene promoter along with the first 24 
amino acid residues of the receptor subunit followed by the lac-Z reporter (Fire et al., 1990). 
Stable lines of transformed C. elegans were assayed for p-galactosidase activity, resulting 
from the formation of the translational fusion. Expression of GluClp was observed in the pm4 
muscles situated in the metacorpus of the pharynx at all stages of development. Additional 
activity was also seen in the larval stages L1 to L3 towards the terminal bulb of the pharynx.
Dent et al. (1997) localised the receptor subunit GluCla2A by fusing the first three exons of 
the gene for green fluorescent protein, GFP (Chalfie et al, 1994). Stable lines of transformed 
C. elegans exhibited fluorescence in pm4 cells of the metacorpus as well as the isthmus pm5 
muscle cells. A few neurones found in the head of the nematode were also found to express 
the GluCla2A-GFP fusion.
Both pm4 and pm5 pharyngeal muscle cells are innervated by the M3 neurone (Albertson & 
Thomson, 1975). The presence of post-synaptic GluCIRs on muscle cells stimulated by the 
M3 neurone suggests that the neurone releases the neurotransmitter glutamate at the 
synapses. C. elegans pharyngeal preparations were utilised in a series of patch clamp 
experiments to monitor single channel currents produced as ion channels open and close (Li 
et al., 1997). Biologically non-active neurotransmitters were synthesised possessing a N-(a- 
carboxy-2-nitrobenzyl) group, transforming then into photolabile or caged compounds. A 
pulse of ultra violet light was used to convert these compounds into active neurotransmitter.
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This could be achieved at a localised area of the dissected pharynx within microseconds. 
Electropharyngeograms (EPGs) were recorded to establish the current transients associated 
with muscle contraction and relaxation. In between these two phases a small number of 
negative spikes, referred to as inhibitory post-synaptic potentials (IPSPs), can be detected. 
Removal of the two M3 neurones from the pharynx led to an absence of IPSPs resulting in a 
longer time interval between contraction and relaxation of muscle implying that M3 neurones 
are required to induce relaxation. Application of caged glutamate on pharynxes that have 
had their M3 neurones removed by laser ablation, followed by localised photolysis at the pm4 
muscles of the metacorpus, generated the renewal of IPSPs. The pm5 muscles of the 
isthmus were also able to respond to a lesser extent to glutamate.
Avermectin receptors have been detected along Ascaris suum nerve cords preventing 
hyperpolarisation of somatic muscles from direct stimulation of the VI neurones, 
corresponding to VD and DD motor neurones in C.elegans (Kass et al., 1980). Transmission 
between interneurones and motor neurones along the nerve cord was blocked by avermectin 
suggesting that GIUCIRs were present along this region, although to date no spatial 
expression has been published.
1.7.2 GABA receptors
1.7.2.1 Nematode subunits
A second set of inhibitory ion channel receptor is the GABA receptor. To date, only one gene 
in C. elegans, UNC-49, is known to encode a component of the GABA-gated chloride 
channel (Maclntire et al., 1993a): moreover this gene has the potential to encode several 
proteins via splicing mechanisms that are members of this family of receptors (Bamber et al., 
1997). An excitatory GABAergic receptor may be present on the surface of enteric muscles. 
It is thought to play a role in the defecation cycle in C. elegans, consequently a gene has 
been identified denoted exp-1 that may encode a component required in the regulation of this 
excitatory transmission (Avery & Thomas, 1997).
In Haemonchus contortus, isolation of a putative inhibitory amino acid receptor subunit 
having a 32 % homology to the rat GABAa receptor a-subunit was reported (Laughton et al., 
1994). Expression of homomeric channels in Xenopus oocytes gave no response to 1 mM 
GABA or acetylcholine, however application of 1 mM glycine invoked a small depolarisation 
in 5 out of 20 oocytes tested. To date, evidence of an inhibitory glycine receptor in 
nematodes does not exist therefore the recorded measurements may reflect an artefact 
resulting from the use of one subunit type in a multimeric channel.
1.7.2.2 Localisation in Nematodes
The locations of 26 neurones out of a total of 302, present in the C. elegans adult 
hermaphrodite, were identified using an antiserum raised against GABA. These GABAergic 
neurones comprised of 6 DD motor neurones, 13 VD, 4 RME, 1 DVB and 1 AVL as well as
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one RIS interneurone (Mclntire et al., 1993b). The function of these cells was determined by 
selective laser beam microsurgery on each of the 26 neurones as well as characterising 
mutants that were defective in GABA expression. The sole use of these techniques however, 
was unable to determine the function of the RIS neurone, which was located in the nerve 
ring. Ablation of this neurone had no effect, with the resultant nematode possessing a wild- 
type phenotype. In accordance to C. elegans immunolocalisation, Ascaris suum GABA 
immunoreactivity appeared to be most concentrated at corresponding VD and DD motor 
neurones (Johnson & Stretton, 1987).
The GABAergic VD and DD motor neurones innervate body muscles required for the 
sinusoidal mode of locomotion. Innervation results in a wave of alternating contraction and 
relaxation on opposing ventral and dorsal muscles. An example of their action is when the 
excitatory motor neurones VA and VB release acetylcholine causing the ventral muscles to 
contract. These neurones simultaneously stimulate DD motor neurones, which respond by 
releasing GABA on to reciprocal dorsal muscle causing relaxation. Ablation of DD and VD 
motor neurones result in instant contraction of the dorsal and ventral body wall muscles due 
to the excitatory transmission becoming the sole form of muscle innervation (Mclntire et al., 
1993b). The resulting “shrinker” phenotype observed in VD and DD ablated worms, is that 
the body shrinks in response to touch.
The four RME motor neurones control the extent of movement produced by the head 
necessary for foraging (Mclntire et al., 1993b). These innervate muscles in the head 
providing it with the ability to move rapidly from side to side within a restricted arc. This 
movement is grossly exaggerated when the RME cells are ablated; individuals following this 
treatment are described as having a loopy phenotype. GABA released by the RME cells is 
believed to limit the extent of head deflection during foraging.
The AVL and DVB motor neurones stimulate the enteric muscle required for defecation. 
These GABAergic cells are unusual in that they are excitatory, causing contraction of the 
intestinal, sphincter and anal repressors during the act of defecation. Ablation of these two 
neurones decreases the frequency of enteric muscle contraction (Mclntire et al., 1993b).
Mutations detected in five genes, unc-25, unc-30, unc-46, unc-47 and unc-49, have been 
divided into three classes, depending at which stage GABA transmission is affected (Mclntire 
et al., 1993a). Three of the five genes, unc-25, unc-46 and unc-47 have defective 
presynaptic function. The unc-25 mutant lacks the ability to synthesis GABA, as the gene 
encodes the enzyme glutamic acid decarboxylase or GAD, thus preventing production of 
GABA from glutamic acid. The observed phenotype of unc-25 mutants is similar to that 
produced by ablation of all the GABAergic neurones, with shrinkage of loopy worms that are 
unable to defecate. Similarly, unc-47 and unc-46 mutants prevent the normal release of 
GABA into the synaptic cleft. These mutants displayed the same phenotype as unc-25
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mutants although defects observed in unc-46 were weaker. The unc-47 mutant appeared to 
accumulate elevated amounts of GABA immunoreactivity suggesting that it coded for a 
GABA vesicular transporter. In both mutants, GABA functions do not differ to those found in 
wild type, therefore these genes may define components believed to contribute to packaging 
of GABA into synaptic vesicles, transport or fusion to the synaptic membrane.
The phenotype of unc-30 mutants is that of a “shrinker”, unlike the mutants that affect 
presynaptic function these do not have “loopy” or defecation defective phenotypes. This 
suggests that the presence of UNC-30 promotes the differentiation of type-D GABAergic 
neurones, VD and DD.
The unc-49 gene is required for post-synaptic function coding for an inhibitory GABAA-like 
receptor subunit. These mutants are both “loopy” and “shrinkers” but do not cause defective 
defecation, indicating its absence in AVL and DVB neurones.
Skinner (1997) localised the HG1 receptor subunit in both H. contortus and A. suum. An 
antiserum was raised to a synthetic peptide, the sequence of which corresponded to a site in 
the extracellular N-terminal domain of the protein. HG1 was found expressed on the 
postsynaptic membrane of neuromuscular junctions in both species. This result implies the 
presence of an HG1-like subunit in the parasitic nematode Ascaris suum. Additional staining 
was observed in H. contortus, specific to a number of cephalic neurones. A cell 
corresponding to the C. elegans sensory neurone AQR and two to four neurones similar to 
the Rl and RM neurones all appear to express HG1.
1.7.3 The nicotinic Acetylcholine Receptor (nACR)
1.7.3.1 Topology
Advances into the three-dimensional structure of the nicotinic acetylcholine receptor isolated 
from the receptor rich electric tissue from the electric ray, Torpedo californica, has been 
accomplished. The receptor is heteropentameric in structure, composed of five subunit 
polypeptide chains. These include two a  subunits of 437 amino acid residues, a p subunit of 
469 residues, a 8 subunit of 501 residues and a y subunit of 489 residues (Noda et al., 1982 
& 1983a and Claudo et al., 1983). Once the cDNA sequences coding for these polypeptides 
was established it became evident that they each possessed a signal sequence at the N- 
terminal enabling translocation across the ER membrane, and passage through the secretory 
pathway. Further more, upon examination of their hydropathy plots it was noted that each 
subunit had four transmembrane spanning domains, denoted TM1 to TM4 (Noda et al, 
1983b).
Preceding the first transmembrane domain was a large hydrophilic extracellular domain of 
210-224 amino acids carrying N-linked glycosylation sites. The purified receptor of 290kDa
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Figure 7, Topology of the nicotinic acetylcholine receptor





was found to consist of 20 kDa of carbohydrate obtained from N-linked glycosylation (Nomoto 
et al., 1986). Also, within this domain a pair of cysteines can be found that link together via a 
disulphide bond. These two residues are located at fixed positions with 15 separating them.
The following three hydrophobic membrane spanning domains, TM1 to TM3, of 20-30 amino 
acids link together with short hydrophilic loops. Following TM3 is a longer hydrophilic loop of 
109-142 residues, this connects to the fourth membrane-spanning domain. The loop 
encodes functional phosphorylation sites (Huganir & Greengard, 1987). Finally a short 
carboxy-terminal tail extends from TM4 and is exposed on the extracellular surface. Figure 7 
displays the described topology of the nAChR presenting a typical subunit with its orientation 
in the membrane and its relationship with other subunits in a pentameric receptor complex.
Comparison of TM domains between different subunits reveals that TM2 is the most 
conserved and TM4 is the least conserved and most hydrophobic. When the subunits are 
assembled into a pentamer, TM2 is the most central, facing the lumen of the ion channel 
surrounding the receptors central axis (Revah et al., 1990 ). In contrast, the TM4 domain of 
each of the subunits is exposed the most to the surrounding lipids of the membrane (Verall & 
Hall, 1992).
The receptor structure was established at 0.9 nm resolution using cryo-electron microscopy 
(Unwin, 1993). Each subunit in the complex appeared as elongated bodies of 12.5 nm, of 
which 6.0 nm extended out from the extracellular surface and 2.0 nm was left exposed on the 
cytoplasmic surface. It was calculated that 50 % of the subunit was distributed extracellularly 
and 33 % immersed within the membrane. A rough estimation of secondary and tertiary 
structure was ascertained at 0.9 nm resolution, with TM2 and TM4 believed to be a-helical 
and TM1 and TM3 most likely to be p-strands (Ortells & Lunt, 1994). Three a-helical rods 
from each subunit could be seen using electron microscopy (Unwin, 1993). Approximately 
3.0 nm above the membrane bilayer and are believed to form cavities. Those produced by 
the a-subunit are the most pronounced of all subunits and are thus thought to represent the 
main constituent of the ligand-binding site. Further examination indicates that ligand binding 
sites are at the interfaces between a/y and a/8 (Sine, 1993 & Kreienkamp et al., 1995) as well 
as the pockets produced by the a-subunits.
As already mentioned TM2 is a-helical in nature and forms the wall lining of the pore. They 
do not form a straight path through the membrane but rather bend at a mid-point through the 
layer seen as a kink in the helix structure (Unwin, 1993). Each subunit codes a highly 
conserved leucine residue located at the level of the kink. The side chains of these residues 
project out into the pore creating a tight hydrophobic ring, acting as a barrier to hydrated ions. 
All five subunits arrange symmetrically around the central axis of the pore. A ring of 
negatively charged amino acids, such as glutamate, is found near the cytoplasmic surface of 
the pore lining. It is thought that this organisation repels negative ions surrounding the
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intracellular opening. Deeper into the pore, three hydrophobic rings exist, one of threonines, 
one of serines and one of leucines, the latter being responsible for the kink in the tertiary 
structure. A final ring of negatively charged residues can be found close to the extracellular 
surface where negative ions are repelled (Revah et al, 1990).
In the absence of the ligand the receptor is in a closed confirmation with the leucine kinks 
pointing inwards. When ligand binds to the receptor a change in the configuration of the TM2 
helices is observed altering the orientation of the kinks. In an open channel the leucine side 
chains have rotated over to the side drawing away from the central axis, permitting an influx 
of Na+ and Ca+ ions into the cell (Unwin, 1995).
1.7.3.2 Nematode Subunits
More than 20 nAChR subunits are present in C. elegans, including the a subunit coded by 
the gene unc-38, and the non-a subunits coded by unc-29 and lev-1 genes (Fleming et al., 
1997). Each is believed to be a component of the levamisole sensitive receptor found on 
body wall muscle. The eat-18 gene encodes a third subunit, specific to the pharynx (Raizen 
et al., 1995). To date, only one nAChR subunit has been identified in Haemonchus contortus 
and is denoted Hca1 (Hoekstra et al., 1997). This subunit has a 72 % amino acid identity 
with its counterpart in Onchocerca volvulus (Ajuh & Egwang, 1994).
1.7.3.3 Localisation in Nematodes
The localisation of C. elegans nAChRs have been determined by the production of antibodies 
against a choline acetyltransferase coded by the cha-1 and a vesicular acetylcholine 
transporter molecule coded by the unc-17 gene (Alfonso et al., 1993 & 1994). The former 
enzyme is required to break down the released transmitter in the synaptic cleft or at the 
neuromuscular junction and the latter is responsible for the recycling of released transmitter 
from the cleft, back into the neurone. The presence of these two components would 
therefore suggest that acetylcholine receptors are in the vicinity. Immunolocalisation of cha-1 
and unc-17 expressed proteins indicate that acetylcholine is released by the motor neurones 
VA, VB, VC, DA, DB and AS and three pharyngeal motor neurones M1, M2 and M5. 
Receptors are also present on the sublateral motor neurones SAA, SAB, SIA, SIB, SMB and 
SMD (Rand & Nonet, 1997).
1.7.4 Predicted Ligand Binding Sites
As already described: subunits of the ligand gated ion channel superfamily share related 
sequence homologies possessing the same predicted topological features. Subunits related 
to this superfamily each have a highly conserved TM2 region and a cys loop. A considerable 
amount of research has been covered to establish the amino acid residues coded by GABAa 
receptor subunits in vertebrates that are essential for agonist and modulator binding and has 
been reviewed by Smith and Olsen (1995). The GABA binding site is not just restricted to a
39
i f e d d k d n g t :
A K R K LiqjgQ E M I  Q R p
L E S L A R L T S P I H I P I E Q P Q  'TSD1 S K fg L  A H L 
L A N N A K V N F R  iS K g jK  K v | d Q il 
N G E Y S M  <QsHQ E 0 E  N A L
egbr^c RG M A T W =
C e c b r2 t . K D RGM A T W P
M L l i
- G lu e : G A G K L F V
SK N P P A I: M T M  M
1 3 0
E R Y E E S G D T E V B P | | V V  
E R  Y E E S G D T E  v H p 8 | | v  
G V K G D G Q  . . . . @ D § V : I  
D D I Q C - - .................. L K Y L T
; F Y N
A T S E K A D Q S G  Q I  
A T S E N A D Q S Q  Q I
V ..................... G H g
T ..................... E A N R V
CegG uCla
E N L . T V P B V K K S L
C e a o r^a &E FE K «
I k  |  
BN  D 
FPU 
Y P D »
egGuC.
E?G H FDmGluCi
A E| HR? HM E
Q D V V 
G D V V  
T N T S 
E K F L  
K N Y T
C ecbr2£
e g b r2 b
CegGuCl
Dm GluC i
e G lu C l
V V K NjFU
MSeiHDP ST N A D
K DSF  S Y Y I  
□  SYjYIi
F s3 YS
F S Y Y I *  
F S Y Y L
Q lS Y iim
QLYlb
Q I iY  I  F  
Q I  Y l l ?  
QI» Y E lP
K DA.
T T I  Q R TA-
K V D
C e g b r2 a
C e g b r2 b
CegG uC la
Dm G luC i
C e G lu C Ib
C e g b r2 a
C e g b r2 b
CegG uC la
Dm G luC i
C e G lu C Ib
C e g b r2 a
C e g b r2 b
CegG uC la
D m G luC i
C e G lu C Ib
C e g b r2 a
C e g b r2 b
C egG uC la
Dm G luC i
C e G lu C Ib
C e g b r2 a
C e g b r2 b
CegG uC la
Dm G luC i
C e G lu C Ib
[A AR 
IY GR
I  A N ...............................
[A  SR;S G S N K A N M H  
|Q DS,v  r q n d r s r e
3 9 0
D . M T Q ............................................ V S Q R I
E . F L R U E  K K K K T R I D D C V C P S D
Q G V E R K A R T  E R E K A E I  P L L Q N L .......................
e n m k k J r | d L E Q A S L D A A S D L L D T D S N A T  
A A R K A Q R | r  E K L  E M V D A
<10  <20
...........................R O M K Q I P  T . . . . £  G Y RP
...........................RP P L R H D L  . . . . S A Y RS
............................. H N D V P T K V F N Q E E K V R T
F A M K P L V R H P G D P p A  L E K R L Q C E V H
................................................T e v y q p p c t c h t
TM4
< 3 0  < < 0  < 5 0
L S A S Q G i S S F C C R I . . F V R R Y K E R  
V K . . . . R L P I I K R I S E I L S T N I D I  
V P L N R R Q M N S F L N L L E T K T E W N D I  
M Q A P K R P N C C K T W L S K F P J R Q C S R  
F E A .  . . R i E T F R D K V R R Y F T K P D Y L P
F V VA K I
s  r :f g |
S T jySJ
K Q S R D ...........................
Q Q N V L F .......................
F R E E E D E ...................
I M S A N A S T P E S L V
Figure 8. Amino acid alignment of nematode GluCI subunits. Comparison of C. elegans 
and D. melangastor subunits has been made with transmembrane domains marked TM1-4 
amino acids predicted to play a role in ligand binding are indicated with an *. Homology is 
also summarised with different shades of grey.
pocket developed by the tertiary structure of one subunit but rather, is formed at the 
interfaces between adjacent subunits. Sequence alignment between subunits clarified highly 
conserved amino acids which when mutated prevented ligand binding.
A number of residues were also common to GluCIRs and therefore have been predicted to 
play some role in ligand binding (Wolstenholme, 1997). In particular, the amino acid residues 
coded between position 209-212 (YAXT) and 256-259 (TGXY) seen in the alignment in figure 
8 correspond to residues 157-160 and 202-205 of the GABAa p2 subunit isolated in rat are 
required for agonist binding. Mutation of tyrosine-157 or -205 to phenylalanine, or threonine- 
160 or -202 to serine in the p subunit significantly lowered the binding affinities for both GABA 
agonist and antagonists (Amin & Weiss, 1993). As these site are conserved in GluCIRs they 
are not thought to be involved in discriminating between GABA and glutamate 
(Wolstenholme, 1997).
Other conserved residues between the GluCIR subunits are glutamine-200, and 
phenyalanine-103, the latter corresponding to the F64 in the rat GABAa a1 subunit binding to 
GABA. The amino acid at position 223 of the C. elegans GluClp varies between subunit 
types, the a-subunits coding a tyrosine and the p subunit a histidine. Interestingly, 
DrosGluCIa codes a tryptophan at this position. Expression of GluCIa homomeric channels 
in Xenopus oocytes is non-responsive to glutamate, however a point mutation of threonine- 
306 to proline in the TM2 domain creates a glutamate sensitive channel with an EC50 for 
glutamate of 1.4mM (Etter et al., 1996). This suggests that the GluCIa subunit has glutamate 
binding sites, which are unable to couple binding to channel gating.
1.7.5 Inhibitory TGIC subunits isolated from H. contortus
Amplification of inhibitory TGIC subunits from Haemonchus contortus was attempted by use 
of the Polymerase Chain Reaction (PCR). Degenerate primers were designed to conserved 
sequence present within the extracellular and first transmembrane spanning domain of 
GABAa and glycine receptor subunits (Laughton, 1993). Identification of 5 heterogeneous 
products of approximately 0.45 kbp was achieved in this manner using cDNA from H. 
contortus as template. Each of these partial sequences was related to inhibitory TGIC 
subunits. Partial sequences were denoted HG1 to HG5, the abbreviation for HG1 being 
Haemonchus GABA/Glycine receptor subunit 1. A PCR related method known as RACE 
(Rapid Amplification of cDNA Ends), devised by Frohman et al. in 1988, was utilised to 
isolate full-length sequences.
The first full-length copy of an inhibitory subunit from H. contortus was HG1 which when 
expressed in Xenopus oocytes responds to glycine (Laughton et al., 1994). The absence of 
glycine receptors in helminths to date suggests that the homomeric expression of individual
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member of the GABAA-like receptors, sharing its highest amino acid identity with the C. 
elegans UNC-49 subunit. Expression of HG1 subunits occurs on several cephalic neurones 
that correspond to the C. elegans sensory cell AQR and Rl & RM neurones (Skinner, 1997). 
Localisation was also specific to post-synaptic membranes at neuromuscular junctions in 
both H. contortus and A. suum.
Other full-length copies to be amplified by RACE-PCR include HG2 and HG3, a pair of 
alternatively spliced products (Jaggannathen et al., in preparation). The high level of amino 
acid identity with GBR-2A and -2B, suggest that HG2 and HG3 may be parasitic orthologues, 
respectively, thus representing a third class of subunits of y-type coded by H. contortus 
(Skinner, 1997). Following on from these findings a partial sequence lacking part of the N- 
terminal domain has been isolated from Ascaris suum and appears to orthologous to the 
GBR-2B and HG3 subunit amino acid sequences (Jaggannathan, pers. comm.).
Table 1. Inhibitory TGIC subunits PCR derived from C. elegans and parasitic species.
Species Subunit name Available sequence References
C. elegans GluCip Full-length cDNA EMBL, U41525 Cully etal., 1994
GBR2a Full-length cDNA EMBL, U40573
Laughton etal., 1997
GBR2b Full-length cDNA EMBL, U41113
GluClal Full-length cDNA EMBL, U42524 Cully et al., 1994
GluCla2a (long) Full-length cDNA EMBL, AJ000538,
Dent et al., 1997
GluCla2b (short) Full-length cDNA EMBL, AJ000537.
H. contortus HG1 Full-length cDNA EMBL, X73584 Laughton etal., 1994
HG2 Full-length cDNA Laughton, 1993, &
Jagernnathan et al., un­
published resultHG3 Full-length cDNA
HG4 Partial sequence, 450 bp Laughton, 1993
HG5 Partial sequence, 450 bp Laughton, 1993.
Ascaris suum ASG2 Partial sequence, lacking~200bp of 5’ 
terminus.
Jagernnathan et al., un­
published result
Dirofilaria
immitis GluCIX Partial sequence 423bp, EMBL U59744
Cully et al, un-published 
results.
Onchocerca
volvulus GluCIX Partial sequence, 990 bp EMBL, U59745
Cully et al, un-published 
results.
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1.8 Aims of Study
Studies will be carried out on the nematode Haemonchus contortus to establish relevant drug 
targeting mechanisms within a parasitic species. HG4 and HG5 partial sequences share 
high amino acid identities with the glutamate-gated chloride channels. These receptors are 
targeted by the anthelmintic drug avermectin (Arena et al., 1992). The first aim of this work is 
to derive full-length sequences for both HG4 and HG5 subunits. This will make expression 
studies in Xenopus oocytes possible, whereby expression of homomeric and heteromeric 
receptors can be analysed, including co-expression with HG2 and HG3.
Sequences isolated from avermectin-susceptible and -resistant isolates of the species, will 
be compared. This will determine whether resistance had developed as a result of an 
alteration in the coding sequence, such as a change in the ligand-binding site.
Another aim is to map the expression pattern of HG4 in adult H. contortus thus clarifying 
where drug targets exist. This will be established by raising antiserum to a peptide designed 
to a site along the N-terminal extracellular domain, sharing a low homology with related 
receptor subunits.
This work should contribute to defining the target of avermectin and the mechanism of drug 
resistance in the agriculturally important worm H. contortus.
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2 Materials and Methods
2.1 General Materials
2.1.1 Molecular Biology Reagents
Molecular biology grade chemicals were purchased from BDH Chemicals (Poole, Dorset, 
UK), Sigma Chemical Company Ltd (Poole, Dorset, UK) or Fisons Scientific Equipment 
(Leicestershire, UK). Agarose was supplied by Biogene Ltd (Kimbolton, Cambridgshire, UK), 
ethidium bromide came from Sigma and radiochemicals from Amersham Life Sciences (Little 
Chalfort, Buckinghamshire, UK).
2.1.2 Enzymes
Restriction endonucleases, DNA polymerase 1 and Polynucleotide Kinase were supplied by 
NEB (Hitchin, Hertfordshire, UK), Calf intestinal alkaline phosphatase was purchased from 
Boehringer Mannheim UK (Diagnostics and Biochemicals) Limited, (East Sussex, UK) and 
T4 DNA ligase from Gibco BRL (Renfrewshire, Scotland).
2.1.3 Miscellaneous
X DNA was purchased from NBL gene Sciences Ltd. (Cramlington, Northumberland, UK) and 
dNTPs from Pharmacia, Biotech UK (St Albans, Hertfordshire, UK). TEMED was supplied by 
Anachem Ltd. (Luton, Bedfordshire, UK) and Ammonium persulphate from Gibco BRL 
(Renfrewshire, Scotland).
2.1.4 Vectors 
Table 2, List of vectors.
Plasmids Genotype and Size Supplier
pBluescript® II SK (+) Ampr, 2961 bp
Stratagene Ltd. 
(Cambridge, UK)
pALTER®-1 Amps, Tetr, 5680 bp
Promega UK Ltd. 
(Southampton, UK)




See Appendix 1 for vector maps
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2.1.5 Buffer solutions
Table 3, Buffer compositions.
Buffer Composition
TE 10 mM Tris-HCI, 1 mM EDTA, pH 7.6
10X TBE 0.89 M Tris-HCI, 0.89 M Boric Acid, 20 mM EDTA, pH 8.0
10X TTE 1.78 M Tris base, 0.57M Taurine, 10 mM Na EDTA
Phenol/Chlorofor
m
50 % (v/v) Phenol equilibrated with 10 mM Tris-HCI pH7.6, 49% (v/v) 
chloroform, 1% (v/v) Isoamyl Alcohol
PBS 137 mM NaCI, 2.7 mM KCI, 4.3 mM Na2HP04.7H20 , 1.4 mM KH2P 04, 
pH 7.3
2.1.6 Microbiological reagents
Media reagents were supplied by Difco Laboratories (East Molesey, Surrey, UK) and Sigma 
(Poole, Dorset, UK), whilst Petri dishes came from Bibby Sterilin Ltd (Stone, Staffordshire, 
UK). Glycerol was purchased from BDH and both IPTG and X-Gal were supplied by Alexis 
Corporation (Bingham, Nottingham, UK). Ampicillin, tetracycline and dimethylformamide 
were ordered from Sigma.
2.1.7 Bacterial Media 
Table 4, Media Composition
Media Composition (in g/L)
Luria Bertani (LB) 
Broth
10 g bacto-tryptone, 5 g yeast extract, 10 g NaCI
LB agar LB broth, 15 g agar
DYT Broth 16 g bacto-tryptone, 10 g yeast extract, 5 g NaCI
SOC medium 20 g bacto-tryptone, 5 g yeast extract, 10 ml 1 M NaCI, 2.5 ml 1 
M KCI, 10 ml 2M Mg2+ Stock (1 M MgCI2.6H20 , 1M 
MgS04.7H20 , sterile filtered), 10 ml 2M glucose (sterile filtered)
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2.1.8 E. coli Strains
Table 5, List of E. coli strains.
Strain Genotype Supplier
XL1 - Blue
supE44, hsdR17, recA1, endA1, gyrA46, thi, relA1 






supE44, hsdR17, recA1, endA1, gyrA96, thi-1, relA1 
lac [F’proAB lacqZAM15 Tn 10 (Tetr) Amy Camrf
Stratagene Ltd
JM109
endA1, recA1, gyrA96, thi, hsdR17 (rK', m«+) relA1, 






thi, supE, A(lac-proAB), [mufS::Tn10] [F\ proAB, 
/aglqZAM15]
Promega
3 chloramphenicol resistant at concentrations less than 40 pg/ml 
Genotype definitions are detailed in Appendix 2.
2.2 Production of cDNA from Haemonchus contortus
2.2.1 H. contortus tissue
Adult H. contortus was kindly supplied by Dr Ed Munn (Babraham Institute, Cambridge, UK), 
eggs were provided by Dr. Ian Harrow (Pfizer Research, Sandwich,Kent, UK) and both eggs 
and adults of susceptible and resistant isolates, the latter being a White River isolate from 
South Africa (See Appendix 4 for further details), were generously donated by Dr Gerald 
Coles (School of Veterinary Medicine, Bristol, UK).
2.2.2 Isolation and purification of H.contortus eggs
Method 1
Sheep faeces infected with H. contortus eggs were collected in nappies. Faeces were stored 
at 4° C overnight and than mashed up by hand. Using a high-pressure water jet, the slurry 
was washed through a series of sieves of decreasing pore diameter (150 pm, 53 pm, 48 pm). 
The resulting sediment was filtered through a 38 pm sieve, the pore diameter being smaller 
than the size of the eggs, thereby concentrating the eggs on the top surface of the sieve. 
Eggs were then purified from remaining plant material by flotation. This was achieved by 
transferring the eggs to a 5-litre beaker containing a saturated salt solution filled up to the
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brim. The resulting solution was stirred thoroughly and left for 10 min, enabling the eggs to 
rise up to the surface. These were then recovered by aspirating the top inch of the solution. 
The retrieved eggs were transferred to a 25 pm sieve and washed with tap water to remove 
the salt. The eggs were then transferred into 1 ml NUNC (GibcoBRL) cryovials and snap 
frozen for storage in liquid nitrogen.
Method 2
A handful of sheep dung infected with Haemonchus contortus was transferred to a food 
processor with an equal volume of water and homogenised by two 10 sec pulses. The 
mixture was sieved through a 158 pm pore sized sieve removing the majority of the debris 
and allowing the eggs to pass through for collection into a jug. 50 ml volumes were spun 
down in Falcon tubes at 1500 rpm for 2 min. The supernatant was extracted and another 50 
ml was added and spun down as before. This was repeated until the pellet reached just 
above the 5 ml mark on the side of the tube. Flotation involved resuspending the eggs in a 
saturated NaCI solution and covering the top of the Falcon tube with a coverslip. With the 
absence of air bubbles existing at the interface, tubes were spun at 1000 rpm for 2 min. As a 
result of the salt concentration gradient produced from the spin, the eggs were able to float 
up to the top and coat the coverslip. Purified eggs were rinsed off the coverslip with distilled 
H20  into a 17 ml Falcon tube and spun at 1500 rpm for 2 min. The supernatant was removed 
and the eggs were pipetted into NUNC cryovials and snap frozen for storage in liquid 
nitrogen.
2.2.3 Isolation of total RNA
Total RNA was isolated from frozen H. contortus eggs and adults using a single step, 
guanadinium thiocyanate-phenol-chloroform extraction technique (Chomczynski and Sacchi,
1987). Using a mortar and pestle, 1 g of nematode tissue was ground to a fine powder under 
liquid nitrogen. This was then added to 10 ml of denaturing solution (4 M guanadinium 
thiocyanate, 25 mM sodium citrate pH 7, 0.5 % sarcosyl, 0.1 M 2 -  mercaptoethanol) and 
homogenised using a glass-Teflon homogeniser. The solution was then poured into a 30 ml 
Corex tube and the following order of reagents were added, mixing after each addition: 1 ml 
of 2 M NaOAc, pH 4, 10 ml of water saturated phenol, and 2 ml of chloroform-isoamyl alcohol 
(49:1, v/v). The resulting mixture was shaken vigorously for 10 seconds and cooled on ice 
for 15 min followed by a 20 min spin at 10,000 g at 4 °C to separate the phases. RNA 
present in the aqueous phase was removed and added to 2-propanol followed by incubating 
at -20 °C for at least 2 h. RNA was sedimented at 10,000 g for 20 min at 4 °C and the pellet 
dissolved in 3 ml of denaturing solution. Addition of 3 ml of 2 - propanol precipitated the RNA 
at - 20° C for at least 1 h. Centrifuging at 10,000g for 20 min at 4 °C produced a pellet which 
was then resuspended in 75 % (v/v) DEPC treated ethanol, sedimented and vacuum dried. 
Finally 500 pi of RNase free 0.5 % (w/v) SDS was added to the total RNA and heated at 65 
°C for 10 min.
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2.2.4 Isolation of Poly-[A]+ RNA from total RNA
This method uses Dynabead Oligo dT25 (Dynal, Wirral, UK) magnetic beads. These beads 
are 2.8 nm in diameter and have a 25 nt chain of deoxythymidylate which are covalently 
attached to the bead via a 3’ linker group.
Dynabead Oligo dT beads were prepared first by placing a microcentrifuge tube containing 
0.2 ml (1 mg) bead suspension into a Dynal MPC E-1 magnetic separator. The supernatant 
was removed and the beads were washed by adding 200 pi of 2x binding buffer (20 mM Tris- 
HCI pH 7.5,1 M LiCI, 2 mM EDTA) and using the Dynal separator to remove the supernatant. 
Beads were then resuspended in 100 pi of 2x binding buffer. Total RNA (200 pg) was 
dissolved in 100 pi of DEPC-treated water and then heated for 2 min at 65 °C followed by 
addition to the washed beads. After a 5 min hybridisation at room temperature the tube was 
placed into the separator thus enabling the supernatant to be removed from the beads. 
Beads were washed twice with 200 pi of washing buffer (10 mM Tris-HCI pH 7.5, 0.15 M LiCI, 
1 mM EDTA) and then resuspended in 30 pi of elution buffer (2 mM EDTA pH 8.0) before 
being heated at 65° C for 2 min. Eluted poly-[A]+ RNA was extracted after separation from 
beads and used immediately for cDNA synthesis.
2.2.5 Synthesis of first strand cDNA
Poly-[A]+ RNA from H. contortus was reverse transcribed into cDNA using the Superscript 
enzyme from Gibco BRL.
To 30 pi of eluted poly-[A]+ RNA was added 10 pi of 5x Superscript buffer (0.25 M Tris-HCI 
pH 8.3, 0.375 M KCI, 15 mM MgCI2), 5 pi of 0.1 M DTT, 2.5 pi of 10 mM dNTPs, 2 pi RNasin 
(40 U), 1 pi Oligo (RoRi) dT primer (1 pg/ pi) and 1 pi of Superscript enzyme (200 U). This 
mixture was incubated at 37° C for 90 min. The reaction was stopped by addition of 1 pi of 
EDTA (0.5 M) and aliquots of cDNA were then stored at -20° C.
2.3 Oligonucleotide Production
2.3.1 Synthesis and Deprotection
The Applied Biosystems 381A DNA Synthesiser was used to synthesis oligonucleotides 
using chemicals supplied by Cruachem, Glasgow, UK. Once synthesised the primers 
needed to be deprotected. This was achieved by first freeing the beads from the column and 
soaking them in ammonium hydroxide overnight at 55° C. Glacial acetic acid (1 ml) was 
added on ice followed by 6 ml of absolute ethanol. After incubating for 30 min on ice the 
primer was precipitated at 10,000 rpm (4° C). The pellet was washed with 85 % ethanol, 
vacuum dried and then resuspended in sterile double distilled water. The absorbance at 260 




Oligonucleotides were purchased from Perkin Elmer’s Biosystems Division, Cheshire, UK 
using the ABI 3948 Nucleic Acid Synthesis and Purification System. Primers were received 
ready to use in 20 % (v/v) acetonitrile/water.
2.4 The Polymerase Chain reaction, PCR
2.4.1 Expand™ Long template PCR System
PCR amplification of receptor subunit cDNA was performed using oligonucleotides designed 
to complement conserved areas (i.e. SL1 and RoRi sequences) and regions specific to the 
known partial sequences. The Expand™ PCR system from Boehringer Mannheim UK Ltd 
(East Sussex, UK) uses a combination of the thermostable Taq DNA polymerase and Pwo 
DNA polymerase. The presence of the latter enzyme allows 3’-5’ exonuclease proof-reading 
to occur increasing the fidelity of DNA synthesis during the reaction. The long template PCR 
system is designed to give a high yield of PCR products from episomal DNA amplifying up 
fragments as long as 40 kbp from X DNA.
A typical reaction would contain 5 pi of 10x PCR buffer 1 (500 mM Tris-HCI pH 9.2 (25° C), 
160 mM (NH)2S 0 4, 17.5 mM MgCI2), 350 pM dNTP, 300 nM of both sense and antisense 
primers, 500 ng of cDNA template and sterile double distilled H20  to give a final volume of 50 
pi. Reactions were then overlaid with 50 pi of mineral oil to prevent evaporation of 
components during the PCR. Thermocycling conditions included an initial denaturing step of 
94° C for 2 min followed by addition of 2.5 U of Taq/Pwo mix. The cDNA template was then 
denatured for 30 sec at 94° C, primers were made to hybridise to the template at a previously 
calculated annealing temperature for 30 sec and then strands were elongated at 68° C for 2 
min, this cycle profile was repeated for 45 cycles. Finally a 7 min step at 68° C was included 
to make sure that the PCR fragments were fully elongated.
The exact parameters of the temperature cycling however depends on the primers used i.e. 
their length and GC content. Optimal amounts of specific product were obtained by altering 
the annealing temperature and performing Mg2+ titrations with a concentration range of 0.5 
mM to 4 mM.
2.4 2 Expand™ High Fidelity PCR System
The high fidelity system (supplied by Boehringer Mannheim UK Ltd, East Sussex, UK) uses 
the same DNA polymerases (Taq and Pwo) as the long template system but has been 
optimised to amplify up DNA fragments of up to 3 kbp having an error rate of 8.5 xIO-6 as 
opposed to 2.6 x10'5 with just Taq DNA polymerase (detailed in supplied protocol). A typical 
reaction would contain 10 pi of 10x Expand HF buffer 2 (supplied with the kit, containing 15 
mM MgCI2), 200 pM dNTP, 300 nM of both sense and antisense primers, 100 ng of cDNA 
template and finally sterile double distilled water giving a total volume of 100 pi. Mixes were 
then overlaid with 50 pi of mineral oil and placed in a thermocycler ready to perform PCR. A
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general cycle profile would commence with a denaturing step at 94° C for 2 min followed by a 
pause to add 2.6 U of Taq/Pwo enzyme mix. Initially 45 cycles were performed starting with 
a denaturing step for 30 sec at 94° C, followed by 30 sec at a calculated annealing 
temperature (AT), allowing hybridisation of primers to template and ending with an elongation 
step of 3 min at 72° C. The reaction was then stopped after a final elongation cycle of 72° C 
for 7 min.
2.4.3 Analysis by Agarose Gel Electrophoresis
A 1 % (w/v) agarose gel was made using 10 g of agarose and heating in 100 ml of 1x TBE 
buffer. Once dissolved, ethidium bromide (0.5 pg/ml) was added and poured into a gel cast. 
After the gel had set, DNA samples (containing 1/5th of the volume loading dye (15 % (v/v) 
ficoll, 0.25 % (w/v) bromo-phenol blue, 0.25 % (w/v) xylene cyanol)), and a standard 
(Lambda DNA digested with Pst1) were loaded into the wells and electrophoresed at 150 V 
for 1 h. Photographs of the gels were taken under uv light using a Polaroid camera with a 
yellow filter and Polaroid 667 black and white IS03000/36 film.
For RNase free gels the gel tank, cast and comb were treated with 1 % v/v hydrogen 
peroxide (Sigma) to remove RNases. Loading dye was also made up to volume using DEPC 
treated water instead of double distilled sterile water.
2.4.4 Purification of DNA bands from Agarose Gels
PCR products were cut out of 1 % (w/v) agarose gels using a razor blade and purified using 
the Sephaglas™ Band Prep kit, supplied by Pharmacia. The purification procedure involved 
melting 0.25 g of agarose at 60° C in the presence of 250 pi of modified Gel Solubilizer (a 
buffered solution containing Nal and 5 pi of 50 % glacial acetic acid) for 10 min, vortexing 
periodically. 5 pi of Sephaglas™ BP suspension was then added per pg of DNA present in 
the agarose slice and vortexed gently every minute over a 5 min incubation at room 
temperature. The Sephaglas/DNA mix was then spun down for 30 sec and was discarded. 
40 pi of Wash buffer (20 mM Tris-HCI pH 8.0, 1 mM EDTA, 0.1 mM NaCI and 18 ml absolute 
ethanol) was added to resuspend the pellet followed by a 30 sec pulse spin to enable 
removal of the supernatant. This washing procedure was repeated two more times. The 
pellet was left for at least 10 min to air dry followed by elution of he DNA by incubating at 
room temperature for 5 min in 10 pi (per pg of DNA) of Elution Buffer (10 mM Tris-HCI pH 8.0 
and 1 mM EDTA). The sample was spun for 1 min and the supernatant containing the DNA 
was then transferred to a sterile microfuge tube and the elution procedure was repeated with 
another equal volume of Elution Buffer.
2.4.5 QIAquick™ Preparation
The QIAquick™ system supplied by QIAGEN Ltd (Crawley, West Sussex, UK.) was designed 
for a quick clean up of DNA. To DNA sample, 5 volumes of Buffer PB (supplied with kit) was 
added, mixed and pipetted into a QIAquick spin column fixed onto a 2 ml collection tube. The
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DNA was bound to the column by spinning for 60 sec at 13,000 rpm. The flow-through was 
discarded and the column was washed with 0.75 ml of Buffer PE (supplied with kit) by 
spinning at 13,000 rpm for 60 sec. Flow-through was removed and the column was 
centrifuged for an additional 1 min at maximum speed to remove any residual ethanol present 
in the PE buffer. Elution of DNA was achieved by adding 30 pi of H20  to column and 
incubating for 1 min at room temperature over a microfuge tube followed by centrifuging at
13,000 rpm for 1 min.
2.5 Vector Preparation for Cloning of Inserts
2.5.1 Linearising vector for Cloning in Blunt Ended products
The vector pBluescript® SK II (4 pg/pl) was digested with the restriction enzyme EcoRV (4U), 
1/10 th of the final volume of 10x buffer B (100 mM Tris-HCI, 50 mM MgCI2, 1 M NaCI, 10 mM 
2-mercaptoethanol, pH 8.0) and sterile double distilled water giving a final volume of 50 pi. 
This was incubated at 37° C for at least 2 h. DNA extraction was performed by adding an 
equal volume of phenol/chloroform and then precipitating at -20° C for 15 min with 2 volumes 
of absolute ethanol. The pellet, produced by spinning at 13,000 rpm for 10 min at 4° C, was 
dissolved in 90 pi of 10 mM Tris-CI pH 8.0.
2.5.2 Dephosphorylation of vector
Calf intestinal phosphatase (CIP) removes 5’-phosphate groups from linear DNAs thereby 
preventing the vectors circularising without an insert. 10 pi of 10x CIP buffer (10 mM ZnCI2f 
10 mM MgCI2, 100 mM Tris-CI pH 8.3) and 2 pi of CIP (1/2 unit / pmol of 5’-terminal 
phosphate residues) was added to the purified EcoRV cut vector. After a 15 min incubation 
at 37° C another 2 pi of CIP was added and incubated at 55° C for 45 min. To terminate the 
reaction 1 pi of 500 mM EDTA pH 8.0 was added along with incubating at 75° C for 10 min. 
DNA was purified using an equal volume of phenol/chloroform and precipitated with 0.1 
volume of 3 M NaOAc pH 5.5 and 2x volume of absolute ethanol at -20° C. The pellet was 
washed with 70% (v/v) ethanol to remove salts and resuspended in TE pH 7.6 (10 mM Tris- 
CI pH 7.6 and 1 mM EDTA) giving a final concentration of 100 pg/ml.
2.5.3 Linearising Vector for Cloning in Sticky Ended Products
pBluescript® SK II (4 pg/pl) was digested in a total volume of 50 pi with 4 Units of both Not1 
and Xba1 restriction enzymes in the presence of BSA (100 pg/ml) and 5 pi of 10x NEBuffer 3 
(50 mM Tris H-CI, 10 mM MgCI2, 100 mM NaCI, 1mM DTT (pH 7.9 at 25° C)). This reaction 
was placed at 37° C overnight. Vector DNA was then purified by vortexing with 1 volume of 
phenol/chloroform followed by a spin in the microfuge. The aqueous top layer was then 
transferred to a fresh microfuge tube and DNA was precipitated with 0.1 volume of NaOAc 
(pH 7.0) and 2 volumes of ice cold absolute ethanol, incubating at -20° C for 2 h. The DNA 
was spun down producing a pellet which was washed with 70% v/v ethanol to remove salts
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and resuspended in TE pH 7.6 (10 mM Tris-CI pH 7.6 and 1 mM EDTA) giving a final 
concentration of approximately 100 pg/ml.
2.6 Cloning of PCR Products into a Plasmid
2.6.1 Products generated using primers without restriction sites
This method was used when the PCR primers did not introduce restriction sites into the 
amplified product. Amplification products (100 ng-1 pg) were mixed with a 0.1 volume of 10x 
One-Phor-AII buffer (100 mM Tris-acetate pH 7.5, 100 mM magnesium acetate and 500 mM 
potassium acetate), 0.4 mM ATP, 8U DNA Polymerase and 10U polynucleotide kinase. This 
was incubated at room temperature for 3 min during which time a stepwise degradation from 
free 3’ hydroxyl ends occurs. Four x dNTP’s (0.2 mM) were then added and incubated for 30 
min at 37° C, allowing strand extension in the 5’-3’ direction and enabling the phosphorylation 
of the 5’ end by polynucleotide kinase. Addition of 2 pi of 0.5 M EDTA at pH8.0 stopped the 
reaction. DNA was then purified from the reaction mix by adding an equal volume of 
phenol/chloroform and precipitated with 0.1 volume of 3M NaOAc pH 5.5 and 2.5 volume of 
absolute ethanol at -20° C. The pellet was washed with 70% (v/v) ethanol to remove salts 
and resuspended in sterile double distilled water.
2.6 2 Products produced from primers with restriction sites
Sephaglas purified PCR products were cut with 20 units of Nsi1 and Not1 in a double 
digestion. This reaction was carried out in a total of 50 pi in the presence of 100pg/ml of BSA 
and 5 pi of 10x NEBuffer 3 (50 mM Tris H-CI, 10 mM MgCI2, 100 mM NaCI, 1mM DTT (pH 
7.9 at 25° C)). A 50 pl double digest was also carried out on Sephaglas purified PCR 
products using 20 units of Xba1 and Nsi1 in the presence of 100pg/ml of BSA and 5 pl of 10x 
NEBuffer 2 (10 mM Tris H-CI, 10 mM MgCI2, 50 mM NaCI, 1 mM DTT (pH 7.9 at 25° C)). 
After incubating both double digests overnight at 37° C, DNA was purified using an equal 
volume of phenol/chloroform and precipitated with 0.1 volume of 3 M NaOAc pH 5.5 and 2x 
volume of absolute ethanol at -20° C. Finally 70% (v/v) ethanol was used to remove salts 
from the pellet and the DNA was resuspended in sterile double distilled water.
2.6.3 Ligation into vector
250 ng of vector was mixed with a 3 fold molar excess of amplified DNA purified from an 
agarose gel. To this 4 pl of 5x T4 DNA ligase buffer (250 mM Tris-CI pH 7.6, 50 mM MgCI2, 
25 % (w/v) PEG8000, 5 mM ATP, 5 mM DTT) and 5 units of T4 DNA ligase were added, 
giving a final volume of 20 pl. The resulting reaction was left to incubate at room temperature 
overnight. A 1:4 (v/v) dilution was made with H20  to dilute out the PEG and prevent it 
inhibiting transformation.
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2.6.4 Transforming plasmids into competent XL1 Blue Cells
5 ml of LB broth was inoculated with XL1 Blue E. coli cells and shaken overnight at 37 °C. A 
200 fj.l aliquot of this overnight culture was used to inoculate 40 ml of LB broth and shaken at 
37 °C until the culture reached an absorbency of 0.3 at 550 nm. Cells were centrifuged at
3,000 rpm for 10 min at 4 °C and the pellet resuspended in 20 ml of ice cold 100 mM CaCI2. 
Cells were incubated for 20 min on ice followed by a spin at 3,000 rpm for 5 min at 4 °C. The 
resulting pellet was resuspended in 4 ml of ice-cold 100 mM CaCI2 that was then aliquoted 
(300 pl) for use. Half of the ligated DNA was added to the 300 pl aliquot of competent cells 
and placed on ice for 40 min. Cells were heat shocked at 42° C for 1 1/2 min, immediately 
followed by 2 min on ice. To each sample of heat shocked cells 0.7 ml of LB broth was 
added and left to incubate for 1 h at 37° C. The resulting XL1 Blue suspensions were spread 
out onto LB /  ampicillin (100 pg/ml) plates coated with 50 pl of both 0.1 M IPTG and 2 % (w/v) 
X-Gal (dissolved in dimethylformamide). The vector pBluescript® II SK(+) contains the lac-Z 
selection marker encoding the enzyme p-galactosidase. Addition of the inducer, IPTG, and 
the substrate, X-Gal, to the surface of the agar distinguished successful transformation as 
white colonies.
2.7 Screening of Colonies
2.7.1 Small Scale Plasmid Preparation from E. coli
Single colonies of E. coli were used to inoculate 3 ml of LB broth containing ampicillin (100 
pg/ml) and shaken overnight at 37° C. Cells were pelleted and resuspended in 100 pl GTE 
(50 mM glucose, 25 mM Tris-HCI pH 8.0, 10 mM EDTA) followed by the addition of 200 pl of 
0.2 M NaOH containing 1 % (w/v) SDS. Samples were incubated on ice for 5 min and then 
150 pl of ice cold 3 M KOAc pH 4.8 was added and vortexed. DNA extraction was performed 
with an equal volume of phenol/chloroform and then precipitated with 2 volumes of ice cold 
absolute ethanol by keeping at -20° C for 10 min. The pellet produced by spinning at 
12,000g for 10 min at 4° C was washed with 70 % v/v of ethanol and spun as above prior to 
resuspending the pellet in 50 pl of TE pH 7.6 containing 10 pg/ml of RNase A.
2.7.2 Wizard™ Plus Minipreps DNA Purification System
E. coli colonies were inoculated into 3 ml of LB broth containing 100 pg/ml of ampicillin and 
shaken overnight at 37° C. Cells were harvested and DNA was extracted using the Promega 
Wizard™ Plus kit. This was done by first adding 200 pl of cell resuspension solution (50 mM 
Tris pH 7.6, 10 mM EDTA, 100 pg/ml RNaseA) to the harvested pellet of cells and then 
vortexing. Cells were lysed by using 200 pl of cell lysis solution (0.2 M NaOH, 1% w/v SDS) 
and inverting until the suspension went clear. 200 pl of neutralisation solution (1.32 M KOAc 
pH 4.8) was added and inverted causing coagulation. The resulting mix was spun down and 
the supernatant containing the plasmids was passed through a Wizard™ minicolumn via a 3 
ml syringe containing 1 ml of Wizard™ Minipreps DNA purification resin. Plasmids present in 
the column were washed by gently pushing through 2 ml of column wash solution (80 mM
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KOAc, 8.3 mM Tris-HCI pH 7.5, 40 pM EDTA and 55 % (v/v) ethanol) using a syringe 
followed by a 2 min spin to dry. Plasmids were eluted from the column by adding 50 pl of 
H20 , incubating for 1 min at room temperature and spinning down for 20 sec.
2.7.3 Restriction Digests
Digests were performed in a total volume of 20 pl, which included 0.1 volume of the 
appropriate 10x reaction buffer along with 1 Unit/pg DNA of the relevant restriction 
endonuclease and 5 pl of plasmid DNA. For some restriction digests the presence of BSA 
was required in which case 2 pl of a 1 mg/ml solution was added. When larger quantities of 
DNA needed to be restricted, volumes were increased but the ratios of components in the 
reaction were kept the same. Digests were mixed and incubated at 37° C for 1 h. 5 pl of 
loading dye was then pipetted into each sample and loaded onto a 1 % (v/v) agarose gel.
2.7.4 Glycerol Stocks
Glycerol stocks were made by mixing 150 pl of glycerol with 850 pl of overnight culture which 
had been previously made by inoculating LB broth containing 100 pg/ml with an XL1 Blue 
colony and shaking overnight at 37 °C. Stocks were stored at -20 °C
2.7.5 Quantifying amount of plasmid DNA
The concentration of plasmid DNA was estimated visually on a 1 % w/v agarose gel by 
comparing the intensity of the ethidium bromide stained bands to those produced by plasmids 
with known concentrations. Samples of 1/4, 1/2 and 1 pg of pBluescript® II SK (+) were 
made up to 20 pl with 5 pl of loading dye and double distilled H20 . Aliquots of 1 and 2 pl of 
plasmid DNA were also made up to 20 pl in the same way.
2.8 Sequencing
2.8.1 Direct sequencing of PCR products
The Sequenase™ PCR Product Sequencing Kit, supplied by Amersham Life Sciences (Little 
Chalfont, Buckinghamshire, UK), was used to sequence PCR products using the 
dideoxynucleotide chain termination method (Sanger et al., 1977). To 5 pl of PCR 
amplification mixture were added 10 U of Exonuclease 1 and 2 U of Shrimp Alkaline 
Phosphatase. This was incubated for 15 min at 37° C, 15 min at 80° C and then placed on 
ice. An oligonucleotide designed to anneal internally to the sequence was added in excess 
(10 pmol). The reaction mixture was made up to 10 pl with H20 , placed at 100° C for 3 min 
and then rapidly cooled to 0° C. To the annealed DNA, 2 pl of 5x Sequenase buffer (200 mM 
Tris-HCI pH 7.5, 100 mM MgCI2, 250 mM NaCI), 1 pl of 0.1 M DTT, 5x labelling mix (5 pM 
dNTP, diluted down 1:5 v/v with H20 ), 5 pCi [a-35S] dATP and Sequenase™ Version 2.0 T7 
DNA polymerase (3.2 U) was added. This was incubated at room temperature for 5 min 
followed by aliquoting 3.5 pl into pre-warmed (37° C) tubes containing 2.5 pl ddNTP (8 pM) 
each and left at 37° C for 10 min. The reaction was stopped using 4 pl of stop solution (95 %
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(w/v) formamide, 20 mM EGTA, 0.05% (w/v) Bromophenol Blue, 0.05% (w/v) Xylene Cyanol 
FF).
2.8.2 Sequencing of Plasmid constructs
The Sequenase™ Quick Denature™ Plasmid Sequencing Kit, supplied by Amersham Life 
Science uses the dideoxynucleotide chain termination method (Sanger et al., 1977) to 
sequence PCR products that have been cloned into the vector pBluescript® II SK (+). Firstly, 
8 pl of plasmid DNA was denatured in the presence of 10 pmol of primer by 2 pl of 1.0 M 
NaOH for 10 min at 37° C. The reaction was then neutralised by adding 2 pl of 1.0 M HCI 
and 2 pl of Plasmid Reaction Buffer (400 mM Tris-HCI pH 7.5, 100 mM MgCI2, 250 mM 
NaCI), incubating at 37° C for 10 min then chilling on ice for 10 min. To the ice-cold mix 1 pl 
of 0.1 M DTT, 2 pl of diluted labelling mix (5 pM dNTP, diluted down 1:5 v/v with H20 ), 5 pCi 
[a-35S] dATP and diluted Sequenase™ Version 2.0 T7 DNA polymerase (3.2 U) was added. 
This was incubated at room temperature for 3 min and 4.5 pl of this labelling mix was then 
transferred to pre-warmed (37° C) tubes containing 2.5 pl of ddNTP (8 pM) and left at 37° C 
for 5 min before stopping the reaction using 4 pl of Stop solution.
2.8.3 Preparation of poly-acrylamide sequencing gels
Front plates were washed with water and polished dry with 75 % (v/v) ethanol. 
Dichlorodimethylsilane (BDH Chemicals, Poole, Dorset, UK) was used to silanate the surface 
of the plate. After 5 min the plate was rinsed with water and polished with 75 % (v/v) ethanol. 
Back plates were cleaned by soaking for at least 5 h in 5M KOH followed by rinsing in water 
and polishing with 75 % (v/v) ethanol. To the surface of the plate a solution of 1.2 ml of 10 % 
acetic acid, 200 pl of silane A-174 adhesion promoter (BDH Chemicals) and 25 ml absolute 
ethanol was poured. This was left for 5 min after which time the plate was rinsed with water 
and polished dry with 75 % (v/v) ethanol. One 0.2 mm spacer was placed on each side of 
the back plate and the front plate was placed on top with the silanated surface face down and 
clamped loosely together. A 6 % (v/v) acrylamide solution was prepared using Sequagel 
reagents from Flowgen (Lichfield, Staffordshire, UK). Immediately before pouring, 300 pl of 
freshly prepared 16 % ammonium persulphate and 40 pl of TEMED were added to the 
acrylamide solution. Once poured the flat edge of a shark’s tooth sequencing comb was 
inserted about 5 mm into the top of the gel, which was then clamped more tightly. The gel 
was left to set for 30 min after which the comb was removed and the residual unpolymerised 
acrylamide was washed away with 1x TTE, if running samples from the PCR Product 
Sequencing Kit, or 1x TBE for samples derived from the Plasmid Sequencing Kit. The comb 
was then reinserted so that the teeth could just pierce the surface of the gel. Immediately 
before the gel was ready for loading reaction samples were heated up to 80° C for 2 min. 
The gel was run vertically in the TTE or TBE buffer for 4 hours at 30 mA, 40 W and 1500 V. 
Gels were then fixed for 10 min in a solution containing 10 % v/v methanol and 10 % v/v 
acetic acid, then washed in water for 10 min followed by drying and exposing overnight on
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Kodak X-ray film using a light tight cassette. The film was then passed through an X-Ograph 
Compact X2 X-ray processor.
2.8.4 Automated sequencing
Either 250 ng of Wizard™ Plus preparations or 50 ng of PCR product (both eluted in H20 )  
were sequenced in a total volume of 6 pl in the presence of excess primer using the ABI 
Prism™, 377DNA Sequencer from Perkin Elmer.
2.9 Managing the Sequence Data via the Gnome GCG package
Sequence data was transferred to the GCG (Genetics Computer Group, Inc., Wisconsin, 
USA), suite of programs, accessible via the gnome work station, for analysis and comparison 
with existing sequences in the database.
2.10 Site Directed Mutagenesis
Selection of oligonucleotide-directed mutants were generated using the Altered Sites® II kit 
from Promega (Southampton, UK). The pALTER®-1 vector contains genes for ampicillin and 
tetracycline resistance, these selection markers were to be used as a way of obtaining a high 
frequency of mutants. The gene to be mutated was ligated into the multiple cloning site of 
pALTER®-1 and transformed into JM109 cells in the presence of tetracycline as the vector 
initially comes with an inactivated ampicillin gene. The mutagenesis reaction proceeded 
using an ampicillin repair oligo, a mutagenic oligo, and a tetracycline knockout oligo thus 
restoring ampicillin and inactivating tetracycline resistance to the mutant strand as well as 
incorporating the required mutation. To avoid selection against the desired mutation the 
mutagenesis reaction was transformed into a repair minus strain of E. coli (BMH71-18 mutS). 
A subsequent transformation of mutated plasmid into JM109 was plated out in the presence 
of ampicillin to ensure the correct segregation of mutant and wild type plasmids.
2.10.1 Subcloning into pAlter®-1 using JM109 E. coli strain
An HG4 cDNA clone in pBluescript® II SK (+) encoded a single nucleotide mismatch 
compared to the consenusus, 75 nt downstream from the fist nucleotide of the methionine 
start codon. This mismatch was to be mutated from a guanine to a thymine using the 
mutagenesis system. The HG4 cDNA was removed from the plasmid construct by digestion 
at 37 °C overnight with Sac1 and Xba1 (see section 2.7.3). An identical restriction digest was 
performed on pALTER®-1 which had been extracted via a Wizard Preparation (section 2.7.2) 
from a 3 ml culture of JM109s containing the vector. Each digest was electrophoresed on a 1 
% (w/v) agarose gel. Cut pALTER®-1 and HG4 DNAs were excised out of the gel and purified 
using Sephaglas™ (section2.4.4) followed by an additional purification step of passing 
through a QIAquick column (section 2.4.5). The vector and HG4 insert were ligated together, 
as described in section 2.6.3, prior to transformation into competent JM109 cells purchased 
from Promega. Ligation mix was diluted 1:4 and half of the sample was added to prechilled 
15 ml Falcon tubes. Competent JM109s were thawed on ice and 50 pl aliquots were added
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to Falcon tubes and left to incubate on ice for 30 min. Tubes were transferred to a 42 °C 
water bath and heat shocked for 50 sec and then returned to ice for 2 min. Addition of 900 pl 
of SOC medium to the heat shocked cells was followed by shaking (180 rpm) for 2 h at 37 
°C. One tenth and nine tenths of the JM109 suspension were each spread out onto LB / 
tetracycline (12.5 pg/ml) plates coated with 50 pl of both 0.1 M IPTG and 2 % (w/v) X-Gal (in 
dimethylformamide) allowing blue/white selection to be made. Plates were incubated 
overnight at 37 °C after which time a number of white colonies were selected and inoculated 
into LB containing 10 pg/ml of tetracycline. These where grown up overnight, shaking at 180 
rpm at 37 °C and then Wizard™ Plus minipreps (see section 2.7.2) were used to extract 
plasmids. Confirmation of successful cloning of HG4 was achieved by digestion with Not1 
and Pst1 restriction enzymes (section 2.7.3) followed by automated sequencing (section 
2.8.4) using the T7 primer (Appendix 3).
2.10.2 Design and Phosphorylation of Primers
For effective selection of mutated vector the mutagenic oligonucleotide was designed to 
hybridise to the same strand of pALTER as the antibiotic repair nucleotide. A sense primer 
(MUTs, Appendix 3) of 17 bases was designed with the mismatch located in the centre and 8 
perfectly matched nucleotides present on either side. Production of mutants increases 
greatly when the oligonucleotides have been phosphorylated therefore all the primers 
supplied in the kit had been 5-phosphorylated. This meant that only the mutagenic oligo 
needed to be phosphorylated. This was achieved by adding 100 pmol of MUTs to 2.5 pl of 
10 x kinase buffer (700 mM Tris-HCI, pH 7.6, 100 mM MgCI2, 50 mM DTT) 5 units of T4 
polynucleotide kinase, 2.5 pl of 10 mM ATP and H20  giving a final volume of 25 pl. The 4 
pmol/pl reaction mixture of phosphorylated MUTs was incubated at 37 °C for 30 min prior to 
kinase inactivation at 70 °C for 10 min.
2.10.3 Denaturation of Double-Stranded DNA Template
The double stranded DNA was alkali-denatured before it could undergo mutagenesis. 0.5 
pmol (approximately 2 pg of HG4/pALTER®-1 construct) of double stranded DNA template 
was denatured with 2 pl of 2 M NaOH/2 mM EDTA in a final volume of 20 pl made up with 
H20 . After incubating for 5 min at room temperature, 2 pl of 2 M ammonium acetate pH 4.6 
and 75 pl of absolute ethanol were added and incubated at -70 °C for 30 min. Precipitated 
single stranded DNA was spun down at top speed for 30 min followed by washing with 70 % 
(v/v) ethanol and spinning for 15 min at top speed. The dried pellet was dissolved in 100 pl 
of TE pH 8.0.
2.10.4 Annealing Reaction and Mutant Strand Synthesis
Added 10 pl (0.05 pmol) of alkaline denatured double stranded DNA to 1 pl (0.25 pmol, 2.2 
ng/pl) of both phosphorylated tetracycline knockout oligo & ampicilin repair oligo and 0.31 pl 
(1.25 pmol, 4 pmol/pl) of phosphorylated mutagenic oligo (MUTs). To this, 2 pl of 10 x
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annealing buffer (200 mM Tris-HCI, pH 7.5, 100 mM MgCI2, 500 mM NaCI) and H20  was 
added to make up a total volume of 20 pl. Non-specific annealing of oligos was minimised by 
heating the reaction for 5 min at 75 °C and then allowing to cool slowly to room temperature 
(1 °C/min to 45 °C, then more rapidly). The sample was then placed on ice and 3 pl of 10 x 
synthesis buffer (100 mM Tris-HCI pH 7.5, 5 mM dNTPs, 10 mM ATP, 20 mM DTT), 1 pl (5- 
10 units) of T4 DNA polymerase, 1 pl (1-3 units) T4 DNA ligase and H20  was added to give a 
total volume of 30 pl. The tube was then transferred to 37 °C for 90 min, allowing mutant 
strand synthesis and ligation to take place.
2.10.5 Transformation into BMH71-18 mutS E. coli strain
The 30 pl of mutagenesis reaction was transferred into prechilled 15 ml Falcon tubes 
followed by 150 pl of competent mismatch repair minus E. coli, BMH71-18 mutS. A 10 min 
incubation on ice was followed by a heat shock for 50 sec at 42 °C and then transferral to ice 
for 2 min. Cells were then shaken (180 rpm) at 37 °C in 900 pl of LB broth for 30 min, 500 pl 
of sample was then added to 4.5 ml LB / 125 pg/ml ampicillin in a 50 ml Falcon tube and 
shaken (180 rpm) overnight at 37 °C.
2.10.6 Transformation into JM109 E. coli strain
100 pl aliquots of competent JM109 cells were added to either 5 pl or 10 pl of chilled 
mutagenised pALTER®-1/HG4 construct obtained using the Wizard™ Plus miniprep (section 
2.7.2) on all of the BMH71-18 mutS transformed cells. These were placed on ice for 30 min, 
heat shocked at 42 °C for 50 secs, transferred to ice for 2 min and finally shaken at 180 rpm 
in SOC medium for 2 h at 37 °C. 1/100, 1/10 and 9/10 aliquots were plated out onto LB 
plates containing 125 pg/ml of ampicillin and incubated overnight at 37 °C. A selection of 
colonies was screened by purifying plasmids with the Wizard™ Plus miniprep kit and 
digesting them with restriction enzymes (section 2.7.3). Correct constructs were then 
prepared for automated sequencing (section 2.8.4) in the presence of the T7 primer 
(Appendix 3).
2.11 Production of Peptide Antibodies to HG4
2.11.1 Coupling of Peptide to Carrier Protein
The HG4 synthetic peptide was prepared using the MilliGen 9050 PepSynthesizer (Millipore, 
Watford, Hertfordshire, UK). In order to generate a sufficient immunological response, it was 
necessary to conjugate the peptide to a carrier protein before immunisation. The carrier 
protein porcine thyroglobulin (Sigma) was coupled to the peptide using gluteraldehyde 
(Sigma). This enables cross-linking through free amino groups.
10 mg of both freeze-dried peptide and thyroglobulin were dissolved together in 0.1 M 
NaHC03 to give a final concentration of 2 mg/ml. 10 pl of a 25 % w/v solution of 
gluteraldehyde taken from a fresh ampoule was added. The mixture was left to rotate end 
over end in a glass vial overnight at room temperature. A 0.1 volume of 1 M glycine ethyl
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ester, pH 8.0, was added and rotated as before for 30 min at room temperature. The sample 
was then left to dialyse overnight against PBS. Finally the volume was adjusted to give 1 mg 
of peptide conjugate / ml of solution.
2.11.3 Pre-immune Bleed
A pre-immune bleed of 5 ml was taken from the ear vein of the rabbit before injecting the 
adjuvant/immunogen complex. This sample was used as a pre-immune control.
2.11 4 Use of Adjuvant
Addition of an adjuvant to the hapten carrier conjugate induces a strong immune response to 
the immunogens when injected into the rabbit. A 250 pi aliquot of aluminium hydroxide 
based adjuvant, called Imject® Alum supplied by Pierce (Chester, UK), was added drop by 
drop to an equal amount of immunogen with stirring. This was left to mix for a further 30 min 
at room temperature.
2.11.5 Dose
Two 100 pi subcutaneous injections were given to an anaesthetised rabbit. Further boosts 
were given every ten days until an adequate antibody titre was reached.
2.11.6 Serum Collection by Test Bleeding
Samples of blood were taken from the ear vein of the rabbit before each injection to monitor 
the production of specific antibodies. Comparison of antibody titres isolated from successive 
injections allowed the antibody response to be monitored.
2.11.7 Serum Preparation
Each test bleed was allowed to clot for 1 h at 37 °C. The clot was then separated from the 
sides of the collection vessel with a spatula and placed overnight at 4 °C to retract. The 
resulting serum was removed at this stage and the remaining clot was spun at 3000 rpm at 
room temperature for 10 min to release any further serum. 1 ml aliquots of serum were 
stored at -20 °C.
2.11.8 Exanguination
Once the antibody titre had reached a satisfactory level the rabbit was terminated by 
exanguination. Blood was collected and left at room temperature for 5 h after which time the 
sample was spun at 3000 rpm at 4 °C for 10 min. This aided the extraction of the serum, 
which was then stored at -20 °C. Cutting of the clot into cubes preceded an incubation 
overnight at 4 °C, encouraging further retraction of the coagulated blood. A final spin was 
made at 3,000 rpm for 10 min at 4 °C, followed by removal of serum to a screw cap plastic 
tube, which was stored at -20 °C.
59
2.12 Antibody Quantification
2.12.1 Enzyme Linked Immunoabsorbant Assay (ELISA)
This technique (Schots et a!., 1978) was used to screen serum collected from bleeds so as to 
monitor antibody specificity and titre. 96-well Falcon Probind ELISA plates were coated with 
100 pi of a 10 pg/ml solution of #  coating buffer (15 mM Na2C 0 3t 35 mM NaHC03, 0.1% 
(w/v) NaN3> pH 9.6). Plates were placed at 4 °C overnight, followed by washing three times 
with 300 pl/well of PBS/0.1 % v/v Tween-20. Non specific binding was blocked by addition of 
300 pl/well of blocking buffer (PBS/0.1 % (v/v) Tween-20 /1  % (w/v) Casein) and ieft for 2 h 
at room temperature. Plates were washed twice with PBS/0.1 % (v/v) Tween-20 followed by 
addition of test serum. Serial dilutions of serum were made starting with a 1/50 (v/v) dilution 
(in 200 pi of PBS) pipetted into the first well. Further 1:2 (v/v) dilutions were carried out in 
subsequent wells by transferring 100 pi of 1/50 (v/v) diluted serum to 100 pi of PBS present 
in the next well and so on. The plates were incubated at 4 °C overnight followed by washing 
three times with PBS/0.1 % (v/v) Tween-20 to remove unbound antibody. Incubation with a 
1:1000 (v/v) dilution of goat anti-rabbit IgG conjugated with horse-radish peroxidase in 
PBS/0.1 % (v/v) Tween-20 at 4 °C overnight followed. PBS/0.1 % (v/v) Tween-20 was used 
to wash off antibody three times before washing a further two times with PBS. A 100 pi of 
freshly prepared substrate (50 mM sodium acetate/ citrate buffer, pH 6, 0.1 mg/ml 
tetramethylbenzidine, 0.006 % v/v hydrogen peroxide) was added to each well and left for IQ- 
20 min until a blue colour could be visualised. Adding 50 pi of 1.84 M H2S 0 4 (1: 10 v/v 
dilution of concentrated H2S 0 4) stopped the reaction. The absorbance in each well was 
measured at 450 nm using a plate reader.
2.12.2 Protein Determination
The Bio-Rad Protein assay (supplied by Bio-Rad laboratories Ltd, Hemel Hemstead, 
Hertfordshire, UK) is based on the Bradford dye binding procedure (Bradford, 1976) in which 
the colour change of Coomassie brilliant blue G-250 dye to various concentrations of protein 
are measured at an absorbance of 595 nm. Protein assays were accomplished in microtitre 
plates by adding 200 pi of Bio-Rad reagent (supplied by the manufacturers) to a 10 pi (0.05 - 
0.5 mg/ml protein) aliquot of protein sample. The absorbance was measured at 595 nm.
2.13 Purification of Polyclonal Antibodies by Affinity Chromatography
Peptide was first immobilised on a cyanogen bromide-activated Sepharose 4B gel 
(Pharmacia). 1g of CNBr-activated Sepharose 4B was suspended in 50 ml of 1 mM HCI pH 
2.0, prior to washing on a sintered funnel with 1 mM HCI pH 2.0, 200 ml of distilled H20  and 
200 ml 0.1 M NaHC03 pH 8.3 respectively. 10 mg of peptide was dissolved in 5 ml of 0.1 M 
NaHCOs/O.5 M NaCI pH 8.3. The swelled sepharose beads were spun down at 1500 rpm at 
room temperature for 2 min enabling extraction of residual NaHC03. The 5 ml sample of 
peptide was then added and left to rotate end over end overnight at 4 °C. Excess peptide 
was removed by washing with three gel volumes of 0.1 M NaHCCyo.5 M NaCI pH 8.3. Each
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wash involved a centrifugation step of 1500 rpm for 2 min followed by removal of 
supernatant. The remaining active groups were blocked with 0.1 M Tris-HCI pH 8.0 rotating 
end over end overnight at 4 °C. Three cycles of alternating pH’s were then used to wash the 
Sepharose. Each cycle consisted of a wash with 0.1 M sodium acetate/citrate buffer pH 4.0 
containing 0.5 M NaCI followed by 0.1 M Tris-HCI pH 8.3 containing 0.5 M NaCI. The resin 
was then transferred to 5 ml of 20 mM Na2HPO4/0.5 M NaCI containing 0.01 % w/v sodium 
azide.
The slurry, of Sepharose immobilised with peptide, was packed into a column which had 
been linked up to a uvicord (LKB-Optical Unit UV-1 from Pharmacia) and graph plotter. In 
doing so the absorbance at 280 nm could be monitored to detect any proteins passing 
through the column at any given time. The beads were washed with 20 mM Na2P 0 4 pH 7.3 
prior to addition of the elutant (0.05 M diethylamine pH 11.5), thus removing any unbound 
peptide from the column. Once a constant base level had been registered by the uvicord, 10 
ml of serum was recycled through the column overnight at 4 °C. Washing with 20 mM 
Na2P 0 4 pH 7.3 followed this until the original base level had been reached. This ensured 
that no unbound serum remained in the column. Bound antibody was eluted with 0.05 M 
diethylamine pH 11.5. Fractions, corresponding to plotted peaks relating to protein detected 
by the uvicord, were immediately dialysed against PBS overnight at 4 °C. The resulting 
sample was concentrated by transferring the dialysis tube into polyethylene glycol-20,000. 
The sample was pipetted out of the tubing once the volume had been reduced to 2 ml, 
followed by storing 200 pi aliquots at -20 °C in the presence of 0.01 % v/v sodium azide. The 
column was washed with 20 mM Na2P 0 4 pH 7.3 before regenerating with three alternating 
cycles of 0.1 M Tris HCI / 0.5 M NaCI (pH 8.3) and 0.1 M sodium acetate/citrate buffer 
containing 0.5 M NaCI (pH 4.0). Storage in 20 mM Na2P 0 4 pH 7.3 and 0.01 % (v/v) sodium 
azide at 4 °C enabled the reuse of the column.
2.14 Production of Protein Antigens by Bacterial Over Expression
The protein fusion system, developed by NEB, was utilised to discover if purified antibody 
would bind to a folded form of the extracellular domain of HG4, along which the peptide 
epitope was located. Specific binding to the expressed protein would indicate whether the 
antibody epitope was exposed on the surface of the protein. This could be detected by 
running the expressed fusion protein on a SDS-PAGE gel followed by Western blot and 
probing with the purified antibody.
The DNA sequence coding for the N-terminal extracellular domain was inserted in-frame into 
the pMAL-c2 expression vector down-stream from the malE gene, which encodes maltose- 
binding protein (MBP). Cloning of this construct resulted in the periplasmic expression of an 
MBP-fusion protein upon induction with IPTG. This was carried out in the following manner:
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2.14 1 Design of Primers
The sense primer pMALs and the antisense primer pMALa (Appendix3) were designed 
specifically to anneal to target sequences flanking the cDNA sequence that encoded the 
extracellular domain of HG4. The pMALs primer incorporated a Sal 1 restriction site whilst 
pMALa encoded a stop codon followed by a Pst1 site. Each restriction site was present in 
the polylinker found down stream from the malE gene thus allowing the PCR amplified 
product to insert in the correct orientation.
2.14.2 Isolation of Extracellular Domain of HG4 and ligation into the 
pMAL vector
A Wizard™ preparation of an HG4 cDNA clone in pBluescript® II SK (+) was prepared as 
described in section 2.7.2. 8 pg of plasmid was then digested with the restriction enzymes 
Not 1 and Xba 1 (section 2.7.3) and ran on a 1 % w/v agarose gel (section 2.4.3). HG4 
cDNA was purified with the Sephaglas™ Band Prep (section 2.4.4) and used as template in a 
PCR reaction using the High Fidelity Expand Kit (section 2.4.2) with pMALs and pMALa 
primers. The sample was loaded onto a 1 % w/v agarose gel and a product corresponding to 
the correct size of the extracellular domain of HG4 (HG4-ex) was excised and purified using 
the Sephaglas™ Band Prep. A double digest, using Sal 1 and Pst 1 restriction enzymes, was 
performed on both pMAL vector and PCR product of HG4-ex followed by a QIAquick™ clean 
up (section 2.4.5). Restricted products were then ligated as described in section 2.6.3.
2.14.3 Transformation into XL2 Blue strain of E. coli
To 15 ml Falcon tubes containing 50 pi of ligation mix (previously diluted 1:4 with H20 )  25 pi 
of ultra competent XL2 Blues were added. After incubating on ice for 30 min the cells were 
heated shocked at 42 °C for 30 sec followed by 2 min on ice. 0.9 ml of DYT, preheated to 42 
°C, was added and left to cultivate for 2 h at 37 °C, shaking at 180 rpm. A tenth and nine 
tenths of the culture were plated out onto LB/ampicillin (100 pg/ml) plates and incubated 
overnight at 37 °C.
2.14.3 Replica Plating
The transformants were replica plated on a LB/ampicillin (100 pg/ml) master plate and on a 
LB/ampicillin (100 pg/ml)/IPTG (0.1 mM)/X-Gal (80 pg/ml) indicator plate and placed at 37 °C 
overnight. White colonies on the indicator plate were screened using the Wizard™ Plus kit 
and digested to confirm that HG4-ex had been successfully transformed into pMAL-c2.
2.14.4 Induction of Fusion Protein
100 pi of an overnight culture of HG4-ex/pMAL was inoculated into 5 ml LB/ampicillin (100 
pg/ml) and grown to an optical density of 0.5 at 600nm. A 1 ml aliquot was transferred into a 
sterile microfuge tube and placed on ice whilst the remaining culture was induced with 15 pi 




IPTG induced and uninduced cells were resuspended respectively in 100 pi and 50 pi of 
SDS-PAGE loading buffer (4 ml dH20 , 1 ml 0.5 M Tris-HCI, pH 6.8, 0.8 ml glycerol, 1.6 ml 10 
% w/v SDS, 0.4 ml 2-p mercaptoethanol and 0.2 ml of 0.05 % w/v bromophenol blue). These 
samples were then heated in a boiling water bath for 5 min. 15 pi of each sample was then 
loaded onto a 10 % v/v SDS-PAGE gel along with protein molecular weight markers (Bio- 
Rad). 5 pl/well of pre-stained marker was loaded on the gel used in Western blotting and 10 
pi of 1:20 diluted standard marker in SDS-PAGE loading buffer was loaded on the gel to be 
stained with Coomassie brilliant blue R250 dye.
2.15.2 Preparation of a 10 % SDS-Polyacrylamide Gel
Two separating gels were made using 6 ml of Protogel™ (30 % w/v acrylamide stock 
solution, 29.2 g acrylamide, 0.8 g Bis (N, N’-methylenebisacrylamide), 100 ml H20 , from 
Flowgen), 4.5 ml of solution B (1.5 M Tris-HCI, pH 8.8, 0.4 % w/v SDS), 100 pi of 10 % w/v 
ammonium persulphate, 20 pi of TEMED and 7.5 ml of H20 . The solution was poured into 
Atto™ minigel rigs, overlaid with isopropanol and allowed to set. The solvent was removed 
and the gel interface was rinsed with distilled H20 . A stacking gel (4.5 % v/v) was then 
prepared by mixing 0.9 ml of Protogel™ with 1.5 ml of solution C (0.5 M Tris-HCI, pH 6.8, 0.4 
% w/v SDS), 50 pi of 10 % w/v ammonium persulphate, 20 pi of TEMED and 3.6 ml of H20 . 
The solution was poured over the two separating gels and combs were inserted before 
leaving to set. The gels were placed into the electrophoretic chamber and 1x running buffer 
(5x stock: 15g/l tris base, 72g/l glycine, 5g/l SDS, for 1X: diluted 60 ml of 5x stock with 240 ml 
H20  for electrophoresis) was added. Combs were removed and wells were washed out with 
buffer to remove any urea that may have collected there. Samples were then loaded and ran 
at 100 volts, at maximum current for 20 min followed by 150 volts, maximum current until the 
dye front had reached the bottom of the gel. Gels were removed from the apparatus, one 
was soaked overnight at room temperature by rotating in Coomassie Stain (0.5 g Coomassie 
Blue R-250, 200 ml methanol, 50 ml acetic acid, 249.5 ml H20 ), the other (loaded with 
prestained markers) was used for Western blotting. The Coomassie stained gel was put into 
destain solution (400 ml methanol, 100 ml acetic acid, 500 ml H20 )  and slowly rotated until 
background staining was removed.
2.16 Western Blot
2.16.1 Blotting
Two gel sized sets of 5 sheets of 3MM Whatman filter paper (supplied by Whatman Ltd, 
Maidstone, Kent, UK) were soaked in transfer buffer (2.92 g/l glycine, 5.8 g/l Tris, 0.375 g/l 
SDS, 200 ml methanol (20 % v/v)). The first set was aligned on the graphite transfer plate of 
a NovaBlot blotter (from Pharmacia) followed by nitrocellulose membrane (Amersham, Little 
Chalfont, Buckinghamshire, UK), that had previously been soaked in methanol and then
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transfer buffer. The SDS-PAGE gel was rinsed in water and rolled out on top of the 
membrane. The stack was overlaid with the second set of soaked filter paper and any air 
bubbles, between layers, were removed by rolling a 10 ml pipette over the top of the 
sandwich. The upper graphite plate was lowered on top and the rig was then connected up 
to the power supply, set at 0.8 mA x surface area of gel for 2 h.
2.16.2 Probing with Primary and Secondary Antibodies
Western blots were rinsed in PBS for 10 min prior to an hour incubation on a rotating table 
(40 rpm) in blocking buffer at room temperature. Blots were washed three times with 
PBS/0.1 % v/v Tween-20 before incubating on a rotating table overnight at 4 °C with primary 
antiserum diluted 1:200 (v/v) in blocking buffer (10 % w/v Marvel™ non-fat milk powder in 
PBS, 0.01 % sodium azide). The membrane was washed three times as before, followed by 
rotating for 2 h at room temperature in the presence of secondary serum (horseradish 
peroxidase-conjugated goat anti-rabbit antibody) diluted 1:10,000 in blocking buffer. 
Unbound antibody was removed by washing three times in PBS/0.1 % v/v Tween-20.
2.16.3 Detection by ECL
The ECL detection kit was supplied by Amersham Life Science (Little Chalfont, 
Buckinghamshire, UK) and works on the principle that Horse Radish Peroxidase in the 
presence of H20 2 will oxidise luminol under alkaline conditions promoting 
chemiluminescence. In the presence of enhancers, such as phenol, the light emission can 
last up to 20 min during which time the reaction can be detected by overlaying the blot with 
autoradiography film.
An equal volume of detection solution 1 (supplied by Amersham) was mixed with detection 
solution 2 (supplied by Amersham) and poured onto the surface of the antibody bound blots 
followed by a 1 min incubation at room temperature. Excess detection fluid was drained off 
and the blot was wrapped in clingfilm before overlaying with X-ray film, protein side up in a 
film cassette over a series of exposure times. Films were developed using an X-Ograph 
Compact X2 processor.
2.17 Immunolocalisation Of HG4 in Whole Worms
2.17.1 Adult Worm Collection
A sheep, infected with avermectin-susceptible Haemonchus contortus, was slaughtered and 
its abomasum was removed during butchering. The stomach lining was cut through and 
water was used to rinse away the guts semi-digested contents. Adult Haemonchus contortus 
could be seen attached to the gut lining. The organ was placed into the isolation apparatus 
as depicted in figure 9 in the presence of DMEM, Dulbecco’s Modified Eagle Medium 
supplied by Gibco BRL (Renfrewshire, Scotland) and kept at 37 °C using a heat-emitting 






Water bath at 37 °C
Figure 9. Apparatus set up to collect adult H. contortus from sheep abomasum.
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debris was removed by washing the worms in broth kept at 37 °C. Once washing had been 
repeated several times the worms were transferred into fix.
2.17.2 Tissue Fixation and Permeabilisation
Haemonchus adults were incubated in freshly prepared fixative (4% w/v paraformaldehyde in 
PBS) for 8 h at 4°C. Worms were washed three times in PBS and transferred to storage 
buffer (0.1 % w/v paraformaldehyde in PBS), thus enabling long term storage at 4 °C.
In order to carry out immunolocalisation work, antibodies were required to enter the 
nematode via the cuticle. It was therefore a requirement that the multi-layered cuticle coating 
the worm was permeabilised. This was done by incubating the worms in BME solution (5% 
v/v p-mercaptoethanol, 1 % v/v Triton X-100 and 125 mM Tris pH 6.9) at 37 °C overnight, 
promoting the reduction of disulphide bonds, followed by briefly washing in PBS. Worms 
were then treated with 120 collagen digestion units/ml of collagenase in collagenase buffer (1 
mM Ca2CI and 100 mM Tris pH 7.5) at 37 °C for either 10 h or 20 h rotating at 40 rpm, or still 
for 48 h. Once the cuticle had been digested the worms were washed in PBS before serum 
incubation.
2.17.3 Immunocytochemistry
Dilutions of Primary antibody in antibody dilution solution (0.1 % w/v BSA, 0.5 % v/v Triton X- 
100 and 0.05 % w/v NaN3 in PBS) were pipetted onto the worms and incubated at 4 °C for 72 
h. Unbound antibody was removed by washing three times with PBS. Worms were then 
exposed to a 1:200 dilution of secondary serum; TRITC-conjugated goat anti-rabbit IgG 
(Sigma) in antibody dilution solution. After incubating overnight at 4 °C, unbound IgG was 
removed with three 15 min washes, followed by an overnight wash of PBS/0.1 % v/v Triton X- 
100. Immunolabelled nematodes were mounted onto slides using VectaShield (Vector 
Laboratories, Bretton, Peterborough, UK) and viewed under an Olympus BHS Episcopic 
Fluorescence microscope. Microscope settings used were; green excitation region, exciter 
filter G (IF-545+BG36), Dichromic mirror G (DM-580+0.590) and barrier filter R-610. A more 
detailed examination was achieved using a Zeiss Axiovert 100M inverted confocal 
microscope from Zeiss (Germany).
2.17.4 Post-adsorption of Antibody with Peptide
A negative control was set up to confirm that the primary antibody was binding specifically. 
HG4 peptide (final concentration of 0.5 pg/ml) was incubated with 1:10 dilution (in antibody 
dilution solution) of primary antibody for 1 h at 37 °C. These samples were used directly on 
collagenase treated worms.
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3. The Isolation of Full-Length HG4 cDNA
3.1 Introduction
This chapter describes the sequence of events leading to the identification of a full-length 
consensus sequence coding for the avermectin receptor subunit, HG4. The methods utilised 
to accomplish this are detailed as well as reasons for their preferential use over other existing 
methods. The production of a consensus sequence is also accomplished for further 
characterisation through expression in Xenopus laevis oocytes. Finally, an attempt is made 
at isolating HG4 from avermectin resistant H. contortus to determine whether resistance has 
developed from an alteration in the transcribed code.
3.1.1 Techniques to Isolate Genes of Interest
Isolation of genes provides the opportunity to establish the structure and function of 
expressed proteins in a living organism. Recombinant DNA technology has proven a useful 
tool in detecting these genes. The process of isolating and cloning such fragments begins 
with either construction of a DNA library or the use of the Polymerase Chain Reaction.
Screening of a genomic library enables the retrieval of a full-length gene including 
untranscribed 5’ and 3’ regions. For complex organisms, such as nematodes, a complete 
library will contain so many clones that identification of the desired gene may prove to be a 
lengthy task. A reduced number of clones can be catalogued in a cDNA library, produced 
from reverse transcribed mRNA. With this library, only the genes expressed at a particular 
stage of development are represented. cDNA libraries offer a method of obtaining a full- 
length clone of interest in one step. The success of isolation is however dependent on the 
relative abundance of the clone of interest. Highly abundant messages can represent 10 % 
or more of the total mRNA. In contrast, very rare messages, such as those coding 
transmitter-gated ion channel (TGIC) subunits, can be less than 1 part in 106 (Moore, 1987). 
Due to the scarcity of TGIC subunits it is essential that a high cloning efficiency must be 
maintained. Even with this considered, screening of millions of plaques may need to be 
accomplished before isolating the clone of interest (Harvey et al, 1991).
A relatively new technique, known as the Polymerase Chain Reaction (PCR), overcomes the 
problems encountered in screening cDNA libraries for clones of low abundance mRNAs. 
This method is so sensitive that it can amplify a single copy gene sequence from a single cell 
(Holding & Monk, 1990). It was therefore decided that PCR was to be used to amplify TGIC 
subunits specific to the avermectin receptor. This circumvents the inevitable lengthy process 
of screening millions of plaques, which follows the construction of a library.
PCR can amplify a segment of DNA that lies between two regions of known sequence. Two 
oligonucleotides are used as primers to anneal to opposite strands of template DNA with their 
3’ ends facing each other. This enables synthesis, by DNA polymerase, to extend across the
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segment of DNA between the two primers, in a 5’ to 3’ direction. The template DNA is initially 
denatured with heating in the presence of buffer, Mg2+, excess primers and dNTPs. 
Denaturation is followed by the addition of a thermostable DNA polymerase after which the 
reaction mixture is cooled to a temperature that allows the primers to hybridise to the target 
sequences (the annealing temperature). The temperature is then increased to ensure that 
the DNA polymerase synthesises a complementary strand under optimal conditions (the 
extension temperature). One cycle of denaturing, annealing and extension results in 
synthesis of a new strand of undefined length, a second cycle gives a single stranded 
product corresponding to the exact length of the stretch of DNA found between the two 
primers. Each strand synthesised is complementary to one of the two primers and can 
therefore participate as template in the exponential amplification produced by subsequent 
cycles (Coen & Scharf, 1990).
3.1.2 HG4 Partial Sequence
A partial 450 base pair cDNA fragment denoted HG4 had previously been isolated by PCR 
with cDNA produced from a population of H. contortus eggs (Laughton, 1993). This had 
been achieved using the degenerate primers DS and DA. These had been designed to 
conserved regions of GABAa and glycine receptor subunit sequences from both invertebrate 
and vertebrate species. One of the resulting partial sequences, denoted HG4 (Figure 10a/b), 
shared homology with the inhibitory amino acid receptor family. More specifically, it 
possessed a 66% amino acid identity with the glutamate-gated chloride channel beta subunit 
(GluCip) isolated from Caenorhabditis elegans. This class of receptor is believed to be the 
target for the anthelmintic, avermectin. Administration of this drug to H . contortus infected 
livestock induces expulsion of nematodes from the host. Avermectin has been shown to 
target glutamate-gated chloride channels in the free-living nematode C. elegans (Arena et a i, 
1991, 1992). Consequently, hyperpolarisation of receptor-expressing cells occurs which 
ultimately leads to paralysis of muscles (Geary et a i, 1993). Attempts to isolate full-length 
cDNAs from a parasitic nematode such as H. contortus were to be made using a variation of 
the PCR technique. Once this target has been obtained, further characterisation can be 
accomplished to determine the exact mechanism through which avermectin works. It will 
also be possible to establish why resistance to the drug has developed.
3.1.3 RACE PCR
Isolation of target cDNAs corresponding to TGIC subunits will be amplified using a variant of 
PCR known as RACE, an acronym for the Rapid Amplification of cDNA Ends (Frohman et al.t
1988). Unlike PCR, where amplification of DNA between two known or presumed sequences 
occurs, RACE can achieve amplification of the region between a short known sequence in a 




W V P D
TAGACCCACGGTCTGTGGAAAAlGGGCTGGCTTTTTCGTCGTGTGGCCGTAGAGTAGCTA
P T K A A H R H
ACGGACAACATGTTCCTTCGAATTCATCCAGATGGAAAGGTGTTGTACAGTAGTCGAATT
6 1 --------------------+ ------------------- + ------------------- f ------------------ + -------------------- + --------------------+ 120
TGCCTGTTGTACAAGGAAGCTTAAGTAGGTCTACCTTTCCACAACATGTCATCAGCTTAA
T D N M F L R I H P D G K V L Y S S R I  -
AGCATTACCAGCTCCTGTCACATGCAACTACAACTCTACCCCTTGGATTTGCAGTTCTGT
1 2 1 -------------------------- + --------— —  — —  + -------------------------+ ------------------------ h ----------------------------h-------------------------- 1- 1 8 0
TCGTAATGGTCGAGGACAGTGTACGTTGATGTTGAGATGGGGAACCTAAACGTCAAGACA
S I T S S C H M Q L Q L Y P L D L Q F C -
GACTTTGATCTCGTCAGCTATGCCCATACCATGAAGGATATTGTCTACGAATGGGATCCC +-------------+------------ +------------+-------------+------------+
CTGAAACTAGAGCAGTCGATACGGGTATGGTACTTCCTATAACAGATGCTTACCCTAGGG
D F D L V S Y A H T M K D I V Y E W D P
1 8 1 +  2 4 0
B
CTGGCTCCTGTGCAGCTCAAACCCGGTGTAGGAAGTGACCTGCCTAACTTTCAGCTCACA
2 4 1  ------------------------ + ---------------------------+ -------------------------+ ------------------------- + ------------------------- + ---------------------- +  3 0 0
GACCGAGGACACGTCGAGTTTGGGCCACATCCTTCACTGGACGGATTGAAAGTCGAGTGT
L A P V Q L K P G V G S D L P N F Q L T -
AATATCACCACCAATGAGGACTGTACTAGCCATACCAATACTGGGTCGTACGCCTGCCTG
3 0 1 ---------- —  —+ --------------- — —  h—  +  —  — ------------ + -------------------------- h---------------------------+  3 6 0
TTATAGTGGTGGTTACTCCTGACATGATCGGTATGGTTATGACCCAGCATGCGGACGGAC
N I T T N E D C T S H T N T G S Y A C L
AGGATGCAGCTCACCCTAAAAAGGCAGTTCAGTTACTACCTGGTCCAGTTGTACGGTCCC
3 6 1 -------------------------- + --------------------------(■-------------------------+ -------------------------+ -------------------------+ ---------------------- +  4 2 0
TCCTACGTCGAGTGGGATTTTTCCGTCAAGTCAATGATGGACCAGGTCAACATGCCAGGG




T T M I V I V S
’ACCCAAAGCAAAACCTAGTTC









Primer Nucleotide Sequence Amino Acid Sequence
DS 5’(AC)T(CT)TGGGTGCCAGACACCT(AT)(CT)TT 3’ (l/L)WVPDT(Y/F)F
DA 5’ (AG)(AG)(AG)TTNA(AGT)CCA(AG)AAN(CG)(AT)NACCCA 3’ WVSFW(I/L)N
N = For all nucleotides
Figure 10a, HG4 partial sequence, b, PCR approach. The 450 bp HG4 fragment was 
amplified using oligonucleotides DS and DA. Positions of these degenerate primers are 
depicted and nucleotide and amino acid composition is detailed. Five partial sequences 
were amplified using these primers and were denoted HG1-5.
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exploits the presence of two ubiquitous stretches of sequence flanking 3’ and 5’ cDNAs ends.
The universal sequence present at 3’ ends can be incorporated during reverse transcription 
of mRNA into cDNA by use of an adapter/primer known as RoRi(dT)17. In the presence of 
reverse transcriptase the poly (dT)17 anneals to the complementary poly (A) tail of the 
message initiating cDNA synthesis. The oligo (dT) adapter/primer is designed to allow the 
binding of two nested 17-mer primers: Ro (outer) and Ri (inner). This region also enables 
binding of a 28-mer RoRi that encompasses both inner and outer sequences.
In contrast, the majority of 5’ ends possess a specific sequence derived from a trans-splicing 
event universal to nematodes. A spliced leader sequence (SL1) is donated from the 5’ end of 
a small, non-polyadenylated RNA to primary transcripts thus forming a common 22 nt 5’ 
terminal sequence on mature mRNAs (Davis, 1996). The leader sequence 
‘CTCAAACTTGGGTAATTAAACC’ was originally identified in the free-living nematode C. 
elegans (Krause & Hirsh, 1987). Since then identical sequence to SL1 has been described 
at the 5’ ends of a variety of parasitic nematodes including Haemonchus contortus (Bektesh 
etal, 1988).
Primers designed to hybridise to either RoRi or SL1 sites will be used in conjunction with 
gene specific primers (Appendix 3). The latter will be generated according to the previously 
isolated HG4 partial sequence to amplify both 3’ and 5’ ends respectively.
3.1.4 Semi-Nested PCR
A common occurrence when performing RACE PCR is that a significant amount of non­
specific products can be amplified. These result from the presence of only one set of gene 
specific primer during the reaction. To overcome this problem a second round of PCR will be 
accomplished using first round amplification products as template. Included in this reaction 
will be the first round gene specific primer and a primer designed to hybridise to an internally 
located stretch of sequence (Frohman & Martin, 1989).
3.1.5 PCR induced Mutations
The most frequently used thermostable DNA polymerase in PCR reactions is the one isolated 
from Thermus aquaticus (Taq DNA polymerase). One drawback with Taq is that it lacks 
editing functions and incorporates an incorrect nucleotide at a rate of 2 X 10"4 nucleotides per 
cycle (Coen & Scharf, 1990). The low abundancy of mRNA coding for TGIC subunits makes 
it necessary to use high levels of cycling, which has the potential of introducing a high 
number of mutations. One step taken to reduce the error frequency will be to use a 
combination of thermostable polymerases with and without proof reading activity. The 
Expand™ PCR system suits this requirement as it uses both Pwo DNA polymerase isolated 
from Pyrococcus wosei as well as the traditional Taq polymerase. The former enzyme 
possesses a 3’ exonuclease activity. Even with this added precaution individual clones from
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an amplified pool may still contain unreliable sequence. It has therefore been decided that 
PCR amplification is to be done in triplicate yielding three individual sequences, which can 
then be aligned to give a consensus sequence.
3.1.6 Amplification of HG4 from Avermectin Resistant H. contortus
Current beliefs are that avermectin resistance has resulted from more than one alteration in 
the genetic make-up of the worm (Dent et al, 1997). Multiple genes appear to code for 
avermectin resistance in C. elegans including avr-1, - 5  and-15. The former two are believed 
to play a role in avermectin uptake via the amphids (Perkins, 1906 and Stfarich, 1995). The 
latter avr-15 mutant encodes a defective glutamate-gated chloride channel GluCla2 subunit. 
This defect is caused by a point mutation whereby the codon TGG at position 271 coding a 
tryptophan is mutated to an opal stop codon TGA (Dent et al, 1997). This alteration leads to 
the translation of a truncated protein that is no longer membrane spanning. It is possible that 
several other glutamate-gated chloride channel subunits carry mutations triggering 
avermectin resistance. The HG4 receptor subunit cDNA will be isolated from an avermectin 
resistant population and its sequence will be compared to HG4 from susceptible worms. This 




Figure 11, Total RNA and mRNA extraction from Haemonchus contortus eggs.
Lane 1, mRNA (260 ng) Lane 2, total RNA (1.55 pg)
Ran on a 1 % (w/v) RNase-free agarose gel.
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Total RNA was extracted from two developmental stages of H. contortus, more specifically 
from 1g off adult worms or 1 g of eggs. The mRNA isolated from 200 pg aliquots of total RNA 
was reverse-transcribed, generating cDNA for utilisation in RACE-PCR. A 1 % (w/v) agarose 
gel loaded with total RNA and mRNA from eggs is depicted in figure 11. The faint smear of 
mRNA seen in lane 1 indicates that mRNA isolation was successful and that cDNA synthesis 
could proceed.
3.2.2 Isolation of the 3’ Terminus of HG4 by RACE-PCR
A gene specific sense primer (HG4-GSSP1) was designed to hybridise to a stretch of 21 nts, 
specific toi the partial fragment of HG4. RACE-PCR was carried out using HG4-GSSP1 in 
conjunctioin with the antisense RoRi primer in the presence of cDNA produced from adult 
Haemonchus contortus.
RACE-PCR has a tendency to yield significant amounts of non-specific products due to the 
universal sequence flanking the poly (T) tail that complements the RoRi primer. To 
overcome this problem a semi-nested PCR approach was developed. This required the 
design of a  gene specific sense primer (HG4-GSSP2) which hybridises further down-stream 
of HG4-GSSP1. This technique enabled first round products to be screened using both RoRi 
and the internal HG4-GSSP2 in a second round of PCR as depicted in figure 12.
A potential 3’ RACE product of HG4 was visualised after electrophoresis on a 1 % (w/v) 
agarose gel. Figure 13 depicts a set of PCR reactions yielding the expected size of 
fragments. Lane 2 was loaded with the products of a first round RACE reaction using adult 
cDNA template with HG4-GSSP1 and RoRi primers. A discrete band corresponding to a size 
of approximately 1.06 kbp had been amplified. A semi-nested second round of PCR was 
accomplished using this Sephaglas™ purified 1.06 kbp band as a template along with the 
terminal RoRi primer and the internal primer HG4-GSSP2. The resulting 1.03 kbp band seen 
in lane 5 suggested that the first round product was specific.
3.2.3 Direct Sequencing and Cloning Strategy for 3’ end of HG4
The 1.06 kbp RACE product was primed with HG4-GSSP2 and sequenced using the 
Sequenase™ PCR Product Sequencing Kit. The sequence obtained confirmed that the 
product coded for the 3’ end of HG4. The remaining 1.06 kbp Sephaglas™ purified band was 
treated with DNA polymerase and polynucleotide kinase forming blunt-ended cDNA. This 
was then ligated into an EcoRV cut pBluescript SK+ vector. The resulting construct was 
transformed into the E. coli strain XL1-Blue, promoting blue/white selection. Plasmid DNA 
from white colonies was initially purified using the small-scale plasmid preparation. This 
technique offered a rapid step in which many clones could be purified at once. The 
screening of 18 individual clones was achieved by double digestion with the restriction 












Figure 12, Strategy for Isolating the 3’ end of HG4 using RACE-PCR.
T17 RoRi 3’
in figure 14. The desired constructs released a 1.06 kbp fragment upon digestion as shown 
in lanes 3, 4, 5, 7, 8, 9, 11, 12, 14, and 18. The clone from lanes 7 was re-cultured and 
recombinant plasmids were purified using the Wizard™ Plus DNA purification kit.
Figure 13, Amplification of the 3’ end of HG4 using RACE-PCR.
Lanes 1 & 8: X DNA cut with the restriction enzyme Pst1, respective band sizes listed along 
the side of the gel.
Lane 2: First round PCR reaction using HG4-GSSP1 and RoRi amplifying a 1.06 kbp band 
( * ) •
Lane 3: Single primer PCR control using HG4-GSSP1 
Lane 4: Single primer PCR control using RoRi
Lane 5: Semi-nested PCR of 1.03 kbp using primers HG4-GSSP2 and RoRi with purified 
1.06 kbp band seen in lane 2 as DNA template.
Lane 6: Single primer PCR control using the purified 1.06 kbp band shown in lane 2 as 
template and HG4-GSSP2.
Lane 7: Negative control using primers RoRi and HG4-GSSP2 and no template.
PCRs utilised the Expand™ Long Template PCR System in the presence of 1.75 mM MgCI2 
and 300 nM of each primer. Samples in lanes 1 to 4 were amplified from cDNA template 
synthesised from adult H. contortus mRNA. Cycling conditions: 94 °C denaturation for 2 min, 
followed by the addition of 2.5 U enzyme, after which 40 cycles of 94 °C for 30 sec, 60 °C for 
30 sec and 68 °C for 2 min were run terminating with 7 min at 68 °C. 40 pi of reaction mix
from each sample was separated by electrophoresis on a 1 % (w/v) agarose gel ran in TBE
buffer.
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Figure 14, Restriction digests of HG4 3’ plasmid constructs.
Lanes 1 & 20 contain X cut with Pst1, band sizes are listed in kbp beside the gel.
Lanes 3, 4, 5, 7, 8, 9, 11, 12, 14, & 18 are loaded with constructs possessing the 1.06 kbp 
HG4 3’ PCR product (-»).
Remaining lanes represent plasmids that do not contain the HG4 3’ PCR insert.
Plasmids were previously purified from the E. coli strain XL1-Blue and then digested with the 
endonucleases Xba1 and Xho1 for 1 hour at 37 °C, restricted products were separated by 
electrophoresis on a 1 % (w/v) agarose gel in TBE buffer.
3.2.4 Sequence Analysis of the 3’ end of HG4
Manual sequencing, employing the Sequenase™ Quick-Denature plasmid sequencing kit 
was performed on the Wizard™ Plus purified construct represented in lane 7 of figure 14. A 
preliminary sequence, displayed in figure 15, was obtained consisting of a coding region of 
579 bp followed by a 3’ untranslated region (3’ UTR) of 431 bp, a poly 0T) tail of 17 nts and 
the 28 nt RoRi sequence. This was transferred to the GCG package on the gnome 
workstation and a comparison was made with existing sequences listed in the GenEMBL 
database. The coding region was shown to have a 77.78 % amino acid identity with the C. 
elegans glutamate-gated chloride channel beta subunit, GluClp.
3.2.5 Isolation of the 5’ Terminal of HG4 by RACE-PCR
5’ RACE required the use of a complementary SL1 primer, designed to the splice leader 
sequence, and a gene-specific antisense primer (HG4-GSAP1). As with the isolation of the 
3’ end, a semi-nested approach was taken, primers HG4-GSSP1 and HG4-GSAP1 




1  +  +  +  +  +  +  6 0
TACGTCGAGTGGGATTTTTCCGTCAAGTCAATGATGGACCAGGTCAACATGCCAGGGTGT
M Q L T L K R Q F S Y Y L V Q L Y G P T
ACGATGATAGTGATCGTCTCATGGGTTTCGTTTTGGATCGATATGCATTCAACCGCCGGT
6 1 ---------------------+ ----------------------+ --------------------- + --------------------- + ---------------------+ ----------------------+ 120
TGCTACTATCACTAGCAGAGTACCCAAAGCAAAACCTAGCTATACGTAAGTTGGCGGCCA
T M I V I V S W V S F W I D M H S T A G
CGTGTGGCCCTGGGTGTCACTACCCTGCTGACCATGACCACCATGCAAGCAGCTATCAAT
1 2 1 ------------------------ + --------------------------+ ------------------------- + ------------------------- + -------------------------+ --------------------------+  1 8 0
GCACACCGGGACCCACAGTGATGGGACGACTGGTACTGGTGGTACGTTCGTCGATAGTTA
R V A L G V T T L L T M T T M Q A A I N
GCTAAACTGCCACCGGTGAGCTACGTGAAGGTGGTGGATGTGTGGCTTGGAGCCTGTCAA
1 8 1 -------------------------+ -------------------------- (■--------------------------- 1------------------------- + --------------------------(■--------------------------+  2 4 0
CGATTTGACGGTGGCCACTCGATGCACTTCCACCACCTACACACCGAACCTCGGACAGTT
A K L P P V S Y V K V V D V W L G A C Q
ACATTCGTCTTTGGAGCGTTGCTTGAGTACGCTTTCGTCTCTTATCAAGACAGCCAACGA
2 4 1  -------------------------+ --------------------------+ -------------------------+ ------------------------- + -------------------------+ --------------------------+  3 0 0
TGTAAGCAGAAACCTCGCAACGAACTCATGCGAAAGCAGAGAATAGTTCTGTCGGTTGCT
T F V F G A L L E Y A F V S Y Q D S Q R
CAAACAGAGCAGGCCAAAAGCCGAGCTGCTCGAAAAGCTCAAAAGCGACGAGCTAAAATG
301  -------------------+ --------------------+ ------------------- + ------------------- + ------------------- + --------------------+ 360
GTTTGTCTCGTCCGGTTTTCGGCTCGACGAGCTTTTCGAGTTTTCGCTGCTCGATTTTAC
Q T E Q A K S R A A R K A Q K R R A K M
GAACTCGTCGAAAGAGAACAATACCAACCTCCTTGCACGTGTCATCTGTACCAAGACTAC
3 6 1 ------------------------ + -------------------------- + ---------------------------h-------------------------- h --------------------------1---------------------------+  4 2 0
CTTGAGCAGCTTTCTCTTGTTATGGTTGGAGGAACGTGCACAGTAGACATGGTTCTGATG
E L V E R E Q Y Q P P C T C H L Y Q D Y
GAGCCATCGTTCCGTGACCGGTTGCGGCGCTATTTCACAAAACCCGACTACCTGCCGGCG
4 2 1  ------------------------- + -------------------------- + ------------------------- + ------------------------- + ------------------------- + --------------------------+  4 8 0
CTCGGTAGCAAGGCACTGGCCAACGCCGCGATAAAGTGTTTTGGGCTGATGGACGGCCGC
E P S F R D R L R R Y F T K P D Y L P A
AAAATCGACTACTATGCTCGATTTTGTGTGCCATTAGGCTTTTTAGCCTTCAATGCCATC
4 8 1  -------------------------+ -------------------------- + ------------------------- + ------------------------- + ------------------------- + --------------------------+  5 4 0
TTTTAGCTGATGATACGAGCTAAAACACACGGTAATCCGAAAAATCGGAAGTTACGGTAG
K I D Y Y A R F C V P L G F L A F N A I
Figure 15, See legend see next page.
TATTGGACATCCTGCCTCQTGATGGTGTCAAG ACTAGTCtaatagccatcatcacacagt
541 -------------------+ ------------------- + -------------------+ -------------------+ ------------------- +  + 600
ATAACCTGTAGGACGGAGCACTACCACAGTTCTGATCAGat t  a t  c g g t  a g t  a g t  g t g t  c a
Y W T S C L V M V S R L V
a t t t t g t a a t a t t t c t c g g t g a t t c t a c g a a c t t t g c t c a c t t t t t g c a t t a a a t g g a g a
6 0 1 ----------------------------h--------------------------h ------------------------- + ------------------------- h------------------------- +  - - +  6 6 0
t a a a a c a t t a t a a a g a g c c a c t a a g a t g c t t g a a a c g a g t g a a a a a c g t a a t t t a c c t c t
t c a t a t t g a a t c a a c g a t g g g a t a t c a t a g a g a a a g t t a t g g g a a g c c c t g t t t g t a c t c
6 6 1 -------------------------- + -------------------------+ ------------------------- + ------------------------- H------------------------- +  h 7 2 0
a g t a t a a c t t a g t t g c t a c c c t a t a g t a t c t c t t t c a a t a c c c t t c g g g a c a a a c a t g a g
g a a g t t c a t c t g g g t a t g c c c t g t g g a a a t c a g c c g t a c a c a c t t g t t c a c t t c c g a a a g
7 2 1 ----------------------------H-------------------------+ ------------------------- + -------------------------- h------------------------+ ---------------------------H 7 8 0
c t t c a a g t a g a c c c a t a c g g g a c a c c t t t a g t c g g c a t g t g t g a a c a a g t g a a g g c t t t c
c c h a t g a a a t c g c c tg g g a tg a c tg g t c a g g g t g a c a a g a a g g c c c t t t c t c a c t c a c t c
7 8 1  ------------------------ + ---------------------------+ ------------------------- + ------------------------- + ------------------------+ --------------------------+  8 4 0
g g d ta c t t t a g c g g a c c c t a c t g a c c a g t c c c a c t g t t c t t c c g g g a a a g a g t g a g t g a g
a c t g t c a c c t g t g c a g g a g c g c t t t t c a t g g a g t t t t g g a t t t g g a a t c g t g c g g t c g t t
8 4 1  ------------------------ + ---------------------------+ ------------------------- + ------------------------- + ------------------------+ --------------------------+  9 0 0
tg a c a g tg g a c a c g tc c tc g c g a a a a g ta c c tc a a a a c c ta a a c c t ta g c a c g c c a g c a a
t c c a g t g a c a g a g c t t t c t c t a c t g g a a t a a t t t t g a a c g a t c g g a a g c t c a t t g t t t g a
9 0 i -------------------------- + -------------------------+ ------------------------- + ------------------------- + ------------------------+ --------------------------+  9 6 0
a g g t c a c t g t c t c g a a a g a g a t g a c c t t a t t a a a a c t t g c t a g c c t t c g a g t a a c a a a c t
a t c c t t g a c g a a t a g g a a t t t a t g a a a a g c t a a t a a a c t t t t a c g t a t c a a a a a a a a a a a  
9 6 1  ---------------------+ -----------------------+ --------------------- + --------------------- + --------------------+ ----------------------+ 1020
t a g g a a c t g c t t a t c c t t a a a t a c t t t t c g a t t a t t t g a a a a t g c a t a g t t t t t t t t t t t
a a a a a a c a c g a g a a t tc ta g a tg c ta a c g ta g tc
1 0 2 1  ..............................+ ............................... + .............................. + ----------- 1 0 5 4
t t t t t t g a g c t c t t a a g a t c t a c g a t t g c a t c a g
Figure 15, A preliminary 3’-RACE amplified sequence for HG4 cDNA. Includes the 
coding sequence, 3’ utr, poly(A)17 tail and RoRi sequence. The translated amino acid 
sequence is also displayed below the corresponding nucleotide sequence.
The 1 % (w/v) agarose gel in figure 17 reveals a set of PCR reactions amplifying the HG4 5’ 
cDNA end. Lane 2 was loaded with a RACE-PCR done on adult H. contortus cDNA with 
primers SL1 and HG4-GSAP1. The band of interest, generated from this reaction, has an 
approximate size of 940 bp. Lane 3 was loaded with the reamplification products generated 













PCR, amplifying a 196 bp fragment, can be seen in lane 4 using the 940 bp product as 
template with the primers HG4-GSSP1 and HG4-GSAP1.





Figure 17 Amplification of the 5’ end of HG4 cDNA.
Lane 1: APstl with equivalent band sizes listed beside the gel.
Lane 2: PCR product of 940 bp was obtained using the primers SL1 and HG4-GSAP1 (->). 
Lane 3: PCR reamplification using both SL1 and HG4-GSAP1 primers and purified template 
of the 940 bp product seen in lane 2.
Lane 4: Semi-nested PCR amplified a196 bp band using purified template of the 940 bp 
product seen in lane 2 with primers HG4-GSSP1 and HG4-GSAP1 (->).
The Expand™ Long Template PCR System was used in a series of PCRs in the presence of 
1.75 mM MgCI2 and 300nM of each primer. Adult H. contortus cDNA was used initially as 
template in the reaction run in lane 1.
Cycling conditions: 94 °C denaturation for 2 min, followed by the addition of 2.5 U enzyme, 
after which 45 cycles of 94 °C for 30 sec, 55 °C for 30 sec and 68 °C for 2 min were run 
terminating with 7 min at 68 °C. 10pl of reaction mix from each sample was analysed by 
separation via electrophoresis on a 1 % (w/v) agarose gel run in TBE.
3.2.6 Cloning Strategy used for the 5’ end of HG4
The purified 940 bp fragment represented in lane 2 of figure 17 was blunt-ended using DNA 
polymerase and polynucleotide kinase and then ligated into a pBluescript SK+ vector 
previously digested with EcoRV. This was followed by transformation into the XL1-Blue 
strain of E. coli. Positive white clones were then screened by purifying the plasmids and 
using the restriction enzymes Xba1 and Xho1 to release a 940 bp insert, this is shown in 
figure 18 where lanes 2, 6, 7, 8, 9, 10 and 14 have been loaded with successfully cloned 
constructs. The clone represented in lane 6 was re-cultured and plasmid DNA was purified 
using the Wizard™ Plus kit.
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1 2 6 7 8 9 10 14 15
Figure 18, Restriction digests of the 5’ end of HG4 plasmid.
Lanes 1 & 15: X Pst1, relevant band sizes are indicated.
Lanes 2, 6, 7, 8, 9, 10 & 14 are loaded with purified plasmid containing the HG4 5’ PCR 
product of 940 bp in size (-^).
Remaining lanes contained purified plasmids lacking 5’ PCR product.
Previous to monitoring restriction patterns on a 1 % (w/v) agarose gel, recombinant plasmid 
constructs were purified from XL1-Blue colonies followed by digestion with Xho1 and Xba1 
for h at 37 °C.
3.2.7 Sequence analysis of the 5’ end of HG4
Manual sequencing with the Sequenase™ Quick-Denature plasmid sequencing kit produced 
a preliminary 5’ sequence coding a 22 nt SL1 splice leader sequence followed by a 7 nt 
5’UTR and a 914 bp HG4 coding domain, displayed in figure 19. The sequence was 
transferred to the GCG package on the gnome suite for analysis and comparison with 
existing sequences catalogued in the GenEMBL database. The 5’ sequence of HG4 was 
82.21 % identical at the amino acid level to the GluCip 5’ sequence from C. elegans.
g g t t  ta a  t  t a c c c a a g t  t  tg a g a t  c t  tgaATGTCACAGTATATGATGGTCGCCGTAGCGG
_ 3 0 --------------------------+ ------------------------- + ------------------------- 1 ------------------------- + ----------------------- + --------------------------+  30
c c a a a  t  ta a  tg g g t  tcaaactctagaactTACAGTGTCATATACTACCAGCGGCATCGCC
M S Q Y M M V A V A A -
CCGTGGTCGCAGTGGCAGGTTCGTCCCAGATCTCGCGGCGATCCACTGGTGGCACTCAGG
3 1 -------------------------- + ------------------------- + ------------------------- + ------------------------- + ----------------------- + ------------------------- +  g o
GGCACCAGCGTCACCGTCCAAGCAGGGTCTAGAGCGCCGCTAGGTGACCACCGTGAGTCC
V V A V A G S S Q I  S R R S T G G T Q E -
Figure 19, See legend on next
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AGCAGGAGATTCTCAACGAGCTGCTGTCCAACTACGATATGAGGGTTCGACCGCCACCTT
9 1  +  +  +  +  +  +
TCGTCCTCTAAGAGTTGCTCGACGACAGGTTGATGCTATACTCCCAAGCTGGCGGTGGAA
Q E  I L N E L L S N Y D M R V R P P P S
CCAACTACTCAGATCCAATGGGACCAGTGACAGTCCGGGTCAACATCATGATCAGGATGT
GGTTGATGAGTCTAGGTTACCCTGGTCACTGTCAGGCCCAGTTGTAGTACTAGTCCTACA
N Y S D P M G P V T V R V N I M I R M L
TATCAAAAATTGACGTCGTCAACATGGAGTACAGTATGCAACTAACATTTCGGGGGCAAT
ATAGTTTTTAACTGCAGCAGTTGTACCTCATGTCATACGTTGATTGTAAAGCCCCCGTTA
S K I D V V N M E Y S M Q L T F R G Q W
GGCTTGACTCGCGTCTGGCGTACGCTCACCTCGGCTACCACAACCCACCAAAATTCCTCA
2 7 1 ------------------------ + --------------------------h -------------------------+ ------------------------------ — --------- + --------------------------+
CCGAACTGAGCGCAGACCGCATGCGAGTGGAGCCGATGGTGTTGGGTGGTTTTAAGGAGT
L D S R L A Y A H L G Y H N P P K F L T
CAGTACCACACATCAAAAGCAACCTCTGGATTCCTGACACCTTTTTCCCGACCGAAAAAG
GTCATGGTGTGTAGTTTTCGTTGGAGACCTAAGGACTGTGGAAAAAGGGCTGGCTTTTTC
V P H I K S N L W I P D T F F P T E K A
CAGCACACCGGCATCTCATCGATACGGACAACATGTTCCTTCGAATTCATCCAGATGGAA
GTCGTGTGGCCGTAGAGTAGCTATGCCTGTTGTACAAGGAAGCTTAAGTAGGTCTACCTT
A H R H L I D T D N M F L R I H P D G K
AGGTGTTGTACAGTAGTCGAATTAGCATTACCAGCTCCTGTCACATGCAACTACAACTCT
TCCACAACATGTCATCAGCTTAATCGTAATGGTCGAGGACAGTGTACGTTGATGTTGAGA
V L Y S S R I S I T S S C H M Q L Q L Y
ACCCCTTGGATTTGCAGTTCTGTGACTTTGATCTCGTCAGCTATGCCCATACCATGAAGG
5 1 1 ------------------------ + ------------------------- + -------------------------+ -------------------------+ ------------------------- + --------------------------+
TGGGGAACCTAAACGTCAAGACACTGAAACTAGAGCAGTCGATACGGGTATGGTACTTCC
P L D L Q F C D F D L V S Y A H T M K D
ATATTGTCTACGAATGGGATCCCCTGGCTCCTGTGCAGCTCAAACCCGGTGTAGGAAGTG
TATAACAGATGCTTACCCTAGGGGACCGAGGACACGTCGAGTTTGGGCCACATCCTTCAC
I V Y E W D P L A P V Q L K P G V G S D












6 3 1  - - - - -------------+ -------------------------- + ------------------------+ -------------------------- h -------------------------h ------------------------- +  6 9 0
TGGACGGATTGAAAGTCGAGTGTTTATAGTGGTGGTTACTCCTGACATGATCGGTATGGT
L P N F Q L T N I T T N E D C T S H T N -
ATACTGGGTCGTACGCCTGCCTGAGGATGCAGCTCACCCTAAAAAGGCAGTTCAGTTACT
6 9 1  ------------------------ + -------------------------- + ------------------------+ ------------------------- + ------------------------ + ------------------------- +  7 5 0
TATGACCCAGCATGCGGACGGACTCCTACGTCGAGTGGGATTTTTCCGTCAAGTCAATGA
T G S Y A C L R M Q L T L K R Q F S Y Y -
ACCTGGTCCAGTTGTACGGTCCCACAACGATGATAGTGATCGTCTCATGGGTTTCGTTTT
7 5 1  ------------------------+ -------------------------- + ------------------------+ ------------------------- + ------------------------ + ------------------------- +  8 1 0
TGGACCAGGTCAACATGCCAGGGTGTTGCTACTATCACTAGCAGAGTACCCAAAGCAAAA
L V Q L Y G P T T M I V I V S W V S F W -
GGATCGATATGCATTCAACCGCCGGTCGTGTGGCCCTGGGTGTCACTACCCTGCTGACCA
8 1 1 -------------------------+ ------------------------- + ------------------------+ ------------------------- + ------------------------ + ------------------------- +  8 7 0
CCTAGCTATACGTAAGTTGGCGGCCAGCACACCGGGACCCACAGTGATGGGACGACTGGT
I  D M H S T A G R V A L G V T T L L T M -
TGACCACCATGCAAGCAGCTATCAATGCTAAACTGCCACCGGT
8 7 1 ------------------------- + ------------------------- + ------------------------+ ------------------------- + ------ 9 1 3
ACTGGTGGTACGTTCGTCGATAGTTACGATTTGACGGTGGCCA
T T M Q A A I N A K L P P
Figure 19, A preliminary 5’-RACE amplified sequence for HG4. The sequence includes 
the SL1 sequence, the 5’ UTR and the coding sequence. The translated amino acid 
sequence is also displayed underneath the corresponding nucleotide sequence.
3.2.8 Isolation of Full Length Clones of HG4
A complete sequence for HG4 can be compiled using the 5’-, 3’- and partially amplified PCR 
fragments. However, to ensure that these amplified products represented sequence from a 
single receptor subunit cDNA, a full-length HG4 cDNA was amplified directly from H. 
contortus.
Preliminary HG4 sequence was consulted to design two gene specific primers for use in a 
single step amplification of a full-length copy of the cDNA. Addition of restriction sites at the 
ends of each primer facilitated access of the insert when cloned. These sites were selected 
by screening the sequence for enzyme cleavage motifs using the GCG package. Absence of 
Not1 and Xba1 enzyme cleavage sites consequently meant that they could be incorporated 
into the primer sequence. This was confirmed by digesting both 5’ and 3’ clones with Not1 
and Xba1 and then viewing resultant restriction products on a 1% (w/v) agarose gel.
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A sense primer (HG4-CSP1), with an added Not 1 restriction site at its 5’ end, was designed 
to hybridise to the 5’ sequence downstream of SL1. Similarly, an antisense primer (HG4- 
CAP1) was designed to the 3’ UTR sequence and included a Xba1 site at its 5’ end. Primer 
sequences are listed in Appendix 3.
Full length HG4 was amplified in duplicate (Figure 20a and b) from first strand egg cDNA in 
the presence of sense and antisense primers giving a 1.3 kbp product. Each band was 
Sephaglas™ purified and restricted with Not1 and Xba1. The resulting sticky ended products 
were then ligated into a pBluescript SK+ vector, which had previously been double digested 
with Not1 and Xba1. The new constructs from both PCRs were cloned into XL1-Blues and 
white colonies were selected from each construct for plasmid purification and restriction 
screening.
Figure 20, Amplification of Full-Length HG4 cDNA.
Lane 1: X DNA restricted with Pst1, relevant sizes of bands are listed
Lane 2: Full-length HG4 PCR product of 1.3 kbp amplified using primers HG4-CSP1 and
HG4-CAP1 (-»).
A, Product amplified using the Expand™ Long Template System in the presence of 1.75 mM 
MgCI2. B, Amplification achieved using the Expand™ High Fidelity kit with 1.5 mM MgCI2. 
Each PCR required the use of cDNA reverse transcribed from H. contortus egg mRNA and 
300 nM of each primer.
Cycling conditions: 94 °C denaturation for 2 min, followed by the addition of 2.5 U enzyme, 
after which 45 cycles of 94 °C for 30 sec, 43 °C for 30 sec and 68 °C (A) or 72 °C (B) for 2 
min were run terminating with 7 min at 68 °C (A) or 72 °C (B). 40pl (A) and 80 pi (B) of 
reaction mix from each sample was separated by electrophoresis on a 1 % (w/v) agarose gel 
run in TBE.
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Figure 21 displays successful transformations present in lanes 2, 3, 5 and 6. Automated 
sequencing of clones 8 (in lane 2) and 14 (in lane 6) was performed using the sense primers 
HG4-GSSP1, HG4-GSSP3, T3 and the antisense primers HG4-GSAP1, HG4-GSAP2 and 
KS. Primer sequences are detailed in Appendix 3 and their complementary sites along the 
constructs are illustrated in figure 22.




Figure 21, Restriction of plasmid constructs containing full-length HG4 DNA
Lanes 1 & 9: A, DNA digested with the Pst1 enzyme, relevant sizes of bands are noted next to 
the lane.
Lanes 2 & 3: Plasmid constructs possessing the 1.3 kbp insert amplified with the Expand™ 
Long Template PCR system (figure 20a). Lanes 5 & 6: Plasmid constructs encoding the 1.3 
kbp insert produced using the High Fidelity system (figure 20b).
Remaining lanes were loaded with plasmids that did not encode the 1.3 kbp HG4 DNA. 
Recombinant plasmids were purified from XL1-Blue colonies with the Wizard™ Plus kit 
followed by double digestion with the restriction enzymes Xho1 and Xba1 for 1 h at 37 °C. 
Restriction patterns were monitored on a 1 % (w/v) agarose gel by electrophoresis. 
Successful transformants released a 1.3 kbp fragment indicated by
Full length sequences from clones 8 and 14 were aligned with the preliminary 5’ and 3’ 
sequences to distinguish areas with nucleotide variation as shown in figure 22. 
Consequently, the percentage variation between each clone was calculated at both the 











Figure 22, Sequencing strategy for Full-Length HG4
A schematic diagram representing the pBluescript vector with HG4 ligated into the multiple 
cloning site. Areas coding for transmembrane spanning regions are labelled 1 to 4. 
Sequencing involved the use of gene specific sense primers (HG4-GSSP), gene specific 
antisense primers (HG4-GSAP) and plasmid specific primers (KS and T3). Each of the 
primers used is listed with corresponding sites to which they hybridise to, indicated with an 
arrow, —►. Regions of sequence obtained with primers were also shown by colour coded 
arrows For example the KS primer ( -►  ) was used to sequence the region marked by 
the -> arrow.
1 50
5 ' HG4 g g t t t a a t t a  c c c a a g t t t g  a g a t c t t g a A  TGTCACAGTA TATGATGGTC
3 ' HG4 ..........................................................................................................................................
W h o le  H G 4(8 ) ..... ............................................................................. A  TGTCACAGTA TATGATGGTC
W h o le  H G 4(1 4 ) ............................................................................. A  TGTCACAGTA TATGATGGTC
W h o le  H G 4(3 ) ..... ............................................................................. A  TGTCACAGTA TATGATGGTC
C o n s e n s u s  g g t t t a a t t a  c c c a a g t t t g  a g a t c t t g a A  TGTCACAGTA TATGATGGTC
51 100
5 ' HG4 g c c g ta g c g g  c c g t g g t c g c  a g t g g c a g g t  t c g t c c c a g a  tc tc g c g g c g
3 'HG4 ..........................................................................................................................................
W h o le  H G 4(8 )  GCCGTAGCGG CCGTGGTCGC AGTGGCAGGT TCGTCCCAGG TCTCGCGGCG
W h o le  H G 4(1 4 ) GCfGTAGCGG CCGTAGTCGC AGTGGCACGT TCGTCCCAGA TCTCGCGGCG
W h o le  H G 4(3 ) GCCGTAGCGG CCGTGGTCGC AGTGGCAGGT TCGTCCCAGA TCTCGCGGCG
C o n s e n s u s  GCTGTAGCGG CCGTRGTCGC AGTGGCASGT TCGTCCCAGBL TCTCGCGGCG
Figure 23, See figure legend on following page.
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101  150
5 ' HG4 ATCCJfcCTGGT GGCACTCAGG AGCAGGAGAT TCTCAACGAG CTGCTGTCCA 
3 ' HG4 ...........................................................................................................................................
W h o le  H G 4(8 ) ATCCACTGGT GGCACTCAGG AGCAGGAGAT TCTCAACGAG CTGCTGTCCA
W h o le  H G 4(1 4 ) ATCCACTGGT GGCACTCAGG AGCAGGAGAT TCTCAACGAG CTGCTGTCCA
W h o le  H G 4(3 ) ATCCGCTGGT GGCACTCAGG AGCAGGAGAT TCTCAACGAG CTGCTGTCCA
C o n s e n s u s ATCCRCTGGT GGCACTCAGG AGCAGGAGAT TCTCAACGAG CTGCTGTCCA
151 200
5 ' HG4 ACTACGATAT GAGGGTTCGA CCGCCACCTT CGAACTACTC AGATCCAATG
3 ' HG4
W h o le  H G 4(8 ) ACTACGATAT GAGGGTTCGA CCGCCACCTT CGAACTACTC AGATCCAATG
W h o le  H G 4(1 4 ) ACTACGATAT GCGTGTTCGA CCGCCACCTT CGAACTACTC AGATCCAATG
W h o le  H G 4(3 ) ACTACGATAT GAGGGTTCGA CCGCCACCTT CGAACTACTC AGATCCAATG
C o n s e n s u s ACTACGATAT GMGKGTTCGA CCGCCACCTT CSAACTACTC AGATCCAATG
201 250
5 ' HG4 GGACCAGTGA CAGTGCGGGT CAACATCATG ATCAGGATGT TATCAAAAAT
3 ' HG4
W h o le  H G 4(8 ) GGACCAGTGA CAGTTCGGGT CAACATCATG ATCAGGATGT TATCAAAAAT
W h o le  H G 4(1 4 ) GGACCAGTGA CAGTfCGGGT CAACATCATG ATCAGGATGT TATCAAAAAT
W h o le  H G 4(3 ) GGACCAGTGA CAGTGCGGGT CAACATCATG ATCAGGATGT TATCAAAAAT
C o n s e n s u s GGACCAGTGA CAGTYCGGGT CAACATCATG ATCAGGATGT TATCAAAAAT
251 300
5 ' HG4 TGACGTCGTC AACATGGAGT ACAGTATGCA ACTAACATTT CGGGGGCAAT
3 ' HG4
W h o le  H G 4(8 ) TGACGTCGTC AACATGGAGT ACAGTATGCA ATTGACGTTT CGGGAGCAAT
W h o le  H G 4(1 4 ) TGACGTCGTC AACATGGAGT ACAGTATGCA ACTGACATTT CGGGAGCAGT
W h o le  H G 4(3 ) TGACGTCGTC AACATGGAGT ACAGTATGCA ACTAACATTT CGGGAGCAAT
C o n s e n s u s TGACGTCGTC AACATGGAGT ACAGTATGCA AYTRACRTTT CGGGRGCART
301 350
5 ' HG4 GGCTTGACTC GCGTCTGGCG TACGCTCACC TCGGCTACCA CAACCCACCA
3 ' HG4
W h o le  H G 4(8 ) GGCTTGACTC GCGTCTGGCG TACGCTCACC TCGGCTACCA CAACCCTCCG
W h o le  H G 4(1 4 ) GGCTTGACTC GCGTCTGGCG TACGCTCACC TCGGCTACCA CAACCCTCCG
W h o le  H G 4(3 ) GGCTTGACTC GCGTCTGGCG TACGCTCACC TCGGCTACCA CAACCCACCA
C o n s e n s u s GGCTTGACTC GCGTCTGGCG TACGCTCACC TCGGCTACCA CAACCCWCCR
351 400
5 ' HG4 AAATTCCTCA CAGTACCACA CATCAAAAGC AACCTCTGGA TTCC|GACAC
3 ' HG4
W h o le  H G 4(8 ) AAATTCCTCA CpGTAC CACA CATCAAAAGC AACCTCTGGA TTCCGGACAC
W h o le  H G 4(1 4 ) AAATTCCTCA CpGTACCACA CATCAAAAGC AACCTCTGGA TTCCTGACAC
W h o le  H g 4 (3 ) AAATTCCTCA CAGTACCACA CATCAAAAGC AACCTCTGGA TTCCTGACAC
C o n s e n s u s AAATTCCTCA CRGTACCACA CATCAAAAGC AACCTCTGGA TTCCRGACAC
401 450
5 ' HG4 CTTTTTCCCG ACCGAAAAAG CAGCACACCG GCATCTCATC GATACGGACA
3 ' HG4
W h o le  H G 4(8 ) CTTTTTCCCG ACCGAAAAAG CGGCACACCG GCATCTCATC GAGACGGACA
W h o le  H G 4(1 4 ) CTTTTTCCCG ACCGAAAAAG CAGCACACCG GCATCTCATC GAGACGGACA
W h o le  H G 4(3 ) CTTTTTCCCG ACCGAAAAAG CAGCACACCG GCATCTCATC GAifSACGGACA
C o n s e n s u s CTTTTTCCCG ACCGAAAAAG CRGCACACCG GCATCTCATC GAYACGGACA
igure 23, see figure legend on following page.
86
451  500
5 ' HG4 ACATGTTCCT TCGAATTCAT CCAGATGGAA AGGTGTTGTA CAGTAGTCGA 
3 ' HG4 ..........................................................................................................................................
W ho le  H G 4(8 ) ACATGTTCCT TCGGATTCAT CCAGATGGAA GGGTGTTGTA CAGTAGTCGA
W h o le  HG 4(1 4 ) ACATGTTCCT TCGAATTCAT CCAGATGGAA AGGTGCTGTA CAGTAGTCGA
W h o le  HG4(3 ) ACATGTTCCT TCGAATTCAT CCAGATGGAA AGGTGTTGTA CAGTAGTCGA
C o n se n su s ACATGTTCCT TCGAATTCAT CCAGATGGAA RGGTGYTGTA CAGTAGTCGA
501 550
5 ' HG4 ATTAGCATTA CCAGCTCCTG TCACATGCAA CTACAACTCT ACCCCTTGGA
3 ' HG4
W h o le  HG4(8 ) ATTAGCATTA CCAGCTCCTG TCACATGCAA CTACAACTCT ACCCCTTGGA
W h o le  H G 4(1 4 ) ATTAGCATTA CCAGCTCCTG CCATATGCAA CTACAACTCT ACCCCTTGGA
W h o le  H G 4(3 ) ATTAGCATTA CCAGCTCCTG TCACATGCAA CTACAACTCT ACCCCTTGGA
C o n se n su s ATTAGCATTA CCAGCTCCTG YCAYATGCAA CTACAACTCT ACCCCTTGGA
551 600
5 ' HG4 TTTGCAgTTC TGTGACTTTG ATCTCGTCAG CTATGCCCAT ACpATGAAGG
3 ' HG4
W h o le  HG4(8 ) TTTGCAGTTC TGTGACTTTG ATCTCGTCAG CTATGCCCAT ACgATGAAGG
W h o le  HG 4(1 4 ) TTTGCAJSTTC TGTGACTTTG ATCTCGTCAG CTATGCCCAT a c Ga t g a a g g
W h o le  H G 4(3 ) TTTGCAGTTC TGTGACTTTG ATCTCGTCAG CTATGCCCAT AC0ATGAAGG
C o n se n su s TTTGCABTTC TGTGACTTTG ATCTCGTCAG CTATGCCCAT ACSATGAAGG
601 650
5 ' HG4 ATATTGTCTA CGAATGGGAT CCCCTGGCTC CTGTGCAGCT CAAACCCGGT
3 ' HG4
W h o le  H G 4(8 ) ATATTGTCTA CGAATGGGAT CCCCTGGCTC CTGTGCAGCT CAAACCCGGT
W h o le  HG 4(1 4 ) AGATTGTCTA CGAATGGGAC CCCCTGGCTC CTGTGCAGCT CAAACCCGGT
W h o le  H G 4(3 ) ATATTGTCTA CGAATGGGAT CCCCTGGCTC CTGTGCAGCT CAAACCCGGT
C o n se n su s ATATTGTCTA CGAATGGGAY CCCCTGGCTC CTGTGCAGCT CAAACCCGGT
651 700
5 ' HG4 GTAGGAAGTG ACCTGCCTAA CTTfCAGCTC ACAAATATCA CCACCAATGA
3 ' HG4
W h o le  H G 4(8 ) GTAGGAAGTG ACCTGCCTAA c t t T c a g c t c ACAAATATCA CCACCAATGA
W h o le  HG 4(1 4 ) GTAGGAAGTG ACCTGCCTAA c t t | c a g c t c ACAAATATCA CCACCAATGA
W h o le  H G 4(3 ) GTAGGAAGTG ACCTGCCTAA CTTTCAGCTC ACAAATATCA CCACCAATGA
C o n se n su s GTAGGAAGTG ACCTGCCTAA CTTfCAGCTC ACAAATATCA CCACCAATGA
701 750
5 ' HG4 GGACTGTACT AGCCATACGA ATACTGGGTC GTACGCCTGC CTGAGGATGC
3 ' HG4 ............. ATGC
W h o le  H G 4(8 ) CGACTGiACT AGCCATACCA ATACTGGGTC ATACGCCTGT CTGAGGATGC
W h o le  H G 4(1 4 ) CGACTGCACT AGCCATACTA ATACTGGGTC |TACGCCTGY CTGAGGATGC
W h o le  H G 4(3 ) GGACTGTACT AGCCATACGA ATACTGGGTC GTACGCCTGC CTGAGGATGC
C o n se n su s SGACTGYACT AGCCATACYA ATACTGGGTC RTACGCCTGY CTGAGGATGC
751 800
5 ' HG4 A§CTCACCCT AAAAAGGCAG TTCAGTTACT ACCTGGTCCA GTTGTACGGT
3 ' HG4 ASCTCACCCT AAAAAGGCAG TTCAGTTACT ACCTGGTCCA fjTTGTACGGT
W h o le  H G 4(8 ) AGCTCACCCT AAAACGACAG TTCAGTTACT ACCTGGTCCA Gt t g t a c g g t
W h o le  H G 4(1 4 ) AACTCACCCT AAAAAGGCAG TTCAGTTACT ACCTftGTCCA ATTGTACGGT
W h o le  H G 4(3 ) AfSCTCACCCT AAAAAGGCAG TTCAGTTACT ACCTGGTCCA GTTGTACGGT
C o n se n su s ARCTCACCCT AAAAMGRCAG TTCAGTTACT ACCTRGTCCA llTTGTACGGT
Figure 23, See figure legend on following page.
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801 850
5 ' HG4 CCCACAACGA TGATAGTGAT CGTCTCATGG GTTTCGTTTT GGATCGATAT
3 ' HG4 CCCACAACGA TGATAGTGAT CGTCTCATGG GTTTCGTTTT GGATCGATAT
W h o le  HG4(8 ) CCCACAACGA TGATAGTGAT CGTCTCATGG GTTTCGTTTT GGATCGATAT
W h o le  HG 4(1 4 ) CCCACAACGA TGATAGTGAT CGTCTCATGG GTTTCGTTTT GGATCGATAT
W h o le  H G 4(3 ) CCCACAACGA TGATAGTGAT CGTCTCATGG GTTTCGTTTT GGATCGATAT
C o n se n su s CCCACAACGA TGATAGTGAT CGTCTCATGG GTTTCRTTTT GGATCGATAT
851 900
5 ' HG4 GCATTCAACC GCCGGTCGTG TGGCCCTGGG TGTCACTACC CTGCTfACCA
3 ' HG4 GCATTCAACC GCCGGTCGTG TGGCCCTGGG TGTCACTACC CTGCTGACCA
W h o le  HG4(8 ) GCATTCAACG GCCGGTCGTG TGGCCCTGGG TGTCACTACC CTGCTGACCA
W h o le  HG 4(1 4 ) GCATTCAACG GCCGGTCGTG TGGCCCTGGG TGTCACTACC CTGCTAACCA
W h o le  HG4(3 ) GCATTCAACG GCCGGTCGTG TGGCCCTGGG TGTCACTACC CTGCT&ACCA
C o n se n su s GCATTCAACS GCCGGTCGTG TGGCCCTGGG TGTCACTACC CTGCTRACCA
901 950
5 ' HG4 TGACCACCAT GCAAGCAGCT ATCAATGCTA AACTGCCACC |G T ................
3 '  HG4 TGACCACCAT GCAAGCAGCT ATCAATGCTA AACTGCCACC GGTGAGCTAC
W h o le  HG 4(8 ) TGACCACCAT GCAAGCAGCT ATCAATGCTA AACTGCCACC GGTGAGCTAC
W h o le  H G 4(1 4 ) TGACCACCAT GCAAGCAGCC ATCAATGCTA AACTGCCACC TGTGAGCTAC
W h o le  HG 4(3 ) TGACCACCAT GCAAGCAGCC ATCAATGCTA AACTGCCjfCC fGTGAGCTAC
C o n se n su s TGACCACCAT GCAAGCAGCT ATCAATGCTA AACTGCCMCC KGTGAGCTAC
951 1000
5 ' HG4
3 ' HG4 GTGAAGGTpG TQGATGTGTG GCTTGGAGCC t g t c a a a c At TCGTpTTTGG
W h o le  H G 4(8 ) GTGAAGGTqjG T$GATGTGTG GCTTGGAGCC TGTCAAACAT TCGTGTTTGG
W h o le  HG 4(1 4 ) GTGAAGGTfcG TAGATGTGTG GCTCGGAGCC TGTCAAACGT TCGTGTTTGG
W h o le  H G 4(3 ) GTGAAGGTAG TAGATGTGTG GCTCGGAGCC TGTCAAACGT TCGTGTTTGG
C o n se n su s GTGAAGGTRG TRGATGTGTG GCTfGGAGCC TGTCAAACRT TCGTGTTTGG
1001 1050
5 ' HG4
3 ' HG4 AGCGfTGCTf GAGTACGCTT TCGTCTCTTA TCAAGACAGC CAACGACAAA
W h o le  H G 4(8 ) AGCGfTGCT? GAGTACGCTT TCGTCTCTTA TCAAGACAGC CAACGACAAA
W h o le  HG 4(1 4 ) AGCGCTGCTC GAATACGCGT TCGTCTCTTA TCAAGACAGC CAACGACAAG
W h o le  H G 4(3 ) AGCGfTGCTl GAATACGCGT TCGTCTCTTA TCAAGACAGC CAACGACAAA
C o n se n su s AGCGVTGCTY GARTACGCKT TCGTCTCTTA TCAAGACAGC CAACGACAAR
1051 1100
5 ' HG4
3 ' HG4 CAGAGCAGGC CAAAAGCCGA GCTGCTCGAA AAGCTCAAAA GCGACGAGCT
W h o le  H G 4(8 ) CAGAGCAGGC CAAAAGCCGA GCTGCTCGAA AAGCTCAAAA GCGACGAGCT
W h o le  H G 4(1 4 ) CAGAGCAGGC CAAAAGCCGA GCTGCTCGAA AAGCTCAAAA GCGACGlGCp
W h o le  H G 4(3 ) CAGAGCAGGC CAAAAGCCGA GCTGCTCGAA AAGCTCAAAA GCGACGfGCf
C o n se n su s CAGAGCAGGC CAAAAGCCGA GCTGCTCGAA AAGCTCAAAA GCGACGWGCY
1101 1150
5 ' HG4
3 ' HG4 AAAATGGAAC TCGTCGAAAG AGAACAATAC CAACCTCCTT GCACGTGTCA
W h o le  H G 4(8 ) AAAATGGAAC TCGTCGAAAG AGAACAATAC CAACCTCCTT GCACGTGTCA
W h o le  HG 4(1 4 ) AAAATGGAAC TCGTCGAAAG AGAACAATAC CAACCTCCTT GCACGTGTCA
W h o le  H G 4(3 ) AAAATGGAAC TCGTCGAAAG AGAACAATAC CAACCTCCTT GCACGTGTCA
C o n se n su s AAAATGGAAC TCGTCGAAAG AGAACAATAC CAACCTCCTT GCACGTGTCA
Figure 23, See figure legend on following page.
1151 1200
5 ' HG4
3 ' HG4 TCTGTACCAA GACTACGAGC CATCGTTCCG TGACCGGTTG CGGCGCTATT
W ho le  H G 4(8 ) TCTGTACCAA GACTACGAGC C§TCGTTCCG TGACCGGTT0 CGGCGCTATT
W ho le  H G 4(1 4 ) TCTGTACCAA GACTATGAGC CQTCGTTCCG TGACCGGTTR CGGCGCTATT
W ho le  H G 4(3 ) TCTGTACCAA GACTATGAGC CGTCGTTCCG TGACCGGTTR CGGCGCTATT
C o n se n su s TCTGTACCAA GACTACGAGC CRTCGTTCCG TGACCGGTTR CGGCGCTATT
1201 1250
5 ' HG4
3 ' HG4 TCACAAAACC CGACTACCTG CCSGCGAAAA TCGACTACTA TGCTCGATTT
W h o le  H G 4(8 ) TCACAAAACC CGACTACCTG CCGGCGAAAA TCGACTACTA TGCTCGATTT
W h o le  H G 4(1 4 ) TCACAAAACC CGACTACCTG CCAGCGAAAA TCGACTACTA TGCTCGATTT
W h o le  H G 4(3 ) TCACAAAACC CGACTACCTG CCftGCGAAAA TCGACTACTA TGCTCGATTT
C o n s e n s u s TCACAAAACC CGACTACCTG CCRGCGAAAA TCGACTACTA TGCTCGATTT
1251 1300
5 ' HG4
3 ' HG4 TGTGTGCCAT TAGGCTTTTT AGCCTTCAAT GCCATCTAfT GGACATCCTG
W h o le  H G 4(8 ) TGTGTGCCAT TAGGCTTTTT AGCCTTCAAT GCCATCTATT GGACATCCTG
W h o le  H G 4(1 4 ) TGTGTGCCAT TAGGCTTTTT AGCCTTCAAT GCCATCTACT GGACATCCTG
W h o le  H G 4(3 ) TGTGTGCCAT TAGGCTTTTT AGCCTTCAAT GCCATCTACT GGACATCCTG
C o n se n su s TGTGTGCCAT TAGGCTTTTT AGCCTTCAAT GCCATCTATT GGACATCCTG
1301 1350
5 ' HG4
3 ' HG4 CCTCGTGATG GTGTCAAGAC T A G T C ta a ta g c c a t c a t c a c a c a g t a t t t
W h o le  H G 4(8 ) CCTCGTGATG GTGTCAAGAC TAGTC...........
W h o le  H G 4(1 4 ) CCTCGTGATG GTGTCAAGAC TAGTC...........
W h o le  H G 4(3 ) CCTCGTGATG GTGTCAAGAC TAGTC...........
C o n s e n s u s CCTCGTGATG GTGTCAAGAC T A G T C ta a ta g c c a t c a t c a c a c a g t a t t t
1351 1400
3 ' HG4 t g t a a t a t t t c t c g g t g a t t c t a c g a a c t t t g c t c a c t t t t t g c a t t a a a
C o n se n su s t g t a a t a t t t c t c g g t g a t t c t a c g a a c t t t g c t c a c t t t t t g c a t t a a a
1401 1450
3 '  HG4 tg g a g a t c a t a t t g a a t c a a c g a tg g g a ta tc a ta g a g a a a g t t a t g g g a
C o n s e n s u s tg g a g a t c a t a t t g a a t c a a c g a tg g g a ta tc a ta g a g a a a g t t a t g g g a
1451 1500
3 '  HG4 a g c c c t g t t t g ta c tc g a a g t t c a t c t g g g t a t g c c c t g t g g a a a tc a g c
C o n s e n s u s a g c c c t g t t t g ta c tc g a a g t t c a t c t g g g t a t g c c c t g t g g a a a tc a g c
1501 1550
3 ' HG4 c g ta c a c a c t t g t t c a c t t c c g a a a g c c g a tg a a a tc g c c t g g g a t g a c t
C o n s e n s u s c g ta c a c a c t t g t t c a c t t c c g a a a g c c g a tg a a a tc g c c t g g g a t g a c t
1551 1600
3 '  HG4 g g tc a g g g tg a c a a g a a g g c c c t t t c t c a c t c a c t c a c t g t c a c c t g t g c
C o n s e n s u s g g tc a g g g tg a c a a g a a g g c c c t t t c t c a c t c a c t c a c t g t c a c c t g t g c
1601 1650
3 '  HG4 a g g a g c g c t t t t c a t g g a g t t t t g g a t t t g g a a tc g tg c g g t c g t t t c c a
C o n s e n s u s a g g a g c g c t t t t c a t g g a g t t t t g g a t t t g g a a tc g tg c g g t c g t t t c c a
igure 23, See figure legend on next page.
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1 6 5 1  1700
3 ' HG4 g tg a c a g a g c  t t t c t c t a c t  g g a a t a a t t t  tg a a c g a tc g  g a a g c t c a t t  
C o n se n su s  a g g a g c g c t t  t t c a t g g a g t  t t t g g a t t t g  g a a tc g tg c g  g t c g t t t c c a
1 7 0 1  1750
3 ' HG4 g t t t g a a t c c  t t g a c g a a t a  g g a a t t t a t g  a a a a g c ta a t  a a a c t t t t a c  
C o n se n su s  g t t t g a a t c c  t t g a c g a a t a  g g a a t t t a t g  a a a a g c ta a t  a a a c t t t t a c
17 51  
3 ' HG4 g t a t c t  
C o n se n su s  g t a t c t
Figure 23, Sequence alignment of HG4 from different PCR amplifications. Sequence for 
HG4 3’, HG4 5’, whole HG4(8) and whole HG4(14) were derived from PCR amplifications 
displayed in figures 13, 17, 20a and 20b respectively. The production of HG4 whole(3) is 
described in the next section with details of its amplification in figures 25 and 26. Shaded 
regions highlight nts that vary between the clones. A consensus sequence is also displayed 
with a summary of possible nts highlighted in bold. Y codes either a C or a T, M codes either 
an A or a C, R: an A  or a G, S: a G or a C, K: a G or a T and W: an A or a T. Nucleotides in 
uppercase are coding sequence whilst lower case nucleotides represent the UTRs.
Table 6, Percentage variation between the HG4 RACE amplified cDNA clones at the 
nucleotide level. 3’ HG4, 5’ HG4\ clone 8 and clone 14 were derived by PCR detailed in 
figures 13, 17, 20a and 20b respectively. The production of clone 3 is described in the next 
section with details of its amplification in figures 25 and 26. Values are calculated by dividing 
the number of mismatches by the length of overlapping sequence. These details are noted in 
brackets.
3’ HG4 (579 nt) Clone 8 (1296 nt) Clone 14(1296 nt) Clone 3(1296 nt)
5’ HG4 
(914nt)
0.00% (0/197) 2.08% (19/914) 3.94% (36/914) 0.55% (5/914)
3’ HG4 
(579nt)
0.35% (2/579) 4.49% (26/579) 3.45% (20/579)
Clone 8 
(1296 nt)




Table 7, Percentage variation between the HG4 PCR amplifications at the amino acid 
level. 3’ HG4, 5’ HG4’, clone 8 and clone 14 were derived by PCR detailed in figures 13, 17, 
20a and 20b respectively. The production of clone 3 is described in the next section with 
details of its amplification in figures 25 and 26. Values are calculated by dividing the number 
of amino acid mismatches by the length of overlapping sequence. These details are noted in 
brackets.
3’HG4 (193 aa) Clone 8 (432 aa) Clone 14 
(432aa)
Clone 3 (432 aa)
5’HG4 (304 aa) 0.00% (0/64) 1.32% (4/304) 0.99% (3/304) 0.99% (3/304)
3’HG4 (192 aa) 0.00% (0/192) 0.52% (1/192) 0.00% (0/192)
Clone 8 (432 aa) 0.93% (4/432) 0.69%(3/432)
Clone 14 (432aa) 0.69% (3/432)
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Nucleotide variation may be a direct result of the introduction of errors during the 45 rounds 
of PCR. It is also probable that variation may be attributed to polymorphism existing between 
mRNA transcripts extracted from different nematodes. Sequences from clones 8 and 14 
were compared with existing sequences present in the GenEMBL database and were found 
to have a 79.41 % and 79.66 % amino acid identity respectively with GluCI p. Comparison at 
the nucleotide level showed that the respective clones were 70.24 % and 70.15 % identical to 
GluCI p.
3.2.9 Ligation of 5’ and 3’ PCR Products
The independently amplified clones 8 and 14 each possessed 2 codon alterations, which 
gave rise to a change in the amino acid sequence coding for the receptor subunit as 
summarised in table 3. These differences may be a consequence of polymorphism or they 
may have been introduced by PCR. The enzyme used in the reaction has been calculated to 
have a 8.5 x 10-6 error rate as detailed in the Expand™ protocol. Clones 8 and 14, 
approximately 1.3 kbp in size have undergone 45 cycles thus increasing the likelihood of 
mutations occurring. To eliminate the possibility that the variation seen was PCR induced, 
attempts to amplify the whole HG4 cDNA were made with a reduced number of cycles. 
Reactions using less than 45 cycles however yielded bands of very low intensity which could 
not be used for ligation.
Table 8, Amino Acid variation between HG4 clones 8 and 14.





An alternate approach whereby 5’ and 3’ fragments, amplified using the least number of PCR 
cycles, were ligated together. A unique Nsi1 endonuclease restriction site located 
approximately 850 nucleotides into the sequence was exploited to link both ends together, 
this strategy is displayed in figure 24.
The 5’ fragment was amplified using the primers HG4-CSP1 and HG4-GSAP1 (Appendix 3) 
using a number of different cycles. This was done to try and optimise the level amplified 
possessing the least amount of PCR induced mutations. An approximate 930 bp fragment 
was amplified after 35, 40 and 45 cycles and is shown in figure 25.
Further PCRs were performed to amplify a 3’ end with the least amount of PCR induced 
mutations. The primers HG4-CSAP1 and HG4-GSSP1 were used to amplify a 610 bp 
fragment using 35, 40 and 45 cycles, these products were analysed on a 1% (w/v) agarose 
















Figure 24, Production of a full-length HG4 clone using a three-way ligation
Figure 25, Amplification of the 5’ end of HG4 using a range
Lanes 1& 8: X DNA cut using Pst1 with relevant band sizes noted in parallel.
Duplicate PCRs were done to amplify the 930 bp 5’ end of HG4. Lanes 2 & 3: products 
amplified after 35 cycles. Lanes 4 & 5: after 40 cycles. Lanes 6 & 7: after 45 cycles.
The Expand™ High Fidelity System was utilised requiring the presence of 300 nM of HG4- 
GSAP1 and HG4-CSP1 primer, H. contortus cDNA template reverse transcribed from eggs 
and 1.5 mM MgCI2.
Cycling conditions: 94 °C denaturation for 2 min, followed by the addition of 2.5 U enzyme, 
after which 35, 40 or 45 cycles of 94 °C for 30 sec, 55 °C for 30 sec and 72 °C for 2 min were 
run terminating with 7 min at 72 °C. 80(il of reaction mix from each sample was analysed by 
separation via electrophoresis on a 1 % (w/v) agarose gel run in TBE. The arrow (■♦) 
indicates the amplified band of interest.
1 2 3 4 5 6 7 8
kbp
0.81 — 
0 .5 1 _
Figure 26, Amplification of the 3’ end of HG4 using a range PCR cycles,
Lanes 1& 8: X DNA cut using Pst1 with relevant band sizes noted in parallel.
Duplicate PCRs were done to amplify the 610 bp 3’ end of HG4. Lanes 2 & 3: products 
amplified after 35 cycles. Lanes 4 & 5: after 40 cycles. Lanes 6 & 7: after 45 cycles.
The Expand™ High Fidelity System was utilised requiring the presence of 300 nM of HG4 
GSSP1 and HG4 CAP1 primer, H. contortus cDNA template reverse transcribed from eggs 
and 1.5 mM MgCI2. Cycling conditions as in figure 25.
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The 5’ and 3’ products were Sephaglas™ purified and digested with Not1/Nsi1 and Xba1/Nsi1 
respectively. Figure 27 shows a 1 % (w/v) agarose gel resolving the resultant fragments prior 
to ligation into Not1/Xba1 cut pBluescript SK+ vector.
Figure 27, PCR amplified fragments before and after digestion
Lane 1: X DNA cut using Pst1 with relevant band sizes listed along side.
Lanes 2 & 3: Nsi1 and Xba1 restricted 3’ RACE product produced after 35 cycles.
Lanes 4 & 5: Nsi1 and Xba1 restricted 3’ RACE product produced after 40 cycles of 500 bp . 
Lane 6: 3’ RACE product of 610 bp before digestion.
Lanes 7 & 8: Not1 and Nsi1 restricted 5’ RACE product after 35 cycles.
Lanes 9 & 10: Not1 and Nsi1 restricted 5’ RACE product after 40 cycles of 890 bp.
Lane 11 :5 ’ RACE product of 930 bp before digestion.
An arrow indicates each of the above bands. PCR amplified fragments were purified from the 
agarose gels seen in figures 25 & 26 using the Sephaglas™ kit and then digested with the 
specified enzymes for 1 h at 37 °C. 4 pi of each sample were analysed by running on a 1 % 
(w/v) agarose gel to establish whether digestion was successful.
Both 5’ and 3’ products, produced after 40 cycles, were ligated together in the presence of 
pBluescript SK+, which had previously been digested with Not1 and Xba1. These were then 
transformed into XL1 Blues. Resulting colonies were selected for plasmid DNA purification 
and screened by digesting with Not1 and Xba1 enzymes. Restricted fragments were 
analysed on an agarose gel depicted in figure 28. Successful release of a 1.3 kbp fragment 
upon digestion can be seen in lanes 2, 3, 4, 5, 6, 10 and 11. Clone 3, in lane 3, was re­
cultured and plasmid DNA was purified using the Wizard™ Plus kit for automated 
sequencing.






Figure 28, Restriction of constructs produced from a three-way ligation
Lanes 1 & 12: X DNA cut using Pst1 with relevant band sizes listed along side.
Lanes 2, 3, 4, 5, 6, 10 & 11: Transformed plasmid digested with Not1 and Xba1 releasing a 
1.3 kbp HG4 fragment.
Lane 7: Control of purified plasmid equivalent to that seen in lane 6, digested with Not1.
Lane 8: Control of purified plasmid equivalent to that seen in lane 6, digested with Xba1.
Lane 9: control of undigested plasmid.
Recombinant plasmids were purified from XL1-Blue colonies with the Wizard™ Plus kit 
followed by double or single digestion, as noted above, with the restriction enzymes Not1 
and/or Xba1 for 1 h at 37 °C. Restriction patterns were monitored on a 1 % (w/v) agarose gel 
by electrophoresis. Full-length HG4 products are indicated by ■*.
Each full-length sequence was aligned with the previously obtained clones, in figure 23 and 
the percentage of variation was calculated as summarised in Table t  and 3 . Clone 3 
appears to possess a single bp difference, which results in an amino acid substitution of 
alanine for threonine at position 26. This result suggests that a reduction of thermocycles 
used in the PCR has minimised the possible introduction of mutations relative to that seen for 
clones 8 and 14. By running the sequence through the GCG package on the gnome 
workstation, clone 3 was found to have a 79.66 % amino acid identity with GluCip. With three 
full-length and two RACE sequences for HG4 elucidated a final consensus sequence was 
produced and found to have an 80.25 % amino acid identity with GluCip. This consensus 
sequence has been aligned with that of GluCip in figure 29. Table ^  highlights the amino acid 
identity of HG4 with other closely related members from the inhibitory TGIC family.
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Figure 29, Alignment of HG4 with GluCip
K E Y : Predicted signal cleavage sites are between the residues Q I  (indicated by Y  ) for HG4, EY  for GluCip,
YOD3 ORO TEO AKSR AARKAQKRRA 3 5 7
YODS V R ONDRSREK AARKAQRRRE 3 5 4  
YQDS -R Q -----------------A A R K A Q -R R -
iVM V S R L V ........................4 2 2
IM  S A N A S T P E S L  V  4 3 4  
- M ------------------------------
N X  ( T / S )  are predicted N-linked Glycosylation sites,
SYQD & SFRD a n d  SYQD & TERD are predicted casein kinase II phosphorylation sites. S O R & S F R and S V R & T F R are predicted protein kinase C phosphorylation site










Gamma, y-like subunit Alpha, a-like subunits
HG1 Giya HG 4 H G 2 H G 3 GluCIX
GluCI
a
G ABAa 28% 38% 31% 31% 36% 35% 33% 35% 42% 40% 33% 27% 31% 32% 32% 31%
HG1 - 33% 26% 27% 26% 28% 25% 27% 32% 29% 29% 24% 28% 30% 29% 28%
Giya 40% 41% 43% 42% 42% 42% 47% 47% 43% 36% 40% 41% 41% 46%
8 0 % 48% 47% 46% 48% 57% 57% 49% 39% 45% 47% 47% 44%
H G 4 48% 47% 45% 48% 53% 57% 47% 38% 47% 46% 46% 42%
79% 79% 74% 81% 91% 60% 41% 57% 57% 57% 52%
72% 87% 88% 86% 58% 40% 54% 54% 55% 50%
H G 2 75% 81% 89% 55% 37% 52% 53% 54% 45%
H G 3 88% 85% 59% 40% 54% 55% 55% 49%
GluCIX 91% 68% 55% 63% 63% 68% 55%
72% 53% 72% 72% 72% 59%
40% 61% 67% 67% 50%





Table 9, Comparison of the Amino Acid Identities of HG4 with Related TGIC Subunits.
3.2.10 Analysis of HG4 Full-Length Consensus Sequence
As depicted in figure 29, the HG4 receptor subunit has four transmembrane spanning 
domains and two N-linked glycosylation sights, residues NYS (position 52-54) and NIT (219- 
221) positioned along the N-terminal extracellular domain. The characteristic cys-loop is also 
present with cysteine residues at position 164 and 178. A further two cysteines are located 
downstream from the cys-at sites 226 and 237. These are characteristic of glycine receptor 
subunits found in mammals. The presence of phosphorylation sites has been predicted 
along the intracellular loop between TM3 and TM4. These include the protein kinaseC 
phosphorylation 9  sites SQR (residues 337-339) and SFR (382-384). Casein kinase II 
phosphorylation sites are also predicted, these motifs being SYQD (amino acids 233-236), 
SFRD (337-340) and TKPD (382-385).
Predicted ligand binding sites common to GluCIRs (Wolstenholme, 1997) are encoded by the 
HG4 cDNA. These include the amino acid residues YAHT at positions 185-188 and TGSY at 
positions 232-235, seen in figure 29. Likewise, the amino acid residue glutamine-176 and 
phenylalanine-87 are also conserved in HG4. These residues are predicted to play a role in 
agonist binding.
3.2.11 Production of a Consensus Sequence
In order to characterise the protein expressed by HG4 cDNA, a consensus clone needed to 
be constructed. Expression of a consensus sequence in Xenopus laevis oocytes would 
enable the screening of homomeric HG4 channels with potential agonists and antagonists. A 
technique introducing point mutations to revert PCR amplified sequence to the consensus 
sequence was adopted. This procedure involved the hybridisation of single stranded DNA to 
a complementary synthetic oligonucleotide possessing the desired mutation of a single nt 
mismatch in the centre. Double stranded DNA was then made in the presence of DNA 
polymerase. Nicks present in the duplex were sealed by DNA ligase and transformed into an 
E. coli host (Hutchinson, 1978).
To obtain an HG4 construct coding the consensus sequence, the Altered Sites® II in vivo 
Mutagenesis system was utilised to convert A26 to T26. This required a mutation to be made 
converting the G in codon GCT to an A. This was achieved by designing a sense 
oligonucleotide (MUTS), incorporating ACT at its centre (Appendix 3).
HG4 was cut out of clone 3 using the restriction enzymes Sac1 and Xba1 and ligated into a 
Sac1 / Xba1 digested pALTER®-1 vector. This vector carries gene sequences for both 
ampicillin and tetracycline resistance, thus antibiotic selection could be used to dictate an 
increase in mutant yield. The resulting construct was transformated into JM109 competent 
cells in the presence of tetracycline. Purified plasmid was denatured into single stranded 
template and used in a mutagenesis reaction with 5’ phosphorylated primers: ampicillin repair 
oligonucleotide (ARO), tetracylcine knockout oligonucleotide (TKO) and the MUTS primer.
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Resultant mutant strands, synthesised using T4 DNA polymerase and T4 DNA ligase, were 
transformed into BMH71-18 mutS under no antibiotic selection. A Wizard™ Plus purification 
of plasmid from BMH71-18 mutS cells was transformed into JM109 E. coli cells and plated 
out onto LB/ ampicillin plates. Plasmids from 4 colonies were purified and sequenced with 
the T7 primer to confirm incorporation of the point mutation. Figure 30 displays two 
electrophoretograms before and after mutagenesis, the point mutation is highlighted. 
Mutated HG4 was finally re-transformed into the pBluescript SK+ for expression studies in 




T C Q C A 3 T Q Q C A Q Q T T C Q T C C C A Q A T C T C Q C Q Q C Q A T C C A C t Q Q ’ Q Q C A C T C A Q Q - ‘ Q C A Q Q A Q a ' T C
Figure 30, Electrophoretograms of HG4 Sequence A]Before, and B]After, mutagenesis.
3.2.12 Isolation of HG4 from Avermectin Resistant H. contortus
mRNA extracted from 1g of avermectin resistant H. contortus eggs was reverse transcribed 
into cDNA. RACE-PCR to amplify HG4 cDNA was carried out to enable comparison of its 
nucleotide sequence with that obtained from a susceptible population. This was done to 
detect variations in the amino acid sequence between the two isolates, which may contribute 
to the switch to avermectin resistance. Both 5’ and 3’ ends were amplified using 35 cycles to 
minimise the possible occurrence of mutations introduced by PCR. Two individual 5’ and 3’ 
ends were amplified using primers HG4-CSP1 with HG4-GSAP1 and HG4-GSSP1 with HG4- 
CAP1 respectively. These were then blunt-ended and cloned into EcoRV cut pBluescript SK+ 
vectors for sequencing. The sequence derived for these clones has been aligned with the 
consensus sequence compiled from clones isolated from avermectin susceptible worms and 
can be seen in figure 31. The percentage variation was calculated by comparison with the 
avermectin susceptible HG4 clones and is summarised in Table |6. Whilst differences are
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observed at the nucleotide level no sequence alterations are seen at the amino acid level. 
This suggests that avermectin resistance has not developed due to a change in the genetic 
make up of HG4.
1 50
S u s c e p t ib le  C on g g t t t a a t t a  c c c a a g t t t g  a g a t c t t g a A  TGTCACAGTA TATGATGGTC
R e s is t a n t  5 ' ( 1 ) .... .............................................................................. A TGTCACAGTA TATGATGGTC
R e s is t a n t  5 ' ( 2 ) .... .............................................................................. A TGTCACAGTA TATGATGGTC
R e s is t a n t  3 ' ( 1 ) .... ...........................................................................................................................................
R e s is t a n t  3 '  (2 ) ...........................................................................................................................................
51  100
S u s c e p t ib le  Con GCYGTAGCGG CCGTGGTCGC AGTGGCAGGT TCGTCCCAGl TCTCGCGGCG
R e s is t a n t  5 ' ( 1 )  GCCGTAGCGG CCGTGGTCGC AGTGGCAGGT TCGTCCCAGA TCTCGCGGCG
R e s is t a n t  5 ' ( 2 )  GCCGTAGCGG CCGTGGTCGC AGTGGCAGGT TCGTCCCAGl TCTCGCGGCG
R e s is t a n t  3 ' ( 1 )  ...........................................................................................................................................
R e s is t a n t  3 '  (2 ) ...........................................................................................................................................
10 1  150
S u s c e p t ib le  C on ATCCACTGGT GGCACTCAGG AGCAGGAGAT TCTCAACGAG CTGCTGTCCA
R e s is t a n t  5 ' ( 1 )  ATCCACTGGT GGCACTCAGG AGCAGGAGAT TCTCAACGAG CTGCTGTCCA
R e s is t a n t  5 ' ( 2 )  ATCCACTGGT GGCACTCAGG AGCAGGAGAT TCTCAACGAG CTGCTGTCCA
R e s is t a n t  3 ' ( 1 )  ...........................................................................................................................................
R e s is t a n t  3 ' ( 2 )  ...........................................................................................................................................
151 200
S u s c e p t ib le  Con ACTACGATAT GKGKGTTCGA CCGCCACCTT CGAACTACTC AGATCCAATG
R e s is t a n t  5 ' ( 1 ) ACTACGATAT GAGGGTTCGA CCGCCACCTT CGAACTACTC AGATCCAATG
R e s is t a n t  5 ' ( 2 ) ACTACGATAT GAGGGTTCGA CCGCCACCTT CgAACTACTC AGATCCAATG
R e s is t a n t  3 ' ( 1 )
R e s is t a n t  3 ' ( 2 )
201 250
S u s c e p t ib le  Con GGACCAGTGA CAGTGCGGGT CAACATCATG ATCAGGATGT TATCAAAAAT
R e s is t a n t  5 ' ( 1 ) GGACCAGTGA CAGTGCGGGT CAACATCATG ATCAGGATGT TATCCAAAAT
R e s is t a n t  5 ' ( 2 ) GGACCAGTGA CAGTCCGGGT CAACATCATG ATCAGGATGT TATCAAAAAT
R e s is t a n t  3 ' ( 1 )
R e s is t a n t  3 ' ( 2 )
251 300
S u s c e p t ib le  Con TGACGTCGTC AACATGGAGT ACAGTATGCA AXTRACRTTT CGGGRGCART
R e s is t a n t  5 ' ( 1 ) TGACGTCGTC AACATGGAGT ACAGTATGCA ACTAACATTT CGGGAGCAAT
R e s is t a n t  5 ' ( 2 ) TGACGTCGTC AACATGGAGT ACAGTATGCA ACTAACATTT CGGGAGCAAT
R e s is t a n t  3 ' ( 1 )
R e s is t a n t  3 ' ( 2 )
301 350
S u s c e p t ib le  Con GGCTTGACTC GCGTCTGGCG TACGCTCACC TCGGCTACCA CAACCCWCCR
R e s is t a n t  5 ' ( 1 ) GGCTTGACTC GCGTCTGGCG TACGCTCACC TCGGCTACCA CAACCCACCA
R e s is t a n t  5 ' ( 2 ) GGCTTGACTC GCGTCTGGCG TACGCTCACC TCGGCTACCA CAACCCACCA
R e s is t a n t  3 ' ( 1 )
R e s is t a n t  3 ' ( 2 )
Figure 31, see figure legend on next page.
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351 400
S u s c e p t ib le  C on AAATTCCTCA CAGTACCACA CATCAAAAGC AACCTCTGGA TTCCKGACAC 
R e s is t a n t  5 ' ( 1 )  AAATTCCTCA C&GTACCACA CATCAAAAGC AACCTCTGGA TTCCKGACAC 
R e s is t a n t  5 ' ( 2 )  AAATTCCTCA CAGTACCACA CATCAAAAGC AACCTCTGGA TTCCKGACAC
R e s is t a n t  3 ' ( 1 )  ...........................................................................................................................................
R e s is t a n t  3 '  (2 ) ...........................................................................................................................................
401  450
S u s c e p t ib le  Con CTTTTTCCCG ACCGAAAAAG CRGCACACCG GCATCTCATC GAYACGGACA 
R e s is t a n t  5 ' ( 1 )  CTTTTTCCCG ACCGAAAAAG CAGCACACCG GCATCTCATC GATACGGACA 
R e s is t a n t  5 ' ( 2 )  CTTTTTCCCG ACCGAAAAAG CAGCACACCG GCATCTCATC GATACGGACA
R e s is t a n t  3 ' ( 1 )  ...........................................................................................................................................
R e s is t a n t  3 ' ( 2 )  ...........................................................................................................................................
451  500
S u s c e p t ib le  C on ACATGTTCCT TCGAATTCAT CCAGATGGAA RGGTGYTGTA CAGTAGTCGA 
R e s is t a n t  5 ' ( 1 )  ACATGTTCCT TCGAATTCAT CCAGATGGAA AGGTGTTGTA CAGTAGTCGA 
R e s is t a n t  5 ' ( 2 )  ACATGTTCCT TCGAATTCAT CCAGATGGAA AGGTGTTGTA CAGTAGTCGA
R e s is t a n t  3 ' ( 1 )  ...........................................................................................................................................
R e s is t a n t  3 ' ( 2 )  ...........................................................................................................................................
501  550
S u s c e p t ib le  Con ATTAGCATTA CCAGCTCCTG YCAYATGCAA CTACAACTCT ACCCCTTGGA 
R e s is t a n t  5 ' ( 1 )  ATTAGCATTA CCAGCTCCTG ICAgATGCAA CTACAACTCT ACCCCTTGGA 
R e s is t a n t  5 ' ( 2 )  ATTAGCATTA CCAGCTCCTG $CA£ATGCAA CTACAACTCT ACCCCTTGGA
R e s is t a n t  3 ' ( 1 )  .............................................................................. ............................................................
R e s is t a n t  3 ' ( 2 )  ...........................................................................................................................................
551 600
S u s c e p t ib le  Con TTTGCARTTC TGTGACTTTG ATCTCGTCAG CTATGCCCAT ACSATGAAGG 
R e s is t a n t  5 ' ( 1 )  TTTGCA0TTC TGTGACTTTG ATCTCGTCAG CTATGCCCAT ACCATGAAGG 
R e s is t a n t  5 ' ( 2 )  TTTGCAGTTC TGTGACTTTG ATCTCGTCAG CTATGCCCAT ACCATGAAGG
R e s is t a n t  3 ' ( 1 )  ...........................................................................................................................................
R e s is t a n t  3 ' ( 2 )  ...........................................................................................................................................
601  650
S u s c e p t ib le  C on AYATTGTCTA CGAATGGGAY CCCCTGGCTC CTGTGCAGCT CAAACCCGGT 
R e s is t a n t  5 ' ( 1 )  ATATTGTCTA CGAATGGGAT CCCCTGGCTC CTGTGCAGCT CAAACCCGGT 
R e s is t a n t  5 ' ( 2 )  ATATTGTCTA CGAATGGGAT CCCCTGGCTC CTGTGCAGCT CAAACCCGGT
R e s is t a n t  3 ' ( 1 )  ...........................................................................................................................................
R e s is t a n t  3 ' ( 2 )  ...........................................................................................................................................
651 700
S u s c e p t ib le  C on GTAGGAAGTG ACCTGCCTAA CTTTCAGCTC ACAAATATCA CCACCAATGA 
R e s is t a n t  5 ' ( 1 )  GTAGGAAGTG ACCTGCCTAA CTT|CAGCTC ACAAATATCA CCACCAATGA 
R e s is t a n t  5 ' ( 2 )  GTAGGAAGTG ACCTGCCTAA CTTTCAGCTC ACAAATATCA CCACCAATGA
R e s is t a n t  3 ' ( 1 )  ...........................................................................................................................................
R e s is t a n t  3 ' ( 2 )  ...........................................................................................................................................
701 750
S u s c e p t ib le  C on SGACTGYACT AGCCATACYA ATACTGGGTC RTACGCCTGY CTGAGGATGC 
R e s is t a n t  5 ' ( 1 )  CGACTGTACT AGCCATACCA ATACTGGGTC GTACGCCTGC CTGAGGATGC 
R e s is t a n t  5 ' ( 2 )  CGACTGTACT AGCCATACCA ATACTGGGTC GTACGCCTGC CTGAGGATGC 
R e s is t a n t  3 ' ( 1 )  CGACTGTACT AGCCATACCA ATACTGGGTC GTACGCCTGC CTGAGGATGC 
R e s is t a n t  3 ' ( 2 )  ...........................................................................................................................................
Figure 31, See figure legend on next page.
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751 800
S u s c e p t ib le  Con AlCTCACCCT AAAAMGRCAG TTCAGTTACT ACCTGGTCCA RTTGTACGGT
R e s is t a n t  5 ' ( 1 ) A6CTCACCCT AAAAAGGCAG TTCAGTTACT ACCTGGTCCA GTTGTACGGT
R e s is t a n t  5 ' ( 2 ) AgCTCACCCT AAAAAGGCAG TTCAGTTACT ACCTGGTCCA GTTGTACGGT
R e s is t a n t  3 ' ( 1 ) ALCTCACCCT AAAAAGGCAG TTCAGTTACT ACCTGGTCCA GTTGTACGGT
R e s is t a n t  3 ' ( 2 ) . . . AGTTACT ACCTGGTCCA GTTGTACGGT
801 850
S u s c e p t ib le  Con CCCACAACGA TGATAGTGAT CGTCTCATGG GTTTCGTTTT GGATCGATAT
R e s is t a n t  5 ' ( 1 ) CCCACAACGA TGATAGTGAT CGTCTCATGG GTTTCGTTTT GGATCGATAT
R e s is t a n t  5 ' ( 2 ) CCCACAACGA TGATAGTGAT CGTCTCATGG GTTTCGTTTT GGATCGATAT
R e s is t a n t  3 ' ( 1 ) CCCACAACGA TGATAGTGAT CGTCTCATGG GTTTCGTTTT GGATCGATAT
R e s is t a n t  3 ' ( 2 ) CCCACAACGA TGATAGTGAT CGTCTCATGG GTTTCGTTTT GGATCGATAT
851 900
S u s c e p t ib le  Con GCATTCAACS GCCGGTCGTG TGGCCCTGGG TGTCACTACC CTGCTRACCA
R e s is t a n t  5 ' ( 1 ) GCATTCAACC GCCGGTCGTG TTGCCTTGGG TGTCACTACC
R e s is t a n t  5 ' ( 2 ) GCATTCAACS GCTGGTCGTG TTGCTTTGGG TGTCACGACC CTGCTGACCA
R e s is t a n t  3 ' ( 1 ) GCATTCGACG GCCGGCCGAG TGGCCTTGGG TGTCACTACC CTACTGACCA
R e s is t a n t  3 ' ( 2 ) GCATTCAACS GCTGGTCGTG TTGCTTTGGG t g t c a c Ca c c CTGCTGACCA
901 950
S u s c e p t ib le  Con TGACCACCAT GCAAGCAGCT ATCAATGCTA AACTGCCMCC IGTGAGCTAC
R e s is t a n t  5 ' ( 1 )
R e s is t a n t  5 ' ( 2 ) TGACCACCAT GCAAGCAGCT ATCAATGCTA AACTGCCACC SG T................
R e s is t a n t  3 ' ( 1 ) TGACCACfAT GCAAGCAGCC ATCAATGCTA AATTGCCACC GGTGAGCTAC
R e s is t a n t  3 ' ( 2 ) TGACCACCAT GCAAGCAGCC ATCAATGCTA AACTGCCCCC GGTGAGCTAC
951 1000
S u s c e p t ib le  C on GTGAAGGTRG TRGATGTGTG GCTltGGAGCC TGTCAAACRT TCGT8TTTGG
R e s is t a n t  5 ' ( 1 )
R e s is t a n t  5 ' ( 2 )
R e s is t a n t  3 ' ( 1 ) GTGAAGGTAG TAGATGTGTG GCTTGGAGCC TGTCAAACAT TCGTGTTTGG
R e s is t a n t  3 ' ( 2 ) GTGAAGGTSG TAGATGTGTG GCTTGGAGCC TGTCAAACAT TCGTfTTTGG
1001 1050
S u s c e p t ib le  C on AGCGYTGCTY GAftTACGCRT TCGTCTCTTA TCAAGACAGC CAACGACAAR
R e s is t a n t  5 ' ( 1 )
R e s is t a n t  5 ' ( 2 )
R e s is t a n t  3 ' ( 1 ) AGCGTTGCTT GAGTACGCST TCGTCTCTTA TCAAGACAGC CAACGGCAAA
R e s is t a n t  3 ' (2 ) AGCGTTGCTT GAGTACGCGT TCGTCTCTTA TCAAGACAGC CAACGACAAA
1051 1100
S u s c e p t ib le  Con CAGAGCAGGC CAAAAGCCGA GCTGCTCGAA AAGCTCAAAA GCGACGWGCY
R e s is t a n t  5 ' ( 1 )
R e s is t a n t  5 ' ( 2 )
R e s is t a n t  3 ' ( 1 ) CAGAGCAAGC TAAAAGCCGA GCTGCTCGAA AAGCTCAAAA GCGACGAGCC
R e s is t a n t  3 ' ( 2 ) CAGAGCAGGC CAAAAGCCGA GCTGCTCGAA AAGCTCAAAA GCGACGCGCT
11 01 1150
S u s c e p t ib le  Con AAAATGGAAC TCGTCGAAAG AGAACAATAG CAACCTCCfT GCACGTGTCA
R e s is t a n t  5 ' ( 1 )
R e s is t a n t  5 ' ( 2 )
R e s is t a n t  3 ' ( 1 ) AAAATGGAAC TCGTTGAAAG AGAACAATAC CAACCTCCCT GCACGTGTCA
R e s is t a n t  3 ' ( 2 )  AAAATGGAAC TCGTCGAAAG AGAACAATAT CAACCTCCTT GCACGTGTCA
Figure 31, See figure legend on next page.
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1 1 5 1  1200
S u s c e p t ib le  C on TCTGTACCAA GACTAYGAGC CRTCGTTCCG TGACCGGTTR CGGCGCTATT
R e s is t a n t  5 ' ( 1 ) .... ...........................................................................................................................................
R e s is t a n t  5 ' ( 2 ) .... ...........................................................................................................................................
R e s is t a n t  3 ' ( 1 )  TCTGTACCAA GACTACGAGC CgTCGTTCCG TGACCGGTTf CGGCGCTACT
R e s is t a n t  3 ' ( 2 )  TCTGTACCAA GACTACGAGC CgTCGTTCCG TGACCGGTTg CGGCGCTACT
1 2 01  1250
S u s c e p t ib le  Con TCACAAAACC CGACTACCTG CCRGCGAAAA TCGACTACTA TGCTCGATTT
R e s is t a n t  5 ' ( 1 )  ...........................................................................................................................................
R e s is t a n t  5 ' (2 )  ...........................................................................................................................................
R e s is t a n t  3 ' ( 1 )  TCACAAAACC CGACTACCTG CCTGCGAAAA TCGACTACTA TGCTCGATTT
R e s is t a n t  3 ' ( 2 )  TfACAAAACC CGACTACCTG CCTGCGAAAA TCGACTACTA TGCTCGATTT
1 2 51  1300
S u s c e p t ib le  C on TGTGTGCCAT TAGGCTTTTT AGCCTTCAAT GCCATCTAfT GGACATCCTG
R e s is t a n t  5 ' ( 1 ) .... ...........................................................................................................................................
R e s is t a n t  5 ' ( 2 ) .... ...........................................................................................................................................
R e s is t a n t  3 ' ( 1 )  TGTGTGCCAT TAGGCTTTTT AGCCTTCAAT GCCATCTAgT GGACATCCTG
R e s is t a n t  3 ' ( 2 )  TGTGTGCCAT TAGGCTTTTT AGCCTTCAAT GCCATCTAGT GGACATCCTG
13 01  1325
S u s c e p t ib le  Con CCTCGTGATG GTGTCAAGAC TAGTC
R e s is t a n t  5 ' ( 1 ) .... ....................................................................
R e s is t a n t  5 ' ( 2 ) .... ....................................................................
R e s is t a n t  3 ' ( 1 )  CCTCGTGATG GTGTCAAGAC TAGTC
R e s is t a n t  3 ' ( 2 )  CCTCGTGATG GTGTCAAGAC TAGTC
Figure 31, Alignment of HG4 from an avermectin-resistant H. contortus. Resistant 5’ (1) 
and (2) are 5’ RACE products whilst Resistant 3’ (1) and (2) are 3’ RACE products. These 
are compared with susceptible con, the consensus sequence created from clones isolated 
from a susceptible population of H. contortus, detailed in figure 23. Shaded regions highlight 
nts that vary between the clones. Key: Y codes either a C or a T, M codes either an A or a 
C, R: an A or a G, S: a G or a C, K: a G or a T and W: an A or a T. Nucleotides in 
uppercase are coding sequence whilst lower case nucleotides represent the 5’ UTR.
Table 10, Percentage variation between avermectin-susceptible and -resistant 
populations of Haemonchus contortus. Resistant 5’ (1) and (2) and resistant 3’ (1) and 
(2) nucleotide sequences are compared with each of the clones amplified from avermectin- 
susceptible nematodes. Values are calculated by dividing the number of mismatches by the 
length of overlapping sequence. These details are noted in brackets.
Clones from avermectin 
susceptible isolate
Clones from the avermectin resistant isolate
5’ RACE products 3’ RACE products
1 (861 nt) 2 (914 nt) 1 (625 nt) 2 (532 nt)
5’ end (914nt) 0.58% (5/861) 0.86% (8/914) 4.12% (10/243) 4.71% (8/170)
3’ end (579 nt) 1.39% (2/144) 3.55% (7/197) 3.97% (23/579) 3.08% (17/552)
8(1296 nt) 2.44% (21/861) 2.52% (23/914) 4.16% (26/625) 2.72% (15/552)
14(1296 nt) 3.83% (33/861) 4.16% (38/914) 4.16% (26/625) 1.09% (6/552)
3(1296 nt) 0.58% (5/862) 1.20% (11/914) 3.52% (22/625) 4.00% (22/552)
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Table 11, Percentage variation at the amino acid level between avermectin-susceptible 
and -resistant populations of Haemonchus contortus. Resistant 5’ (1) and (2) and
resistant 3’ (1) and (2) are compared with each of the clones amplified from avermectin- 
susceptible nematodes. Values are calculated by dividing the number of mismatches by the 
length of overlapping sequence. These details are noted in brackets.
Clones from avermectin 
susceptible isolate
Clones from the avermectin resistant isolate
5’ RACE products 3’ RACE products
1 2 1 2
5’ end 0.7 % (2/287) 0.7 % (2/304) 0/81 0.0 % (0/81)
3’ end 0.0 % (0/48) 0.0 % (0/65) 0/193 0.0 % (0/193)
8 0.7 % (2/287) 0.7 % (2/304) 1/198 0.0 % (0/123)
14 0.3 % (1/287) 0.3 % (1/304) 1/198 0.8% (1/123)
3 0.0% (0/287) 0.0 % (0/304) 0.0 % (0/198) 0.0 % (0/123)
Consensus 0.0 % (0/287) 0.0 % (0/304) 0.0 % (0/198) 0.0 % (0/123)
3.3 Discussion
A total of 3 full-length HG4 cDNAs and 2 partial clones were amplified from a susceptible 
population of H. contortus. These were sequenced and aligned with each other to obtain a 
consensus sequence for this receptor subunit. Comparison of sequences revealed as high 
as 4.49% variation existed at the nucleotide level. Alignment of clone 14 with the HG4 3’ 
partial clone (figure 23) identified 26 nucleotide mismatches from a total of 579 overlapping 
base pairs (Table 6). Upon examination of these mismatches the majority appeared to be 
third base changes which do not alter the amino acid sequence. This variation may be a 
consequence of polymorphism resulting from the extraction of mRNA from a population of H. 
contortus. Polymorphism is a common feature detected in nematodes and has been noted 
by Emmons et al. (1979) using restriction patterns to estimate the degree of polymorphism to 
be 1 % in C. elegans. Likewise, in H. contortus a 1.5 % difference was established between 
PCR amplified clones of the HG1 receptor subunit (Laughton et al., 1994). Similarly up to 4 
% variation between cDNAs encoding a levamisole resistant acetylcholine receptor subunit, 
HCA1, was calculated from various H. contortus populations (Hoekstra et al., 1997). Another 
possible but less likely explanation for this level of variation may be that there is more than 
one closely related sequence in the nematode genome.
Comparison of clone 14 with the HG4 3’ partial clone at the amino acid level revealed that 1 
amino acid difference existed over the overlapping 193 amino acid translated sequence 
(Table 7). This alteration may be a result of polymorphism at the coding level or a PCR 
induced artefact. Percentage variation at the amino acid level exists between each clone. 
Two differences are present both in clone-8 and -14 (table 8) when compared to the 
consensus sequence. To reduce the possibility of PCR induced variation; a further PCR was 
done using a reduced number of cycles. Clone 3 was derived from 40 cycles of PCR rather 
than 45 used previously to amplify clones 8 and 14. The resulting sequence was 99.77 %
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identical to the predicted amino acid consensus sequence. This clone possessed one amino 
acid difference at position 26, encoding an alanine instead of a threonine.
The consensus sequence for HG4 was calculated to have an 80.25 % amino acid identity 
and a 69.98 % nucleotide identity with the glutamate gated chloride channel beta subunit, 
GluCip (Cully et al., 1994) present in C. elegans. It is therefore reasonable to suggest that 
the HG4 receptor subunit is the parasitic orthologue of GluCip. Homomeric GluCip channels 
in Xenopus oocytes respond reversibly to glutamate at concentrations equal to or greater 
than 1 mM with more than one glutamate-binding site present (Hill coefficient of 1.9 +/- 0.2). 
Accordingly, if HG4 is a parasitic orthologue of GluCip, expression of homomeric HG4 
channels in Xenopus oocytes is also predicted to yield a reversible response to glutamate at 
equivalent concentrations. In order to express consensus HG4 homomeric channels in 
Xenopus oocytes the alanine present at position 26 of clone 3 was mutated to a threonine, 
expression studies have yet to be completed.
It has also been established that GluCip subunits are located in the pm4 and pm5 pharyngeal 
muscles cells of C. elegans (Laughton et al., 1997a) both of which are innervated by the M3 
motor neurone which releases glutamate at its synapses. It is therefore expected that HG4 
receptor subunits localise to equivalent cells in the pharynx of H. contortus. To examine this 
theory, spatial expression was to be determined by utilising an immuncytological approach 
and has been detailed in future chapters. Co-expression in Xenopus oocytes of GluCip with 
G luC lal, a related receptor alpha-subunit isolated from C. elegans, results in a glutamate- 
gated chloride channel potentiated by avermectin at nanomolar concentrations (Cully et al., 
1994). Further to these findings, a second alpha related receptor subunit, GluCla2 localises 
to pm4 and pm5 cells in the pharynx (Dent et al., 1997). It can therefore be suggested that 
both subunit types assemble together with other like subunits in C. elegans to form an 
avermectin sensitive receptor.
The HG4 receptor subunit cDNA was isolated from an avermectin resistant population of H. 
contortus to establish whether it conveys a specific mutation preventing binding of the drug. 
Sequencing of two 5’- and two 3-RACE products revealed identical translated sequences to 
the HG4 consensus sequence previously isolated from the avermectin susceptible 
population. Therefore, no mutation in transcribed HG4 was responsible for the switch in 
phenotype to avermectin resistance. This result is not surprising as homomeric GluCip 
channels do not bind avermectin when expressed in Xenopus oocytes (Cully et al., 1994). In 
retrospect, an alteration at the ligand-binding domain of a-subunits is more likely to cause 
avermectin resistance. This is because the a-subunit has been shown to bind the drug when 
expressed as homomeric channels in Xenopus oocytes (Cully et al., 1994 & Dent et al., 
1997).
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4 Production of Polyclonal Antibodies
4.1 Introduction
Further characterisation of HG4 is to be accomplished by determining its expression pattern 
within the parasitic nematode, Haemonchus contortus. Sequence comparison of HG4 with 
related proteins suggests that it is the GluCip orthologue. Therefore, localisation of HG4 within 
H. contortus is believed to be on pm4 and pm5 muscles cells of the pharynx, as is the case for C. 
elegans (Laughton et al., 1997a). If this were true, then avermectin may effect pharyngeal 
function in the parasite. In order to define HG4 expressing cells, anti-HG4 antibodies were 
generated. This chapter details possible approaches taken to determine spatial expression of 
proteins. It also discusses the advantages of using an immunohistochemical approach, which is 
the route 'frhat will be taken. Results using this method are displayed as well as corroboration 
that the antibodies bind specifically to a defined epitope.
4.1.1 Techniques employed for localisation of nematode genes
Temporal and spatial expression patterns within nematodes have been studied using a variety of 
techniques such as histochemistry, in-situ hybridisation, gene reporter constructs and 
immunohistochemistry. These methods offer sensitive routes to localise proteins such as 
transmitter-gated ion channel (TGIC) subunits to a minority of cells where levels of mRNA may 
vary with the nematode’s stage of development.
4.1.1.1 Histochemisrty
A histochemical approach is useful when studying the localisation of an enzyme within a tissue. 
Substrate for the required enzyme is catalysed into a visible product upon addition; thus 
highlighting enzyme saturated areas within the tissue of interest. The expression pattern of 
NADPH diaphorase in whole worm mounts of Ascarls suum was achieved with this method 
converting the substrate tek'azolium to an insoluble,* visible formazan in the presence of NADPH 
(Bascal et al., 1996). However, as TGIC subunits possess no specific enzyme activity this 
technique is of no use to this project.
4.1.1.2 In-situ hybridisation
In-situ hybridisation relies upon the hybridisation of a specifically labelled nucleic acid probe to 
the cellular mRNAs within the nematode tissues. Probes may be DNA or RNA but use of the 
former increases the sensitivity of the method. Ribonucleotide probes are detected by 
incorporating nucleotides labelled with radioisotope, biotin or digoxigenin. Radioactivity can be 
monitored by autoradiographic detection whilst biotin and digoxigenin labelled probes can be 
detected by either a fluorescent or enzymatic system. Amplification and localisation of low copy 
RNA can be achieved by amplifying target mRNAs using in-situ PCR. This method has been
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used to screen neonatal heart for the protozoan parasite Trypanosoma cruzi (Taleton et al., 
1997). Detection of intracellular PCR products can either be achieved indirectly by hybridising 
with labelled probe after amplification or through direct detection using labelled nucleotides 
during amplification.
4.1.1.3 Reporter gene constructs
Gene expression can be studied in the free-living nematode Caenorhabditis elegans by using 
vectors containing reporter molecules. These include p-galactosidase, encoded by the 
Escherichia coli lac-z gene, or green fluorescent protein (GFP) isolated from the jelly-fish 
Aequorea victoria (Fire et al., 1990 & Chalfie et al., 1994).
C. elegans is an ideal candidate for this technique as it is well characterised and can be grown 
successfully in vitro. In contrast the in vitro culturing of Haemonchus contortus has not yet 
developed to an equivalent level. Free-living stages (egg to L3 larvae) can be grown by 
incubation in dung but survival of adult worms depends on the simulation of conditions 
experienced in the sheep abomasum. These include the presence of gastric secretions and host 
blood, which as yet have not been fully optimised for in vitro culturing (Stringfellow, 1986). 
However, C. elegans has been used as a model system into which parasitic genes are 
transformed (Kwa et al., 1995). Some debate still exists as to whether this technique reflects the 
exact location of target proteins as it does not consider control elements that may be present in 
intronic or downstream sequences. This method should therefore be used in combination with 
other related techniques.
Typical experiments involve the cloning of reporter fusions where the promoter elements for the 
gene of interest are linked to the reporter gene. The generation of transgenic nematodes is 
achieved by microinjection of the recombinant construct with a plasmid containing a marker 
gene. Selection of F1 progeny displaying the marker phenotype are then assayed for reporter 
activity. For lac-z fusions the chromogenic substrate X-Gal (5-bromo-4-chloro-3-indolyl-p-D- 
galactopyranoside) is added to permeabilized whole worms (Fire et al., 1990). A more recent 
report described by Laughton et al. (1997) utilised the lac-z reporter gene for looking at the 
expression pattern of the inhibitory glutamate receptor p subunit. Likewise, expression of GFP 
tagged proteins such as p-tubulin coded by the mec-7 gene (Chalfie et al., 1994) can be 
monitored under ultra violet light.
Some reporter constructs contain a 5’ nuclear localisation sequence leading to accumulation of 
the reporter molecules in the nuclei. Concentration of these molecules facilitates the identity of 




The main advantage of immunohistochemical localisation is that exploits the ability of antibodies 
to bind to specific protein epitopes, thus localising antigens to subcellular compartments within 
the cell. Neuronal protein distribution has been deduced in a variety of parasitic nematodes 
including H. contortus (Keating et al., 1995) and Ascaris suum (Brownlee et al, 1994) by 
exposure to a primary antibody. Detection of bound primary antibody is achieved by addition of a 
secondary antibody labelled either with a fiuorochrome, an electron dense particle (such as gold) 
or an enzyme. The disadvantage of this approach is that it is the most time consuming of all the 
methods discussed in this section. Not only does the antigen need to be synthesised from the 
target consensus sequence but antibodies must then also be raised specifically against it once 
injected into the host rabbit.
Apart from the time restraints it was considered that localisation of HG4 will be best achieved by 
selecting the latter approach, requiring the production of anti-HG4 antibodies. Subunit proteins 
from the TGIC family have many highly conserved regions. Hence, production of antisera to a 
whole receptor subunit would generate antibodies exhibiting affinities for many antigenic 
determinants over the entire protein surface. This would increase the probability of cross­
reaction with related subunits. It has therefore been decided that anti-HG4 antibodies will be 
raised against a peptide specific to the HG4 subunit rather than using the whole subunit.
A polyclonal serum will be raised in a rabbit rather than producing a monoclonal serum from a 
rodent. This route is preferred, as monoclonal antiserum against peptide-antigens produce low 
titres. Also, conformational changes in the antigenic determinant between the peptide and parent 
protein can reduce binding affinity thus decreasing titre even further. In contrast, a high titre of 
antibodies can be retrieved from raising polyclonal anti-serum. This is because the anti-serum is 
able to recognise a whole range of epitopes spread over the target peptide.
4.2 Results
4.2.1 Design of a Peptide
The first step, when selecting a peptide to raise antibodies against, was to determine whether it’s 
predicted location in the proteins three-dimensional structure would be exposed on the surface. 
This was accomplished by predicting the conformation of the whole subunit. This in turn dictated 
whether individual residues were found, exposed on the surface or buried within the molecule. 
An ideal peptide sequence needed to span mobile regions on the surface of the molecule 
possessing high flexibility and that were hydrophilic in nature.
The predicted secondary structure of HG4 was determined using the computer program 
command “peptidestructure” in the GCG program suite on the gnome workstation. Measures of
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Figure 32, Predicted secondary structure of HG4. A hydrophilicity plot of HG4 is displayed with measures of flexibility, surface probability, 
secondary structure and the antigenic index for each amino acid. This was generated using the command “peptidestructure” in the GCG suite 
accessed via the gnome workstation. The shaded region defines the section from which an antigenic peptide was designed to.
hydrophilicity, flexibility, surface probability, secondary structure as well as antigenic index for 
each amino acid within the protein were calculated by the program and are represented as a 
graphic plot in figure 32.
A sequence alignment of HG4 with related subunits distinguished an area of little homology 
present at the N-terminal extracellular domain (figure 33). In light of secondary structure 
predictions and the sequence-alignment, a peptide corresponding to the amino acid sequence 
RSTGGTQEQEILNELLSN, starting 24 amino acids downstream from the start methionine, was 
synthesised.
4.2.2 Coupling to Carrier Protein
To elicit an antibody response in the rabbit, the HG4 immunogen needed to contain an epitope 
for both B-cell binding and for class ll-T-cell receptor binding. To ensure both of these sites were 
present a carrier protein was conjugated to the peptide. Several methods exist to couple peptide 
to a carrier protein and rely on the presence of free amino, sulphydryl, phenolic or carboxylic acid 
groups. Free amino groups are found on lysine side chains or on the amino-terminal residue. 
Sulphydryl groups are present on cysteine side chains, phenolic groups on tyrosines and 
carboxylic acid groups on aspartic acids, glutamic acids and the carboxy-terminal residue. As 
the peptide sequence (RSTGGTQEQEILNELLSN) contains no sulphydryl or phenolic groups, 
coupling to carrier protein could not be accomplished using m-Maleimidobenzoyl-N- 
Hydroxysuccinamide Ester or Bis-diazotived benzidine reagents. It was also not ideal to couple 
via carboxylic acid groups, as many of these sites were present along the peptide sequence. As 
the peptide only possessed one free amino group, present at the N-terminus, it was decided to 
use gluteraldehyde as a coupling reagent. Thyroglobulin was selected as a carrier protein as it is 
not found in nematodes and thus any antibodies made towards this protein are unlikely to cross- 
react when immunolabelling.
4.2.3 Immunisation and determination of Antibody Titre
The peptide carrier conjugate was mixed with the adjuvant Imject Alum, which contains 
aluminium hydroxide precipitates. Once injected subcutaneously into the rabbit the adjuvant acts 
as a depot from which antigen is protected from rapid catabolism and is released gradually. 
Adjuvant also acts as a non-specific stimulator of the immune response by raising the level of 
lymphokines. These cells stimulate the activity of antigen processing-cells and cause a local 
inflammatory reaction at the site of injection.
Before each injection, samples of serum were taken to check the production of specific 
antibodies. Comparison of antibody titre using the enzyme linked immunosorbant assay (ELISA) 
after successive injections enabled antibody response to be monitored (Schots et al., 1988).
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Figure 33, Alignment of TGIC Subunit N-terminal domains
HG4, HG2, HG1 are inhibitory TGIC subunits from H. contortus. GluClp, GluClal, GluCla2s, GBR2A and zc3173 are from TGIC subinits from C. elegans. O. cGluClX is a TGIC subunit fron O. 
volvulus and D.mGluCIa is from D. melanogastor. Finally Rnglya is a glycine gated alpha TGIC subunit from R. norvegicus.
Test bleeds were taken every 10 days just before the administration of immunogen/adjuvant 
mix.
ELISA pro-bind plates were coated with 3 different types of antigen: HG4 peptide, HG4 peptide 
conjugated to thyroglobulin and thyroglobulin. A serial dilution of serum was added to each well 
followed by exposure to a secondary antibody conjugated with horseradish peroxidase. The 
substrate 3,3’,5,5’-tetrmethylbenzidine (TMB) was added and the reaction was stopped by 
addition of sulphuric acid. This converted the blue colour of the TMB breakdown products into a 
yellow hue, which was measured at an absorbance of 450 nm. Figure 34 displays readings 
from an ELISA using samples taken over 60 days during which time 6 boosts were carried out, 
one every 10 days. A pre-immune bleed was taken as a control to monitor antibody levels 
before administration of immunogen acting as a base line of antibody levels.
Preinnmune
bleed 
- k -  1st bleed
-X —3rd bleed
-x -4 th  bleed 
- r - 5th bleed 
Final Heed
Figure 34, Serum response to the HG4 peptide. An ELISA plate was coated with HG4 
peptide and titres of anti-HG4 antibody were measured by adding serial dilutions of 1) pre- 
immune bleed, 2) 1st bleed, 3) 3rd bleed, 4) 4th bleed, 5) 5th bleed and 6) final bleed. From this 
graph fourth and fifth bleeds contain the highest anti-HG4 antibody titres.
The antibody titre specific to the HG4 peptide had reached a sufficiently high level in the fifth 
bleed with a half-maximal response at 1:1200 dilution. It was therefore decided that the rabbit 
was to be terminated by exsanguination 10 days following the 6th boost. 160 ml of serum was 
extracted from the collected blood and an ELISA was carried out to determine the final anti- 
HG4 antibody titre. Unfortunately the antibody titre had dropped giving a half-maximal 
response at 1:600, thus making the serum collected on the 5th bleed (a total of 10 mis) a more 






















Due to the use of the carrier protein thyroglobulin, a high titre of antibodies had been raised 
specific to the epitopes present on the protein. To check that no cross-reaction of these 
antibodies to the HG4 peptide has occurred, the HG4 peptide was used to coat wells exposed 
with a previously made anti-thyroglobulin antibody (kindly donated by Dr A. Rogers). Results of 
this ELISA are shown in figure 35. Non-specific binding of anti-thyroglobulin antibodies to HG4 
peptide was negligible with levels equivalent to pre-immune serum recognising HG4 peptide. In 
contrast, anti-thyroglobulin antibodies recognised the antigen HG4/thyroglobulin complex and 
thyroglobulin at half-maximal responses of 1:22400 and 1:70400 respectively. This meant that 
purifying anti-HG4 antibody on an affinity column would be specific, ruling out the possibility of 
anti-thyroglobulin antibodies cross-reacting. Antibodies recognising thyroglobulin epitopes 
would pass through the column with out binding non-specifically.
—■— HG4+PreirmiineAb
— A —  HG4+5th Bleed Ab
—K—  HG4+anti-7hyrogk>bulin Ab
X  HG4/Th y rog lobul in + anti- 
Thyroglobulin Ab
—• —  Thyrogtobulin+anti- 
Thyroglobulin Ab
Figure 35, The response of anti-thyroglobulin antibodies on different antigens. An ELISA 
plate was coated with the following antigens: 1) HG4 peptide, 2) HG4 peptide conjugated to 
thyroglobulin, 3) thyroglobulin. Serial dilutions of Pre-immune, 5 bleed and anti-thyroglobulin 
samples were added to antigen 1. Absorbencies from these samples were compared to the 
response measured for anti-thyroglobulin antibodies against antigen 2 and 3.
4.2.4 HG4 Peptide Affinity Column
The column was made using cyanogen bromide activated Sepharose 4BA beads coupled with 
HG4 peptide. 10 ml of 5th bleed serum was recycled overnight followed by elution with 
diethlyamine at pH 11.5. Elution was tracked using a UVI cord and a trace is displayed in figure 
36. The two peaks represent the elution of two groups of antibodies each possessing different
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Figure 36, Elution of anti-HG4 antibodies from an affinity column. A UVI cord, attached to a 
chart recorder, was used to monitor the elution of anti-HG4 antibodies off an affinity column. 
Two peaks labelled 1 and 2 were eluted, each possessing a different affinity to the column. Peak 
1 was eluted initially followed by peak 2 hence antibodies collected in the peak 2 fractions have a 
higher affinity for HG4 peptide epitopes.
affinity to the peptide. Purified anti-HG4 antibodies were dialysed overnight to remove the 
diethylamine and concentrated using PEG-20,000. Bradford assays quantified the levels of 
antibody collected via the column. The collected fraction from peak one had a concentration of 
150 ng/ml whilst the fraction corresponding to peak two contained 40 ng/ml of anti-HG4 antibody. 
An ELISA was done to examine how efficient the column was at binding specific antibodies and 
to look at the efficiency of elution with diethylamine. The antigens HG4 and WWW/thyroglobulin 
were used to coat the wells of a Falcon Pro-bind plate for ELISA analysis. Samples of fifth bleed 
serum, recycled serum, wash collected after recycling and fractions collected from first and 
second peaks after elution were tested. The results are summarised in figure 37a and b. The 
majority of anti-HG4 peptide antibodies were found to bind to the column with a half-maximal 
response for p e a k l and peak|| of 1:3200 (v/v) and 1:10400 (v/v) dilutions respectively compared 
to a negligible value recorded for the left over recycled serum.
Figure 37b illustrates that the majority of anti-thyroglobulin antibodies remain in the recycled- and 
wash-solutions. A relatively low amount of anti-thyroglobulin antibodies however, remains 




















i — 5]1st peak 
\— 6]2nd peak
Figure 37a, ELISA of anti-HG4 antibody titres from different stages of purification. An
ELISA was carried out using a plate coated with HG4 peptide to establish anti-HG4 antibody 
titres at the different stages of affinity purification. Blood samples taken from 1) the pre- 
immune bleed and 2) the 5th bleed were compared 3) 51h bleed sample that had been recycled 
though the column, 4) buffer used to wash column before elution, 5) eluted product from the 
first peak and 6) eluted product from the second peak. Serial dilutions of these samples were 
added to the plate and resulting absorbencies were measured It is clear from this graph that the 
majority of anti-HG4 antibodies has been purified and eluted in peaks 1 and 2, with negligible 
amounts in recycled and wash solutions.
4.2.5 Recognition of the HG4 Extracellular Domain
ELSIA assays showed that affinity purified anti-HG4 antibodies, corresponding to peak 1 and 2 
in figure 36, recognise the HG4 peptide sequence. However, confirmation that both types have 
an affinity to a folded form of the HG4 protein needed to be obtained, as the chosen epitope 
may have been buried in the tertiary structure of the native protein. This was achieved by using 
a prokaryotic over expression system, requiring the use of a pMAL™-2 vector (refer to Appendix 
1). HG4 was to be inserted into pMAL-2, downstream from the malE gene of E. coli, which 
encodes a maltose binding protein (MBP). Fusion of the two sequences would therefore give 
rise to a MBP fusion protein. Two variations of the vector exist; pMAL™-p2 possesses a signal 
sequence whilst the other, pMAL™-c2, does not. The former is required if the protein to be over 
expressed passes through the secretary pathway and the latter could be used if the protein is 
cytoplasmic in nature. The malE gene in each of the vectors is fused to a lacZa gene via a 
polylinker. An in-frame insertion of the HG4 gene into the polylinker site inactivates the p- 
galactosidase activity of the malE-lacZa fusion. Subsequently, colonies transformed with 
pMAL-
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Figure 37b, ELISA of anti-thyroglobulin antibody titres during purification. An ELISA 
plate was coated with thyroglobulin to establish anti-HG4 antibody titres at the different stages 
of affinity purification. Blood samples tested from 1) the pre-immune bleed and 2) the 5th bleed 
were compared 3) 5th bleed sample that had been recycled though the column, 4) buffer used to 
wash column before elution, 5) eluted product from the first peak and 6) eluted product from the 
second peak. Serial dilutions of these samples were added to the plate and resulting 
absorbencies were measured. This graph illustrates that the majority of anti-thyroglobulin 
antibodies remain in the recycled and wash samples.
2/HG4 will be white in colour as opposed to blue pMAL™-2 transformed colonies. It was 
advantageous to use the pMAL-c2 vector, as the resulting expressed fusion protein constitutes 
20-40 % of the total cellular protein compared with 5-10 % levels when expressing pMAL-p2. It 
was therefore decided to express the first 5’ 693 bp (231 residues) of extracellular sequence 
cytoplasmically using pMAL-c2.
4.2.5.1 Cloning of the HG4 Extracellular Domain
A PCR was conducted to amplify the first 693 bp of HG4, coding the N-terminal extracellular 
domain, for cloning into the pMAL™-c2 vector. Primers were designed so that the 5’ HG4 
sequence would insert in the correct orientation, in frame with the malE gene. A stop codon 
was also introduced at the 3’ end, preventing expression of the neighbouring lacZa gene. 
Sense primer pMALs and antisense primer pMALa were designed, the former incorporating a 
Sail restriction site and the latter a stop codon followed by a Pst1 restriction site, the exact 
sequences of which are detailed in Appendix 3. Template for PCR was prepared by digestion of 
a pBluescript/HG4 construct with Not1 and Xba1 restriction enzymes. Isolation of the released 
HG4 insert was achieved by running a 1 % (w/v) agarose gel from which it was cleaned using 
the Sephaglas™ Band Prep and then a QIAquick™ column. A PCR reaction using HG4 
template,
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Figure 38, Amplification of HG4-ex using PCR.
Lanes 1 & 6: A, DNA cut with the restriction enzyme Pst1, respective band sizes listed along the 
side of the gel.
Lane 2: PCR using pMALs and pMALa primers in the presence of HG4 cDNA, which had 
previously been released by Not1/Xba1 digestion of a pBluescript/HG4 construct. This amplifies 
a specific HG4-ex band of 720 bp, which is indicated with a large arrow.
Lane 3: PCR product represented in lane 2 has been purified using Sephaglas and passed 
through a Qiagen QIAquick™ column.
Lane 4: The purified 720 bp fragment represented in lane 3 has been digested with EcoR1 to 
give bands of 434 bp and 259 bp, indicated by the small arrows.
Lane 5: The purified 720 bp HG4-ex fragment represented in lane 3 has been restricted with Sail
and Pst1 for ligation into pMAL-c2.
Amplification of HG4-ex was achieved using the Expand™ High Fidelity kit with 1.5 mM MgCI2. 
Each PCR required the use of 300 nM of pMALs and pMALa primers. Cycling conditions: 94 °C 
denaturation for 2 min, followed by the addition of 2.5 U enzyme, after which 45 cycles of 94 °C 
for 30 sec, 40 °C for 30 sec and 72 °C for 2 min were run terminating with 7 min at 72 °C. The 
reaction was separated by electrophoresis on a 1 % (w/v) agarose gel run in TBE._____________
pMALs and pMALa primers with High Affinity Expand™ amplified a 720 bp product (HG4-ex) and
is seen in the 1 % (w/v) agarose gel in figure 38.
Confirmation that the amplified product was specific was accomplished by digestion using the 
restriction enzyme EcoR1. This gave 2 products of 434 bp and 259 bp in size, seen in lane 4 of 
figure 38. Sequencing also confirmed the specificity of the products. Both HG4-ex and the 
pMAL-c2 vector were restricted with Sail and Pst1 enzymes, also shown in figure 38, enabling 
ligation of HG4-ex into the plasmid. This was then transformed into the E. coli strain XL2 Blue 
and cultured on LB/ampicillin agar plates.
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Figure 39, Restriction digests of HG4-ex plasmid constructs.
Lanes 1 & 16 contain A. cut with Pst1: band sizes are listed in kbp beside the gel.
Lanes 2, 4, 6, 8, 10 and 12 are uncut pMAL constructs carrying HG4-ex.
Lanes 3, 5, 7, 9, 11 and 13 are loaded with the respective EcoR1 digested constructs possessing 
a 259 bp HG4 specific product. The large arrow indicates these bands.
Lane 14: The 720 bp HG4-ex (little arrow) has been digested with EcoR1, the resulting bands of 
434bp and 259 bp are also indicated.
Lane 15: Uncut pMAL-c2 vector.
Plasmids were previously purified from the E. coli strain XL2-Blue and then digested with the 
endonuclease EcoR1 for 1 hour at 37 °C, restricted products were separated by electrophoresis 
on a 1 % (w/v) agarose gel in TBE buffer.
Resultant colonies were replica plated with one of the plates supplemented with IPTG and X-Gal. 
The presence of IPTG suppresses the Lac repressor, encoded by the lacP gene carried by 
pMAL, inducing expression. Constructs possessing HG4-ex were distinguished by colonies being 
white in colour due to their inability of X-Gal breakdown. A selection of 6 colonies corresponding 
to white colonies grown on a LB/Amp plate, containing IPTG and X-Gal, were taken from the 
replica LB/Amp plate. Plasmids were purified using Wizard Plus™ Mini-Preps and digested using 
Sail & Pst1 restriction enzymes followed by electrophoresis through a 1 % (w/v) agarose gel 
(Figure 39). Each of the 6 colonies selected had successfully been transformed with constructs 
encoding HG4-ex.
4.2.5.2 Expression of Recombinant HG4 Fusion Protein
Clone 4, containing HG4-ex/pMAL-c2 (seen in lanes 7 and 8 of figure 39) and a clone carrying 
the pMAL-c2 vector were inoculated each into 5 ml of LB/ampicillin broth. These were grown to a 
density of 2 X108 cells/ml (Aeoo of 0.5) at which point 1 ml of both were retained and IPTG was 
added, inducing protein expression of the remaining culture. IPTG induced and un-induced 
samples from both pMAL-c2 +/- HG4-ex were run on a SDS-PAGE gel (Figure 40a and 41a). A
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Figure 40, Recognition of HG4-ex by Peak 1 purified antiserum.
Lane 1: A) Bio-Rad Molecular weight marker, B) Bio-Rad pre-stained marker. Corresponding 
band sizes are detailed beside the gel.
Lane 2: un-induced XL2-Blue E. coli carrying the pMAL-c2 vector.
Lane 3: IPTG induced XL2-Blue E. coli carrying the pMAL-c2 vector. Gives over-expressed MBP 
of 51 kDa
Lane 4: un-induced XL2-Blue E. coli carrying the pMAL-c2/HG4-ex construct.
Lane 5: IPTG induced XL2-Blue E. coli carrying the pMAL-c2/HG4-ex construct. Top arrow 
indicates a 68 kDa HG4-ex protein, bottom arrow highlights degraded Hg4-ex.
A] 10% (v/v) SDS-PAGE loaded with respective sample previously resuspended in SDS-PAGE 
loading buffer and boiled for 5 min. The gel was run 100 volts for 20 min and then at 150 volts 
each at maximum current until the dye front had reached the bottom of the gel. . The gel was 
soaked overnight in Coomassie Stain and then destain was used to remove background staining, 
seen in lane 5.
B] Western Blot probed with 1:200 diluted, peakl purified, anti-HG4 antibodies followed by 
exposure to a 1:10,000 dilution of horseradish peroxidase-conjugated goat anti-rabbit antibody. 




Figure 41, Recognition of HG4-ex by Peak 2 purified antiserum.
Lane 1: un-induced XL2-Blue E. coli carrying the pMAL-c2 vector.
Lane 2: IPTG induced XL2-Blue E. coli carrying the pMAL-c2 vector. Gives over-expressed MBP 
of 51 kDa
Lane 3: un-induced XL2-Blue E. coli carrying the pMAL-c2/HG4-ex construct.
Lane 4: IPTG induced XL2-Blue E. coli carrying the pMAL-c2/HG4-ex construct. Top arrow 
indicates a 68 kDa HG4-ex protein, bottom arrow highlights degraded Hg4-ex.
Lane 5: A) Bio-Rad Molecular weight marker, B) Bio-Rad pre-stained marker. Corresponding 
band sizes are detailed beside the gel.
A] SDS-PAGE, B] Western Blot probed with a 1:200 dilution of peak 2 purified anti-HG4 
antibodies followed by secondary antiserum. See figure legend 40 for details concerning the 
loading and running of SDS-PAGE and Western Blot.
MBP/p-galactosidase fusion protein of 51 kDa from the pMAL-c2 culture can be a seen upon 
induction with IPTG. Moreover, an approximate 68 kDa fusion of MBP and HG4-ex is produced 
from the pMAL-c2 /HG4-ex culture after IPTG induction.
4.2.5.3 Probing with Purified Anti-HG4 Antibody
Western Blots were carried out to establish whether the affinity-purified antibodies would 
recognise a folded form of the extracellular domain of HG4. IPTG induced and un-induced 
constructs were run on a 10 % (v/v) SDS-PAGE gel and transferred to nitro-cellulose. These
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blots were probed with anti-HG4 antibodies from either peak-1 (figure 40b) or -2  (figure 41b), 
previously obtained during elution from the affinity column. Western blots displayed in figures 
40b & 41b show that the 68 kDa protein, corresponding to the MBP/HG4-ex fusion, is recognised 
along with smaller polypeptides by both anti-HG4 antibodies. It is possible that these smaller 
proteins may be degradation products derived from the fusion protein.
4.3 Discussion
Localisation of HG4 within the whole worm was to be studied following production of anti-HG4 
antibodies raised against the peptide sequence RSTGGTQEQEILNELLSN. This amino acid 
sequence had been chosen due to its heterogeneity with related subunits within the inhibitory 
ligand-gated ion channel family. It was also necessary to select a peptide, which would be 
exposed on the surface of the folded native protein. The peptide also had to be flexible in nature 
and possess a high antigenic index. ELISAs were used to monitor antibody titre during a series 
of boosts (Figure 34); a higher titre was recorded for the fifth bleed compared to that measured 
for the sixth bleed. This meant that the former bleed was a more suitable sample to purify. 
Before proceeding to purify anti-HG4 antibodies on an affinity column, an ELISA was done 
confirming that any anti-thyroglobulin antibodies that may have been generated would not cross 
react with the HG4 epitope (figure 35). Anti-HG4 antibodies were then affinity purified on a 
column bound with HG4 peptide. Addition of diethylamine to the column eluted 2 peaks (figure 
36) corresponding to 2 groups of antibody possessing different affinities to the HG4 peptide. The 
larger of the peaks had a lesser affinity for the HG4 peptide than the smaller peak. ELISA results 
displayed in figure 37a revealed that antibodies eluted in peak 1 and peak 2 give a half-maximal 
response at a 1:3200 and a 1:10400 dilution respectively.
Confirmation that affinity purified antibodies would recognise the peptide when present in the 
folded native protein was achieved by using the prokaryotic pMAL over-expression system. This 
enabled generation of the folded N-terminal extracellular domain of HG4 fused to a maltose 
binding protein when induced with IPTG. Western blots using antibodies eluted in either peak 1 
or peak 2 revealed specific binding solely to folded HG4-ex and its degradation products (figure 
40 b & 41b). Such specificity made antibodies eluted in each fraction ideal candidates for 
immunohistochemical studies on whole worm preparations.
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5. Localisation of HG4 in H. contortus. 
5.1 Introduction
The translated HG4 sequence is 80.25 %identical to the glutamate gated-chloride channel 
subunit, GluClp (Cully et al., 1994). Such a high amino acid identity suggests that HG4 is a 
parasitic orthologue of GluClp. The latter subunit has been localised to pm4 and pm5 muscle 
cells situated in the pharynx of C. elegans by construction of a lac-z fusion protein (Laughton 
et al., 1997a). It therefore seems reasonable to assume that HG4 is expressed in equivalent 
cell types in Haemonchus contortus. This hypothesis will be tested out using the purified 
anti-HG4 antibodies described in Chapter 4. If HG4 localisation is consistent with GluClp 
findings, it is suspected that it assembles with a subunit equivalent to GluCla2A, which has 
also been localised to the pm4 and pm5 cells of C. elegans using green fluorescent protein 
(Dent etal., 1997).
Affinity purified anti-HG4 antibodies will be utilised in the immunolabelling of HG4 in whole 
mount preparations of Haemonchus contortus. This chapter describes the preferred 
approaches taken to optimise the quality of immunohistochemical labelling. Particular 
reference is made to the preparation of whole worms, involving fixation followed by 
permeablisation and exposure to antisera. Examination of these slides will be achieved using 
a fluorescent and confocal microscope. Results obtained whilst optimising the technique are 
discussed along with HG4 specific localisation.
5.1.1 Whole Worms Preparations
Adult H. contortus is translucent permitting, its anatomy to be easily visualised under the 
microscope. Localisation studies utilising fluorescently conjugated antibodies can therefore 
be detected with ease in such an organism. Consequently, whole worms will be examined to 
establish which cells express HG4.
5.1.2 Fixation
Fixation is an essential requirement necessary for retaining the morphology of the tissue, 
thus preventing gradual degradation of the antigen. Optimum levels of fixation permit the 
ability of antibody both to penetrate the helminth and to bind to the fixed antigen. Over­
fixation denatures antigenic sites and blocks their accessibility by excessive cross-linking, 
resulting in a loss of antigen/antibody binding. Prolonged fixation also tends to obscure weak 
signals produced by the antibody. Careful consideration needs to be made on the type of fix 
used and the time given to fix the tissue.
Aldehydes such as gluteraldehyde and paraformaldehyde are generally used in fixation 
protocols and can be used together or individually. Aldehydes fix tissue by way of cross- 
linking antigens, gluteraldehyde being the harshest in nature causing a higher degree of 
antigen damage with over fixing. Recent studies of whole mount preparations of H. contortus 
have pointed to gluteraldehyde causing a higher degree of auto-fluorescence compared to
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that seen when fixing with paraformaldehyde alone (T. Skinner, personnel communication). 
It was therefore decided to fix solely in 4% w/v paraformaldehyde made up in PBS.
5.1.3 Permeablisation
The cuticle of a nematode is a physiologically active structure that acts as a protective barrier 
to environment assault such as attacks by the host’s immune system and extremes of 
desiccation or salinity. Its rigid structure is due to the hydrostatic pressure produced by the 
body fluids within the pseudocoelom and exhibits selective permeability. The chemical 
composition of nematode cuticle consists largely of collagen rich lipids cross-linked by 
disulphide bonds that were originally secreted by the hypodermis. Other cuticular 
components include insoluble structural proteins called cuticlins as well as a small set of 
highly antigenic hydrophilic proteins that are not cross-linked (Blaxter et al., 1992).
In order for antibodies to make contact with their target, the cuticular barrier needs to be 
degraded to such an extent that allows penetration by the antiserum. Either mechanical 
manipulation or enzymatic methods can accomplish this. The former is achieved by following 
a freeze-crack approach whereby the coat is physically torn off of the worm through the force 
of quickly popping off a frozen coverslip from the slide on which the worm is mounted (Miller 
& Shakes, 1995). Nematodes in the following set of experiments however, will be subjected 
to the enzymatic method. An added control handle exists with this method in that the level of 
cuticular degradation is proportionally regulated with the collagenase incubation times. The 
cuticle becomes more susceptible to collagenase treatment after it has been subjected to (3- 
mercaptoethanol. This chemical induces the reduction of disulphide bonds between cuticular 
proteins. Nematodes will therefore be incubated in p-mercaptoethanol overnight followed by 
collagenase treatment for periods of 10 h, 20 h, and 42 h.
5.1.4 Controls and blocking techniques
The presence of blocking agents can improve the degree of specific staining to the antigen 
expressing cells while minimising non-specific background fluorescence. For this reason the 
following experiments use BSA and TritonX-100, the latter being a mild non-ionic detergent 
which also conveniently reduces the tendency of worms sticking to each other in a tangled 
bulk.
A range of antibody concentrations will be tested to optimise the quality of the specific signal. 
Addition of excessive antibody concentrations will increase non-specific background staining 
whereas exposure to too diluted amount of antibody will fail to produce a signal. As the 
primary antiserum to be used for immunohistochemical studies is polyclonal in nature the 
choice of controls is critical. Controls include worms treated with no antibodies, secondary 
antibody alone, pre-immune serum, and post-absorbed (with HG4 peptide) anti-HG4 
antiserum.
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The post-absorbed control is used to establish the presence of any contaminating non­
specific antibodies. These may have been raised in response to either a contamination of 
the innoculant or infection of the host rabbit with nematodes during the immunisation period. 
In the likelihood of these events occurring the post-absorbed control will be able to 
distinguish non-specific staining induced by this nature of immune response. Similarly, 
preimmune serum will be used to identify the presence of antibodies that have been 
produced in response to previous nematode infections experienced by the rabbit. This 
control is less significant compared to the post-absorbed control, as binding seen with this 
sample will not represent antibodies present in anti-HG4 antiserum, as the majority will have 
been removed during the affinity purification procedure.
5.1.5 Direct and Indirect Immunochemistry
Two types of immunochemistry are available; one involves the direct use of a primary 
antibody conjugated with a marker such as an enzyme or fluorochrome on a tissue sample. 
This approach is quick but insensitive, as the signal produced by the antibody is not 
amplified. In contrast the indirect approach no longer requires that primary antibody be 
labelled with marker. Rather, an additional set of secondary anti-rabbit antibodies is 
conjugated with marker, which recognise primary antibody. These commercially bought 
antibodies amplify the signal, as multiple copies are able to bind to a single primary antibody.
5.1.6 Secondary Antibody
The indirect technique will be adopted; requiring the use of affinity purified antisera raised 
against rabbit IgG for detection of the primary antiserum. Fluorescently conjugated secondary 
antibodies will be used rather antibodies tagged with enzyme. The former gives optimum 
results under a confocal microscope, enabling the generation of a three dimensional 
interpretation. The use of enzymes such as Horseradish peroxidase or alkaline phosphatase 
requires the presence of a chromogenic substrate to produce a coloured reaction product. 
The disadvantage with this choice of markers is that it produces a high level of background 
staining and enables the diffusion of coloured reaction products. The fluorescent TRITC 
label has been chosen for use in the following set of experiments as recent localisation 
studies in whole preparations of H. contortus give greater levels in background fluorescence 
when using FITC (T. Skinner, personnel communication).
Images studied using fluorescent microscopy can be limiting as a result of stray light from 
fluorescent objects situated out of the plane of focus. A more precise representation is 
obtained using a confocal scanning microscope using a laser to scan a single optical section 
in the z-axis plane. Sharp images are produced with greater resolution and significantly 
reduced levels of focus fluorescence.
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5.2 Results
5.2.1 Immunocytochemistry following 42 hours of collagenase 
treatment
The cuticles of paraformaldehyde fixed H. contortus, were treated with collagenase following 
reduction of disulphide bonds by p-mercaptoethanol. It was initially decided to monitor 
collagenase digestion under a light microscope. The collagenase was removed from the 
worms after 42 hours, when a form of surface blebbing was visualised. At this point, it was 
assumed that the cuticle was successfully stripping away from the hypodermis-enveloped 
body. Further exposure to Triton X-100 during washing steps, leading up to the final viewing 
of antibody bound tissue, contributed to further degradation of the nematode’s surface.
Worms were exposed to 1:10 (v/v), 1:50 (v/v), 1:100 (v/v), and 1:200 (v/v) dilutions of primary 
antibody dilutions. Following this a 1:200 (v/v) dilution of secondary anti-rabbit antiserum 
was added to each sample. Background fluorescence levels did not appear to be a problem, 
which could be attributed to the sole use of paraformaldehyde as a fixative. Upon viewing 
nematodes treated with each of the listed antisera dilutions, fluorescence was localised to an 
organ specific to the female reproductive system in each case. Figure 42a represents a 
sketch of the female reproductive system and its position within the worm. The pars ejectrix 
(Veglia, 1915), more recently referred to as the ovijector (Lichtenfels et al., 1994) is also 
depicted. This organ consists of a vestibule sac sandwiched between two cylindrical 
sphincters. It is heavily muscularised to aid in its action of expelling fertilised eggs that are 
stored in the connecting uteri. A phase contrast image of this structure in Haemonchus 
contortus is presented in figure 42b.
Figure 43 depicts a fluorescence image of a female treated with a 1:200 (v/v) dilution of 
primary antiserum followed by a 1:200 dilution of secondary antibody. Localisation of 
fluorescence appears to be restricted mainly to each of the ovijector’s sphincters. Apart from 
the ovijector lighting up in all examined females, no other fluorescent labelling existed in 
either males or females.
A negative control was performed, studying whole worms that had not been exposed to either 
primary or secondary antiserum. An identical fluorescence was produced to that seen in 
figure 43, a higher magnification of one of the sphincters is displayed in figures 44. The 
intricate network observed on the surface of the ovijector is therefore not a true presentation 
of HG4 expression but rather an artefact of auto-fluorescence. In figures 43 and 44 the 
fluorescence pattern is confined to the ovijector and could represent a fine network of folds 
from where the lining naturally undulates. This unique pattern may be highly refractive when 






















Figure 42a, The female reproductive system of H. contortus. Positions of the different 
organs are marked including the ovijector, a muscular organ used to eject eggs, stored in the 
uteri, out of the female via the vagina.
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In summary, the ‘no-antibody’ control proved that fluorescence specific to the ovijector is not 
due to the presence of HG4 in this region. However, absence of fluorescence in the rest of 
the worm suggested that the protocol had not been fully optimised. As HG4’s predicted role 
is neurone related, the 42 hours of cuticular digestion may have been too harsh, thus 
stripping away its presence. In accordance, the blebbing originally thought to be the stripping 
of cuticle, could have been the removal of vesicles from the somatic musculature. If this 
were the case then the nematodes nervous system, which is sandwiched between the 
hypodermis and the basolateral membrane would have been removed. It was therefore 
decided that worms were to be digested with collagenase for a shorter length of time. It 
should be noted that future studies of worms consistently revealed the existence of an auto- 
fluorescing ovijector but will not be mentioned any further.
Figure 42b, A phase contrast image of the ovijector. Adult female worm p eviously fixed 
in 4% w/v paraformaldehyde was mounted on a slide for viewing under phase contrast. 
Scale bar approximately 100 pm.
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Figure 43, Fluorescence seen in the female adult ovijector of H. contortus. Whole 
mount of a female adult nematode: view of the ovijector. A 1:10 (v/v) dilution of anti-HG4 
antibody from peak 1 purified antiserum was used followed by a 1:200 (v/v) dilution of 
secondary antibody. Scale bar approximately 50 pm__________________________________
Figure 44, Auto-fluorescence observed on an ovijector sphincter. Adult female 
nematode, one of the ovijector sphincters has been magnified. Displays the auto­
fluorescence obtained when no antibody is added. Scale bar approximately 25 pm.
5.2.2 Immunolabelling after 10 hours of collagenase digestion
Worms were treated with collagenase for 10 hours in an attempt to allow antibody penetration 
and at the same time preserve the underlying neuronal architecture. Primary anti-HG4 
antiserum was added to collagenase treated worms at 1:10 (v/v), 1:50 (v/v), 1:100 (v/v) and 
1:200 (v/v) dilutions followed by a 1:200 (v/v) dilution of secondary TRITC conjugated 
antibody. Examination of each of these preparations under the fluorescence microscope 
revealed staining solely in worms exposed to a 1:10 (v/v/) dilution of primary antiserum. A 
structure in the anterior portion of the worm repeatedly labelled with TRITC. Upon close 
inspection, labelling was present at the same level as the pair of mechanosensory flaps 
termed the deirids situated posterior to the excretory pore. Figure 45a sketches the position 
of the deirids in relation to the pharynx and the excretory system in the head of the worm. 
Figure 45b represents a phase contrast image of head with the deirid flaps clearly indicated. 
Figure 45c reveals the fluorescence obtained surrounding this region. As fluorescence 
microscopy yields information on a single plane, a lot of the anatomical structure is hidden 
out of view. To obtain more of an appreciation for the total structure that has been
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recognised by the antibody, confocal microscopy was used.
Figure 46 displays a three-dimensional confocal image of this structure labelled with the 
antiserum. Staining appears as a semi-circular fibrous sheet that commences at one of the 
laterally located deirids and extends around the ventral quadrants to the oppositely 
positioned deirid (McLaren, 1976). It has been described as a biconcave cluster of highly 
refractive bodies consisting of a ventro-lateral commissure of tightly packed nerve axons. 
These extend around the ventral sides of the nematode and terminate at the lateral fields. In 
accordance with the image seen in figure 46, previous studies have reported that deirids, if 
present, are located more or less opposite the ends of the structure. In 1968, Rogers 
reported a structure called the hemizonid in H. contortus infective larvae, posterior to the 
excretory pore, in a similar position to that seen in figure 46. More recently the hemizonid 
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Figure 45a, The head of Haemonchus contortus. Particular reference has been made to 
the pharynx and its position relative to the excretory system and the mechanosensory 
organs, the dleirids.
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Figure 45b, A Phase contrast image of the H. contortus head. A view of the head of a 
whole mounted adult male, previously digested with collagenase for 10 h. es: excretory sac, 
ep: excretory pore and d: deirids. Scale bar approximately 50 pm.
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Figure 45c, Immunolabelling seen after 10 h of collagenase digestion. A fluorescent 
image of the adult male depicted in the phase contrast in figure 45b. Following 10 h of 
collagenase digestion, the nematode has been exposed to a 1:10 (v/v) dilution of anti-HG4 
antibody (eluted in peak one) followed by a 1:200 (v/v) dilution of TRITC conjugated 
secondary antiserum. A fluorescent ring found in line with the deirids can be seen. Scale bar 
approximately 50 pm.
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Figure 46, A confocal image of the head of H. contortus. Nematodes, treated with 
collagenase for 10 h, were then exposed to a 1:10 (v/v) dilution of anti-HG4 antibody (eluted 
in peak one) followed by a 1:200 (v/v) dilution of TRITC conjugated secondary antiserum. 
These were then viewed under the confocal microscope. A refractive sheet can be seen 
wrapping around the nematode in the vicinity of the deirids. d: deirid, Is: loose strand, arrows 
define diameter of body. Scale bar approximately 50
When collagenase treated worms that had not had been incubated with antisera were 
examined, no fluorescence was detected in the head region. This finding indicates that the 
structure had been recognised by the antibodies and was not an artefact of auto­
fluorescence. Exposure to TRITC-conjugated anti-rabbit IgG alone gave similar non­
fluorescing results. This suggested that the fluorescence observed in figure 46 was due to 
the specific binding of primary antiserum rather than the non-specific binding of anti-rabbit 
IgG.
Worms were then subjected to post-absorbed primary antiserum followed by secondary 
antiserum. Anti-HG4 antiserum was incubated at 37 °C with HG4 peptide for an hour and
then transferred to collagenase treated worms. During the hour incubation, anti-HG4 bound 
to the HG4 peptide epitopes. The remaining unbound antibodies therefore represented a 
population of antibodies that may bind non-specifically. A similar staining pattern to that 
viewed in figure 46 could be seen (result not shown).
A preimmune control was carried out whereby preimmune serum at a 1:10 (v/v) dilution was 
added to whole H. contortus followed by secondary anti-rabbit IgG. Figure 47 portrays a 
nematode with a fluorescing ring-like structure in an equivalent region to that observed in 
figure 46. A more intense fluorescence is observed using the preimmune serum. This is 
believed to be due to a combination of background fluorescence from stained tissue present 
in other planes of vision as well as viewing the structure from a different angle. Labelling is 
also seen just below the semi-ring structure, along longitudinal tracts called cuticular ridges 
that encompass the cylindrical body. Ridges tend to be very pronounced in members of the 
Trichstrongyloidae family in the order Strongylida. Haemonchus contortus has 30 of these 
ridges that arrange into a pattern known as the synlophe (Lichtenfels et al., 1994). Ridges 
are raised areas that commence anterior of the excretory pore and span the length of the 
worm. Their function is to help maintain the nematodes position on the gut wall and are 
composed from both cortical and median layers of the cuticle in the presence of collagen 
fibrils (Bird & Bird, 1991). The presence of these ridges, therefore, may suggest that the 
cuticle has not been removed and thus the semicircular structure in this control may in fact be 
cuticular staining. During examination of infective larvae Rogers noticed that the outer cuticle, 
overlaying the hemizonid, was modified having annular striations that were positioned 0.3 pm 
apart rather than the normal 0.9 pm separation (1968). He also noticed that the modified 
cuticle was 1.3 pm from the posterior edge of the excretory pore and spanned slightly beyond 
the hemizonid structure. A change in cuticle texture may therefore have led to the non­
specific binding of preimmune serum seen in figure 47.
Non-specific labelling as seen in the negative controls may have resulted from the rabbit 
previously being infected with nematodes. This would have stimulated the production of an 
array of anti-nematode antibodies, which would therefore cross react with epitopes presented 
by H. contortus. It is possible that the fraction of bound antibodies in the preimmune control, 
represented a population of antibodies that were co-eluted with the anti-HG4 antibodies 
during affinity purification. Labelling of the hemizonid in the post-absorbed control confirmed 
that co-elution had taken place and that the result was a non-HG4 related artefact.
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Figure 47, Cuticular fluorescence of H. contortus. Preimmune serum at a 1:10 (v/v) 
dilution was added to 10 h collagenase treated worms followed by a 1:200 (v/v) dilution of 
TRITC conjugated IgG. d: deirid, cr: cuticular ridges. Scale bar approximately 100 pm.
5.2.3 Immunological staining seen after 20 hours of digestion
As cuticle had not been totally removed after 10 hours of collagenase treatment a further 
batch of nematodes were digested for a total of 20 hours followed by the standard 
immunolabelling protocol. A 1:10 (v/v) dilution of anti-HG4 antiserum was added to 
collagenase treated worms and viewed under the fluorescence microscope. Figure 48a 
reveals labelling of a neuronal network, stretching from the anterior to the mid-body region of 
the helminth. When viewed under higher magnifications, as seen in figures 48b and 48c, this 
network appears to be confined to commissures that project from both dorsal and ventral 
cords. In females, commissure labelling occurred from just below the mid-region of the 
pharynx and stopped anterior of the vulva. The latter organ was easily located due to its 
connection with the auto-fluorescent ovijector; equivalent fluorescence was detected in 
males. Upon close inspection of figure 48b and c an intermittent fine line between 
commissures is seen to fluoresce, this was believed to be nerve cord staining. A further 
magnification displayed in figure 48d illustrates a clear image of nerve cord. Figure 49a and b 
represent two confocal images in which commissures branch out from a nerve cord situated 
parallel to the pharynx.
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Figure 48, A neuronal network recognised by anti-HG4 antibodies. Nematodes were 
treated with collagenase for 20 h. A 1:10 (/v/) dilution of anti-HG4 antibody (eluted in peak 1) 
was added followed by a 1:200 (v/v) dilution of secondary antibody conjugated with TRITC. 
Labelling highlights neurones that span the anterior portion of the nematode, nc: nerve cord 
c: commissures. A] scale bar approximately 200 pm. B] scale bar approximately 100 pm. C] 
scale bar approximately 100 pm. D] scale bar approximately 10 pm .Arrows in figures b and 
c identify where commissures fold over thus producing a double layer of fluorescence.
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Figure 49, Confocal images of commissure and nerve cord staining. 20 h collagenase 
treated H. contortus were exposed to a 1:10 (v/v) dilution of purified anti-HG4 antibody 
followed by addition of a 1:200 (v/v) dilution of TRITC conjugated IgG. a] a view of a single 
commissure branching out from the nerve cord present near the pharynx, scale bar is 
approximately . b] Several commissures are depicted originating from nerve cord which also 
appears to be possess axons that express HG4 subunits, scale bar approximately represents
SOfAion____________________________ ________ ___________________
The junction between commissures and nerve cord has been compared with those found in 
Ascaris suum. Dr Richard Martin kindly donated slides mounted with A. suum. Dr Carl 
Johnson had previously prepared these by injecting ligatured worms with crude bacterial 
collagenase. This was done to induce the dissociation of muscle cells from the hypodermis. 
Worms were then cut along the lateral line and pinned open, allowing the removal of muscles 
and internal organs and leaving the cuticle and the hypodermal layer intact. The latter of 
which, being embedded with the nervous system. The exposed nervous system was then 
labelled using antibodies to a neurofilament protein. Figures 50a, b and c represent various 
commissure projections from dorsal and ventral cords in A. suum. Comparison of these 
branching structures with fluorescence patterns obtained in H. contortus in figuresQ9a and b 
confirms that fluorescence is localised to commissures. In each case, the nerve fibre leaves 
the cord at right angles, looping over the cord to stem off in the opposite direction. It is this 
change in direction that causes the axon to retrace its path, producing a double layer of 
fluorescence which is seen in figures 48c and 48d marked out by the arrows.
A
Figure 50, See legend on next page.
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Figure 50, Nerve cord and commissure staining observed in the parasitic pig parasite 
Ascaris suum. a], b] and c] illustrate the different types junctions produced from axons 
branching out of the cords. The scale bars for each of these images represent 100 urn.
Worms that were not exposed to antibodies and ones that were incubated in only secondary 
antibody gave no labelling of neuronal anatomy. Both post-absorbed and pre-immune
controls gave no commissure or nerve cord staining. These findings indicate that nerve cord 
and commissure staining is specific to anti-HG4 antiserum recognising HG4 expression.
5.3 Discussion
Immunohistological labelling of whole Haemonchus contortus has proven successful in 
localising HG4 expression to specific neurones within its nervous system. Optimisation the 
techniques used has lead to evidence for three types of fluorescence, only one of which is 
attributable to HG4 expression. Firstly, it has been shown that the female nematode 
possesses an auto-fluorescing ovijector (Figure 43). This was observed consistently in all 
female specimens, including the controls where no antibodies had been added. Secondly, 
cuticular fluorescence was achieved after ten hours of collagenase treatment. This may be a 
result of non-specific trapping of primary antibodies in the tightly packed annular striations 
that occur directly above the hemizonid. Alternatively, it is possible, although less likely, that 
a sub-population of antibodies had been co-purified with anti-HG4 antibodies. This sub­
population may therefore recognise the cuticular antigens overlaying the hemizonid on 
worms treated with collagenase (Figure 37). The final set of experiments using worms 
digested for 20 hours yielded evidence of HG4 expression occurring within the nervous 
system. This is an unexpected result since localisation of the C. elegans orthologue (GluCip) 
has previously been confined to the pharyngeal pm4 and pm5 muscle cells (Laughton et a!., 
1997a). No HG4 localisation to the pharynx was observed in any of the worms studied. This 
raises the question as to whether HG4 is the GluClp orthologue or a novel beta-2 subunit. If 
HG4 is the parasitic orthologue of GluCip, the apparent difference in subunit distribution in 
nematodes cast doubts to the suitability of C. elegans as a model system. Following from 
this, the establishment of avermectin action and mechanisms recorded for C. elegans can not 
be assumed to be identical to those in parasite equivalents.
C. elegans and A. suum neuronal architecture are very similar, both possessing ventral and 
dorsal nerve cords containing seven classes of motor neurones of analogous shape and 
orientation (Stretton & Johnson, 1991 & White et a!., 1986). It is therefore possible that a 
matching organisation occurs in H. contortus. As the entire nervous system of C. elegans 
has been mapped out (White et al., 1986), an attempt at localising HG4 expression to 
identifiable neuronal types has been made. In the free living nematode a pair of 
interneurones called AVE neurones are unique in that they span an equivalent length of the 
ventral nerve cord that is specified by HG4 expression. AVE cell bodies are situated in the 
lateral ganglion. Their axons leave the ganglia and run around the nerve ring via the dorsal 
mid-line to the ventral cord, where they leave the ring. The paired axons run close to the 
centre of the ventral nerve cord and terminate prior to reaching the vulva. In adults, AVE 
interneurones receive many synapses from mechanosensory neurones as well as synapsing 
onto the interneurone AVA and the excitatory motor neurones VAn, DAn and ASn. Each of 
the latter excitatory neurones releases the neurotransmitter acetylcholine.
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There are 12 members in the VAn group of motor neurones that innervate ventral muscles, 
out of these VA1, VA2 and VA3 each receive synaptic input from the AVE neurone. Nine 
DAn motor neurones exist in C. elegans of which DA1, DA2, DA3 and DA4 receive synaptic 
input from the AVE neurones. Eleven ASn motor neurones span the length of the nematode 
of which AS1 to 3 are innervated by AVE interneurones. Out of all the classes of motor 
neurones mentioned, only the VAn family remains along the ventral cord and innervates 
muscles in the ventral quadrants. DA1 to 4 and AS1 to 6 neurones each have a cell body in 
the ventral cord with axons that branch out at right angles. These form commissures, which 
lead to the dorsal cord. DA1, DA3 and DA4 are left-handed commissures whilst DA2 is right 
handed. AS1 to 3 are right-handed commissures. DAn and ASn processes run anteriorly in 
the dorsal cord and form many excitatory neuromuscular junctions with muscle in the dorsal 
quadrants.
AVE interneurones communicate with VAn, DAn and ASn motor neurones, which in turn 
produce neuromuscular junctions with somatic muscle as well as synapsing with inhibitory 
motor neurones VD1-7 and DD1-4. The latter two neuronal types release GABA at 
neuromuscular junctions.
It seems likely that each of the motor neurones mentioned i.e. VA1-3, DA1-4, AS1-6, VD1-7 
and DD1 to 4 express HG4 subunits and these co-assemble with other related subunit 
proteins to form surface receptors. The network whereby the AVE interneurones send 
signals to VAn, DAn and ASn neurones, which in turn synapse with VDn and DDn neurones, 
may be achieved by glutamate transmission. These signals may be received via HG4 
associated glutamate gated chloride channels. Transmission via glutamate at synapses 
along the discussed neurones may therefore achieve a modulatory action on the potential 
produced along the axons.
Some commissures spanning from the anterior to the mid-body region of A. suum have been 
found to possess protruding branches that join either ventral-sublateral or dorsal-sublateral 
cords (Johnson & Stretton, 1987). It is possible that this characteristic occurs in H. contortus. 
The above studies show HG4 expression occurring on commissures which cross sublateral 
cords. It therefore seems plausible that the synaptic input received by the HG4 associated 
receptors may provide a more refined potential. This in turn may modulate transmitter 
release or gap junction transmission at synapses with the sublateral cords. Motor neurones 
present in the sublateral cords enhance the movement in the anterior part of the worm 
occurring in the right-left plane.
These findings suggest that glutamate transmission via HG4 associated receptors 
contributes to the movement in the anterior of the nematode. If this is correct, then the action 
of avermectin on these parasites would be to inhibit locomotion rather than to cause paralysis 
of the pharynx where avermectin sensitive receptors exist in C. elegans (Arena et a!., 1994).
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6 PCR Amplification of HG5 cDNA 
6.1 Introduction
A full-length consensus sequence coding HG4 has successfully been isolated using the 
polymerase chain reaction (PCR) as detailed in chapter 3. This chapter describes attempts 
made to isolate a second full-length glutamate-gated chloride channel (GluCIR) subunit 
using an identical approach. This was done to further characterise the GluCIR family; 
establishing its role as a target for avermectin and whether avermectin-resistance has 
resulted from an alteration in its genetic make-up.
6.1.1 The Partial HG5 sequence
Laughton (1993) was able to amplify a total of 5 PCR products denoted HG1 to HG5, each 
consisting of 450 bp. He achieved this by designing the degenerate primers, DA and DS to 
highly conserved regions of vertebrate and invertebrate GABAa and glycine receptor 
subunits. The HG5 partial nucleotide sequence was compared to existing sequences in the 
EMBL database and was found to be 74 % and 71 % identical at the amino acid level to 
GBR2A and GluCI-a1 receptor subunits respectively (accession numbers U40573 and 
U14524). Both of these subunits are members of the GluCIR family isolated from the 
nematode C. elegans.
6.1.2 Obtaining a Full Length HG5 cDNA Sequence
Rapid Amplification of cDNA Ends (RACE) using PCR will be used to amplify the 5’ end and 
the 3’ end of HG5. This method requires the use of the splice leader sequence, SL1, and 
the RoRi sequence. The former is located at the 5’ terminus, upstream from the 5’ 
untranslated region. In contrast, the latter, having been incorporated during cDNA synthesis, 
is found downstream from the Poly (T)n tail. A gene specific antisense primer designed to 
the partial sequence was used in conjunction with SL1 to amplify the 5’ end and a sense 
primer was made for use with RoRi for isolation of the 3’ end.
6.1.3 HG5 5’ Terminus Comparisons
The HG5 receptor subunit is believed to be a component of the glutamate-gated chloride 
channel as it has a 71 % amino acid identity with the GluCI-a receptor subunit. Expression 
of homomeric GluCI-a channels in Xenopus oocytes were selectively responsive to the 
anthelmintic drug ivermectin at pM concentrations, binding irreversibly to the N-terminal 
extracellular domain of the receptor (Cully et al. 1994). Avermectin resistance may have 
developed as a result of a genetic mutation at the site of ligand binding, preventing coupling 
which in turn impedes the entrance of chloride ions into the cell. As HG5 was predicted to 
be alpha-like in nature, amplification of the N-terminal avermectin-binding domain of HG5 
from an avermectin resistant isolate was attempted by RACE-PCR. This will establish 
whether the cDNA sequence differs from that isolated from the susceptible isolate. If any 











Haemonchus contortus eggs were used as a source from which total RNA was isolated. 
From this pool of RNA, mRNA was extracted using Dynabeads, aliqouts from both total RNA 
and mRNA samples are displayed in figure 11 in Chapter 3. The rest of the mRNA was 
reverse transcribed into cDNA for use as template in RACE-PCR.





Figure 52, Amplification of a 5’ end of HG5 product by RACE-PCR.
Lanel: X DNA cut with the restriction enzyme Pst1, relevant band sizes are detailed along 
the side of the gel.
Lane 2: PCR using primers HG5-GSAP1 and SL1 amplifying a 760 bp fragment (->),using 
an annealing temperature of 55 °C.
Lane 3: PCR using primers HG5-GSAP1 and SL1 with an annealing temperature of 50 °C. 
Lane 4: Semi-nested PCR of 279 bp (->) using primers HG5-GSAP1 and HG5-GSSP1with 
purified 760 bp PCR product seen in lane 2 as DNA template.
Each PCR sample had been amplified using the Expand™ High Fidelity system, in the 
presence of 1.5 mM MgCI2 and 300nM of each primer with cDNA reverse transcribed from 
H.contortus egg mRNA.
PCR Cycling conditions: 94 °C denaturation for 2 min, after which time 2.5 U of enzyme was 
added. 45 cycles of 94 °C for 30 sec, 55 °C for 30 sec and 72 °C for 2 min followed and was 
terminated by a further 7 min at 72 °C.
10 pi of each PCR sample was separated on 1 % (w/v) agarose gel using electrophoresis.
6.2.2 Isolation of the 5’ end of HG5
RACE-PCR was used to amplify the 5’ terminus of HG5, the strategy of which is illustrated in 
figure 51. A complementary antisense primer, HG5-GSAP1 (detailed in Appendix 3), was 
designed to the HG5 partial sequence and used along with SL1 in RACE-PCR with the goal 
of amplifying up an approximate 760 bp product. The arrow in figure 52 indicates a
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promising PCR product in lane 2 of the agarose gel. The 760 bp band was excised from the 
gel for Sephaglas™ purification and then used as template in a semi-nested PCR. A perfect 
match sense primer, HG5-GSSP1, was designed to anneal to an internal region of the 
sequence and was used in conjunction with HG5-GSAP1. Amplification of a 279 bp 
fragment can be seen in lane 4 of figure 52. RACE-PCR was repeated two further times to 
amplify two other individual copies of the 760 bp HG5 5’ end product.
1 2 3 4 5 6 7 8 9
 0.81
— 0.51
Figure 53, Digests of HG5 5’ RACE products ligated into pBluescript II SK (+).
Lanes 1, 3, 4, 6, 7 & 8 are loaded with constructs possessing the 760 bp HG5 5’ PCR 
product (-♦).
Lane 9: X DNA cut with the restriction enzyme Pst1, relevant band sizes are detailed along 
the side of the gel.
Remaining lanes represent plasmids that do not contain theHG5 5’ PCR fragment. 
Transformed colonies were cultured for plasmid purification using the Wizard™ Plus kit. 
Purified DNA was then digested with the endonucleases Xba1 and Xholfo r an hour at 37 °C, 
restricted products were then separated by electrophoresis on a 1 % (w/v) agarose gel ran in 
TBE buffer.______________________________________________________________________
6.2.3 Cloning of the 5’ end
The three 760 bp PCR products were treated with DNA polymerase 1 and polynucleotide 
kinase to produce blunt-ended products. These were ligated into EcoRV-cut pBluescript SK+ 
vectors. Constructs were then transformed into the XL1-Blue strain of E. coli and grown on 
LB agar supplemented with ampicillin, IPTG and the chromogenic substrate X-Gal. This 
enabled the differentiation between white colonies, transformed with recombinant plasmid, 
and blue colonies, transformed with wild-type plasmid. A selection of white colonies 
produced from ligations of each of the three PCR amplified 5’ ends were cultured overnight 
and plasmids were purified using the Wizard™ Plus kit. Screening of the plasmids was 
achieved by digestion with Xba1 and Xho1, followed by examination on an agarose gel.
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Figure 53 illustrates the digestion of purified plasmid constructs from 8 white colonies. 
Lanes 1, 3, 4, 6, 7 & 8 were loaded with recombinant plasmids, each encoding a 760 bp 
HG5-5’ RACE product, these inserts are indicated by the arrow. Constructs represented in 
lanes 1 & 2 were ligated with one 5’ amplification, lanes 3, 4 & 5 with another amplification 
and lanes 6, 7 & 8 another. Each of the three individually amplified 5’-RACE products, were 
thus successfully cloned ready for sequencing. Lane 3 is loaded with a construct carrying a 
slightly smaller 5’-PCR product than the others. The difference in size is believed to be a 
consequence of the ‘blunt ending procedure’, whereby flanking sequence is exposed to the 
exonuclease activity of DNA Polymerase 1.
The constructs represented in lanes 1, 4 and 8 were re-cultured for sequencing on the AB! 
Prism™ 377DNA Sequencer using the primers T3 and KS (appendix 3). Figure 54a displays 
an alignment of the nucleotide sequences amplified from three individual cDNAs, with 
differences shaded in grey. The amino acid variation between the sequences is also 
displayed in figure 54b. The percentage variation between these clones has been 
summarised in table 12. A translated consensus sequence was derived from the 
comparison of all three sequences and can be seen in figure 54b. This was transferred to 
the GCG package accessed via the gnome workstation. Using the ‘pileup’ command an 
alignment with related sequences was achieved and the percentage identity was calculated. 
The 5’ end of HG5 was 67 % identical at the amino acid level with the partial sequence 
isolated from Dilofilaria immitis followed by 62 % identical to GBR-2A & -2B from C. elegans, 
both of which are predicted to be GluCI receptors (accession numbers U59744 and U40573 
respectively).
1 25
H G 55' (3 ) g t t ia g t a t c t a t g t g a t c g a c a c t a  ATGTTCGCCT Tf§ATTCTGCC ATTTC
H G 55' ( 8 )  | t | a g t a t c t a t g t g a t c g a c a c t a  ATGTTCGCCT TiATTCTGCC ATTTC
H G 55' ( 1 2 )  | t | a g t a t c t a t g t g a t c g a c a c t a  ATGTTCGCCT TQATTCTGCC ATTTC
C o n s e n s u s  | t | f a g t a t c t a t g t g a t c g a c a c t a  ATGTTCGCCT TRATTCTGCC ATTTC
26 85
H G55' (3 ) TGTTGCATTT CACjlCGGTCC GAAGGTTTTG GTTACGAGAA GCTATTGGAT GAGCAGAAAA
H G55' ( 8 )  TGTTGCATTT CACfCGGTCC GAAGGTTTTG GTTACGAGAA GCTATTGGAT GAGCAGAAAA
H G55' (1 2 )  TGTTGCATTT CACgCGGTCC GAAGGTTTTG GTTACGAGAA GCTATTGGAT GAGCAGAAAA
C o n s e n s u s  TGTTGCATTT CACRCGGTCC GAAGGTTTTG GTTACGAGAA GCTATTGGAT GAGCAGAAAA
86 145
H G55' (3 ) TTATCAAACA TCTATTGGAA AGTCCCTATA GCGATTACGA TTGGCGGGTT CGTCCCCGTG
H G55' ( 8 )  TTATCAApCA TCTATTGGAA AGTCCCTATA GCGATTACGA TTGGCGGGTT CGTCCCCGTG
HG55' (1 2 ) TTATCAAGCA TCTATTGGAA AGTCCCTATA GCGATTACGA TTGGCGGGTT CGTCCCCGTG
C o n s e n s u s  TTATCAARCA TCTATTGGAA AGTCCCTATA GCGATTACGA TTGGCGGGTT CGTCCCCGTG
Figure 54, see legend on next page.
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146 205
H G 55' ( 3 )  GTCGTCTTGG TCCCGCTGAC GACGACGATT ACGATAGTGA ACCAGTATTC ATTACAGTCA
H G 55' ( 8 )  GTCGTCTTGG TCCCGCTGAC GACGACGATT ACGATAGTGA ACCAGTATTC ATTACAGTCA
H G 55'( 1 2 )  GTCGTCTTGG TCCCGCTGAC GACGACGATT ACGATAGTGA ACCAGTATTC ATTACAGTCA
C o n s e n s u s  GTCGTCTTGG TCCCGCTGAC GACGACGATT ACGATAGTGA ACCAGTATTC ATTACAGTCA
206 265
H G 55' ( 3 )  ACATGTACTT GAGGAGTATT TCTAAAGTCG ACGATGTTAA TATGGAATAT TCATTGCATT
H G 55' ( 8 )  ACATGTACTT GAGGAGTATA TCTAAAGTCG ATGATGTTAA TATGGAfTAT TCGTTGCACT
H G 55' ( 1 2 )  ACATGTACTT GAGGAGTATA TCTAAAGTCG ATGATGTTAA TATGGASTAT TCGTTGCACT
C o n s e n s u s  ACATGTACTT GAGGAGTATW TCTAAAGTCG AlfGATGTTAA TATGGARTAT TCRTTGCAXT
266 325
H G55' ( 3 )  TTACATTTCG AGAAGAGTGG ATTGACGAGA GGC?ATATTT CAAiAGCCCG ACGTTGAAAC
H G 55' (8 ) TCACATTTCG AGAAGAATGG ATTGACGAAA GGC®TATTT CAA||AGCCCG ACGTTGAAAC
H G55'( 1 2 )  TgACATTTCG AGAAGAATGG ATTGACGAAA GGC0GTATTT CAATAGCCCG ACGTTGAAAC
C o n s e n s u s  TYACATTTCG AGAAGARTGG ATTGACGARA GGCJtRTATTT CAAIAGCCCG ACGTTGAAAC
326 385
H G 55' ( 3 )  ATATCGTTCT GTCACCTGGA CAACGAATCT GGGTGCCCGA CAC|iTTCTTC CARAACGAGA
H G 55' ( 8 )  ATATTGTGCT GTCACCTGGA CAACGAATCT GGGTGCCCGA CACf§TTCTTC CAGAATGAGA
H G 55'( 1 2 )  ATATTGTGCT GTCACCTGGA CAACGAATCT GGGTGCCCGA CACjfTTCTTC CAGAATGAGA
C o n s e n s u s  ATATYGTRCT GTCACCTGGA CAACGAATCT GGGTGCCCGA CACIlTTCTTC CARAAYGAGA
386 445
H G 55' ( 3 )  AAAATGGCAA GAAACATGAC ATCGATACTC CGAACATTTT GATTCGGATA CATAACGGTA
H G 55' ( 8 )  AAGATGGCGA GAAACATGAC ATCGATACTC CGAATATTCT AATTCGGATA CATAATGGCA
H G 55'( 1 2 )  AAGATGGCAA GAAACATGAC ATCGATACTC CGAATATTCT AATTCGGATA CATAATGGCA
C o n se n su s  AARATGGCRA GAAACATGAC ATCGATACTC CGAAYATTYT RATTCGGATA CATAAYGGYA
446 505
HG55' ( 3 )  CAGGAAAGAT ACTGTATTCC TGTCGGCTTA CT§TGACCCT GAGCTGTCC0 ATGAGGTTGG
HG55' ( 8 )  CAGGAAAGAT |C T iT A T T C i TGTCGGCTTA CT|TGACCCT GAGCTGTCCR ATGAGGTTGG
H G55'( 1 2 )  CAGGAAAGAT TCTfTATTCA TGTCGGCTTA CT|TGACCCT GAGCTGTCCl ATGAGGTTGG
C o n s e n s u s  CAGGAAAGAT WCTKTATTCM TGTCGGCTTA CTfTGACCCT GAGCTGTCCR ATGAGGTTGG
506 565
H G55' (3 ) CCGATTATCC CCTTGATGTA CAGACATGTG T|GTGGATTT TGCTTCATAC GCCTATACTA
H G55' ( 8 )  CCGATTATCC GCTTGATGTA CAGACATGTG TftGTGGATTT TGCTTCATAC GCCTATACTA
H G 55' ( 1 2 )  CCGATTATCC GCTTGATGTA CAGACATGTG T||GTGGATTT TGCTTCATAC GCCTATACTA
C o n s e n s u s  CCGATTATCC GCTTGATGTA CAGACATGTG TWGTGGATTT TGCTTCATAC GCCTATACTA
566 597
HG55' ( 3 ) CGAAAGACAT AGAATACGGA TGGAAAGAGG AG
HG55' ( 8 ) CGAAAGACAT pGAATACGGA TGGAA^SAGG A&
HG55'( 1 2 ) CGAAAGACAT OGAATACGGA TGGAAGAAGG a |
C o n se n su s CGAAAGACAT MGAATACGGA TGGAARRAGG AR
Figure 54, See legend on next page.
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B1 60
H G 55' ( 3 )  M F A LILP FLL HFTRSEGFGY EKLLD E Q KII KHLLESPYSD YDWRVRPRGR LGPADDDDYD
H G 55' ( 8 )  M F A LILP FLL HFTRSEGFGY E KLLD E Q KII KHLLESPYSD YDWRVRPRGR LGPADDDDYD
H G 55'( 1 2 )  M F A LILP FLL HFTRSEGFGY EKLLD E Q KII KHLLESPYSD YDWRVRPRGR LGPADDDDYD
C o n s e n s u s  M F A LILP FLL HFTRSEGFGY E KLLD E Q KII KHLLESPYSD YDWRVRPRGR LGPADDDDYD
61 120
H G 55' ( 3 )  SEPVFITVNM YLRSISKVDD VNMEYSLHFT FREEWIDERJL YFNSPTLKHI VLSPGQRIWV
H G 55' ( 8 )  SEPVFITVNM YLRSISKVDD VNMEYSLHFT FREEWIDERJa YFNSPTLKHI VLSPGQRIWV
H G 55'( 1 2 )  SEPVFITVNM YLRSISKVDD VNMEYSLHFT FREEWIDERi YFNSPTLKHI VLSPGQRIWV
C o n se n su s  SEPVFITVNM YLRSISKVDD VNMEYSLHFT FREEWIDERI YFNSPTLKHI VLSPGQRIWV
121 180
HG55' (3 ) PDTFFQNEKN GKKHDIDTPN IL IR IH N G T G  KILYSCR LTL TLSCPMRLAD YPLDVQTCW
H G 55' ( 8 )  PDTFFQNEKD GBKHDIDTPN IL IR IH N G T G  K ILYSCR LTL TLSCPMRLAD YPLDVQTCW
HG55'( 1 2 )  PDTFFQNEKD GKKHDIDTPN IL IR IH N G T G  K ILYSCR LTL TLSCPMRLAD YPLDVQTCW
C o n se n su s  PDTFFQNEKD GKKHDIDTPN IL IR IH N G T G  K ILYSCR LTL TLSCPMRLAD YPLDVQTCW
181 199
HG55' ( 3 )  DFASYAYTTK DIEYGWKBE
HG55' ( 8 )  DFASYAYTTK DIEYGWKBE
HG55' (1 2 ) DFASYAYTTK DIEYGWKJCE 
C o n se n su s  DFASYAYTTK DIEYGWKBE
Figure 54, Alignment of three 5’ RACE-PCR amplifications a] nucleotide sequence, b] 
peptide sequence. Shaded regions highlight nts that vary between the clones. A 
consensus sequence is also displayed with a summary of possible nts highlighted in bold. 
For part a] only: Y codes either a C or a T, M codes either an A or a C, R: an A or a G, S: a 
G or a C, K: a G or a T and W: an A or a T. Nucleotides in uppercase are coding sequence 
whilst lower case nucleotides represent the 5’ UTR.
Table 12, Percentage variation between the HG5 5’ RACE. Comparison of amplified 
cDNA clones at both nucleotide and amino acid levels from an avermectin susceptible 
isolate of H. contortus has been addressed.
HG5 5’ ends isolated from avermectin susceptible H. 
contortus
Clone 3 Clone 8
Variation at the 
nucleotide level, over a 
length of 613 bp
Clone 8 5.53% (33/597nt)
Clone 12 5.86% (35/597nt) 0.67% (4/597nt)
Variation at the amino 
acid level, over a length 
of 209 residues
Clone 8 1.01% (2/199aa)









Primers 1 HG5-GSSP2 
2 RoRi
Figure 55, Strategy for Isolating the 3’ end of HG5 using RACE-PCR.
6.2.4 Isolation and cloning of the 3’ end of HG5
With the 5’ sequence of HG5 established, a gene specific sense primer, HG5-GSSP2 
(Appendix 3), was designed for use in a 3’ RACE-PCR with the RoRi oligonucleotide. The 
exact strategy is illustrated in figure 55, with the successful amplification yielding a PCR 
product of greater than 1.3 kbp in length. The exact length could not be predefined, as 
although the coding domain had been predicted to be approximately 1.29 kbp, the length of 
the 3’ untranslated region could not be determined.
Figure 56 depicts a 3’ PCR amplification using HG5-GSSP2 and RoRi primers with 
avermectin-susceptible H. contortus as template. The resulting 1.65 kbp product was 
amplified following 45 cycles. The concentration of this product was too low to sequence 
directly, so 1 pi of the Sephaglas™ purified band was used as template to re-amplify the 
product in a second PCR. The same primers, RoRi and HG5-GSSP2, were added to the 
template and a further 45 rounds of thermal cycling was carried out with the same cycle 
temperatures used for the previous amplification.
Figure 56, Amplification of a 3’ RACE Product.
Lanel: X DNA digested with the restriction enzyme Pst1, relevant band sizes are shown 
along the side of the gel.
Lane 2: 3’ RACE using primers HG5-GSSP2 and RoRi amplifying a 1.65 kbp fragment (-* ). 
The PCR sample had been amplified using the Expand™ High Fidelity system, in the 
presence of 1.5 mM MgCI2 and 300nM of each primer with cDNA reverse transcribed from 
H.contortus egg mRNA.
Cycling conditions: 94 °C denaturation for 2 min, after which time 2.5 U of enzyme was 
added. 45 cycles of 94 °C for 30 sec, 61 °C for 30 sec and 72 °C for 2 min followed and was 
terminated by a further 7 min at 72 °C.
80 pi of PCR sample was separated on 1 % (w/v) agarose gel using electrophoresis.
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The resulting 1.65 kbp amplification was sequenced directly, confirming that it was HG5 
specific. To obtain a consensus sequence of the 3’ end of HG5, a further two PCR reactions 
were carried out using cDNA from avermectin susceptible H. contortus as template. This 
yielded an extra two individual products of 1.65 kbp in size which were re-amplified in an 
identical manner to that described for the first 3’ PCR product (Figure 56). All three 1.65 kbp 
cDNAs were treated with DNA polymerase 1 and polynucleotide kinase to create blunt- 
ended products for ligation into pBluescript II SK (+) via the EcoRV restriction site. These 
were then transformed into the E. coli strain XL1-Blue and colonies were grown up on LB 
agar in the presence of ampicillin, X-Gal and IPTG. Plasmids purified from a selection of 
white colonies were restricted with Xba1 and Xho1 in a double digestion to determine 
whether the 1.65 kbp insert had been successfully ligated into the vector. Figure 57 
represents an agarose gel loaded with digested plasmids. Lanes 4, 5, 6 & 7 contain 
constructs carrying one 3’ end amplified from the first set of PCRs. Similarly constructs in 
lanes 9, 10 & 11 have been ligated with the second PCR amplified 3 ’ end and lanes 12, 13, 
14 & 15 with the third individually amplified insert.
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Figure 57, Clones containing HG5 3’RACE products.
Lanel & 16: X. DNA cut with the enzyme Pst1, relevant band sizes are noted along the side 
of the gel.
Lane 2: Uncut construct carrying 1.65 kbp fragment, previously represented in lane 2 of 
figure 55.
Lane 3: Same construct used as in lane 2 of this figure but cut with the enzyme Xba1.
Lane 4: A single Xho1 digest using construct represented in lane 2, this releases a 1.65 kbp 
fragment indicating that there is an extra Xho1 site near the Xba1 motif.
Lanes 5, 6 & 7: loaded with double digested constructs possessing the 1.65 kbp HG5 3’ end 
product seen in lane 2 of figure 55.
Lanes 8, 9, 10 & 11: double digested constructs ran in these lanes comprise a separately 
amplified 1.65 kbp insert using the same RACE-PCR conditions as detailed in figure 6.
Lanes 12, 13, 14 & 15: a third PCR identical to that described in figure 6 was achieved with 
the resulting 1.65 kbp fragment cloned successfully into plasmids run in these lanes.
Lane 8 represents a plasmid that does not contain the HG5 3’ end insert. Plasmids, 
previously purified with the Wizard Plus™ kit were double digested with the restriction 
enzymes Xba1 and Xho1 for 1 hour at 37 °C unless otherwise stated. Digested products 
were then separated by electrophoresis on a 1 % (w/v) agarose gel in TBE buffer for 
analysis._________________________________________________________________________
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Plasmid-constructs from clones seen in lanes 4, 10 & 15 were sequenced using the primers 
T3, KS, HG5-GSAP1, HG5-GSAP2 and HG5-GSSP3. These sequences were then aligned 
to establish the degree of variation between the three individually amplified PCR products 
displayed in figure 58a and b. Table 13 lists the calculated percentage of variation between 
the clones and the percentages of the consequent amino acid discrepancies seen at the 
translated level respectively. The 3’ end was 66 % identical to the partial GluCIX sequence 
isolated from O. volvulus and 62 % identical to the GBR-2A from C. elegans (accession 
numbers U59745 and U40573 respectively). These results consistent with the identities 
calculated for the partial and 5’ end clones of HG5.
1 50
H G 53' (4 ) TTGCATTTCA CGCGfTCCGA AGGTTTTGGT TACGAGAAGC TATTGGATGA
H G 53' ( 1 0 )  TTGCATTTCA CGCGGTCCGA AGGTTTTGGT TACGAGAAGC TATTGGATGA
H G 53'( 1 5 )  TTGCATTTCA CGCGGTCCGA AGGTTTTGGT TACGAGAAGC TATTGGATGA
C o n s e n s u s  TTGCATTTCA CGCGfTCCGA AGGTTTTGGT TACGAGAAGC TATTGGATGA
51 100
H G53' ( 4 )  GCAGAAAATA ATCAAACATC TACTGGAAAG TCCCTATAGC GATTACGATT
HG53' (1 0 ) GCAGAAAATf ATCAAQCATC TATTGGAAAG TCCCTATAGC GATTACGATT
H G53' (1 5 ) GCAGAAAATf ATCAAACATC TAfTGGAAAG TCCCTATAGC GATTACGATT
C o n s e n s u s  GCAGAAAATW ATCAAJICATC TAfTGGAAAG TCCCTATAGC GATTACGATT
101 150
HG53' ( 4 )  GGCGGGTTCG TCCCCGTGGT CGTCTQGGTC CAGCTGACGA CGACGATTAC
H G 53' (1 0 ) GGCGGGTTCG TCCCCGTGGT CGTCTfGGTC CfJGCTGACGA CGACGATTAC
H G 53' (1 5 ) GGCGGGTTCG TCCCCGTGGT CGTCTfGGTC CCGCTGACGA CGACGATTAC
C o n s e n s u s  GGCGGGTTCG TCCCCGTGGT CGTCTfGGTC CjjfGCTGACGA CGACGATTAC
151 200
H G53' ( 4 )  GATAGTGAAC CAGTATTCAT TACAGTCAAC ATGTACTTAA GGAGTATTTC
H G53' (1 0 ) GATAGTGAAC CAGTATTCAT TACAGTCAAC ATGTACTTQA GGAGTATjfTC
H G53'( 1 5 )  GATAGTGAAC CAGTATTCAT TACAGTCAAC ATGTACTT§A GGAGTAT|TC
C o n s e n s u s  GATAGTGAAC CAGTATTCAT TACAGTCAAC ATGTACTTRA GGAGTATWTC
201  250
HG53' ( 4 )  CAAAGTCGAT GATGTTAATA TGGAGTATTC ATTGCAGTTf ACATTTCGAG
H G53' ( 1 0 )  TAAAGTCGAT GATGTTAATA TGGAGTATTC GTTGCACTTC ACATTTCGAG
H G53' ( 1 5 )  TAAAGTCGAC GATGTTAATA TGGAATATTC ATTGCATTTT ACATTTCGAG
C o n s e n s u s  YAAAGTCGAY GATGTTAATA TGGAfTATTC RTTGCAYTTY ACATTTCGAG
251 300
H G 53' ( 4 )  AAGAATGGAT TGACGAGAGG CTGTATTTCA ATAGCCCAAC GTTGAAACAT
H G 53'( 1 0 )  AAGAATGGAT TGACGAAAGG CTQTATTTCA ATAGCCCGAC GTTGAAACAT
H G 53' ( 1 5 )  AAGAGTGGAT TGACGAGAGG CTGTATTTCA ACAGCCCGAC GTTGAAACAT
C o n s e n s u s  AAGARTGGAT TGACGARAGG CTRTATTTCA AYAGCCCRAC GTTGAAACAT
Figure 58, see legend on next page.
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301 350
H G 53' ( 4 )  ATTGTQCTGT CACCTGGACA ACGAATftTGG GTGCCCGACA CTTTCTTCCA 
H G 53' ( 1 0 )  ATTGTGCTGT CACCTGGACA ACGAATCTGG GTGCCCGACA C |t TCTTCCA 
H G 53' ( 1 5 )  ATCGTTCTGT CACCTGGACA ACGAATCTGG GTGCCCGACA CTTTCTTCCA 
C o n s e n s u s  ATYGTKCTGT CACCTGGACA ACGAATCTGG GTGCCCGACA CTTTCTTCCA
351 400
H G 53' ( 4 )  GAACGAGAAA GATGGCAAGA AGCATGACAT CGATACTCCG AACATTCTGA 
H G 53' ( 1 0 )  GAATGAGAAA GATGGCAAGA AACATGACAT CGATACTCCG AATATTGTAA 
H G53' ( 1 5 )  AAACGAGAAA GATGGCAAGA AACATGACAT CGATACTCCG AACJATTTTGA 
C o n s e n s u s  RAAYGAGAAA GATGGCAAGA ARCATGACAT CGATACTCCG AAYATTYTRA
401 450
H G 53' (4 ) TTCGGATACA TAACGGCACA GGAAAGATCC T<3TATTCQTG |CGGCTTACT 
H G 53'( 1 0 )  TTCGGATACA TAATGGCACA GGAAAGATTC t ! t ATTC|TG  (CGGCTTACT 
H G 53' ( 1 5 )  TTCGGATACA TAACGGTACA GGAAAGATAC T |T A T T C |T G  ffCGGCTTACT 
C o n s e n s u s  TTCGGATACA TAAYGGYACA GGAAAGATXC TKTATTCRTG fCGGCTTACT
451 500
H G 53' ( 4 )  CTGACCCTGA GCTGTCOfcAT GAGGTTGGCC GATTATCCGC TTGATGTACA 
H G 53' ( 1 0 )  fTGACCCTGA GCTGTCCAAT GAGGTTGGCC GATTATCCGC TTGATGTACA 
H G 53' ( 1 5 )  CTGACCCTGA GCTGTCC|AT GAGGTTGGCC GATTATCCGC TTGATGTACA 
C o n s e n s u s  YTGACCCTGA GCTGTCC|AT GAGGTTGGCC GATTATCCGC TTGATGTACA
501 550
H G 53' ( 4 )  GACATGTGTA GTGGATTTCG CTTCATACGC CTATACTACA AAAGATATCG 
H G 53' ( 1 0 )  GACATGTGTR GTGGATTTTG CTTCATACGC CTATACTACQ AAAGACATCG 
H G 53' ( 1 5 )  GACATGTGTT GTGGATTTTG CTTCATACGC CTATACTACjf AAAGACATCG 
C o n s e n s u s  GACATGTGTW GTGGATTTYG CTTCATACGC CTATACTAC| AAAGAYATMG
551 600
H G 53' ( 4 )  AATATGGATG GAAAGAAGAA AAACCGATCC AGATCAAAGA TGGCCTTCGA 
H G 53' ( 1 0 )  AATACGGATG GAAAGAAGAA AAACCGATCC AGATCAAAGA TGGCCTTCGA 
H G53' ( 1 5 )  AATACGGATG GAAAGAGGAG AAACCGATCC AGATCAAAGA TGGCCTTCGA 
C o n s e n s u s  AATAYGGATG GAAAGARGAR AAACCGATCC AGATCAAAGA TGGCCTTCGA
601 650
H G 53' ( 4 )  CAATCATTGC CTTCgTTTTT GCTCAGTAAT GTAAAAACCG GTAATTGTAC 
H G 53' ( 1 0 )  CAATCATTGC CTTC iTTTTT GCTCAGTAAT GTAAAAACCG GTAATTGTAC 
H G 53' ( 1 5 )  CAATCATTGC C TTC iTTTTT GCTCAGTAAT GTAAAAACCG GTAATTGTAC 
C o n s e n s u s  CAATCATTGC CTTCRTTTTT GCTCAGTAAT GTAAAAACCG GTAATTGTAC
651 700
HG 53' ( 4 )  GTCAGTTACC AATACGGGCG CTTATTCATG CCTTCGAAC| ATCATCGAAC 
HG 53' ( 1 0 )  GTCAGTTACC AATACGGGCG CTTATTCATG CCTTCGAACC ATCATCGAAC 
HG 53' ( 1 5 )  GTCAGTTACC AATACGGGCG CTTATTCATG CCTTCGAACC ATCATCGAAC 
C o n s e n s u s  GTCAGTTACC AATACGGGCG CTTATTCATG CCTTCGAACY ATCATCGAAC
Figure 58, see legend on next page.
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701 750
HG53' ( 4 )  TCAAGAGGGA ATTCAGTTAT TA!|CTTTTAC AGCTTTATAT TCCATCTTTT
HG53' ( 1 0 )  TCAAGAGGGA ATTCAGTTAC TACCTTTTAC AGCTTTATAT TCCATCTTTT
HG53' ( 1 5 )  TCAAGAGGGA ATTCAGTTAC TACCTTTTAC AGCTTTACAT TCCATCTTTT
C o n se n su s  TCAAGAGGGA ATTCAGTTAT TAYCTTTTAC AGCTTTAfAT TCCATCTTTT
751 800
H G53' ( 4 )  ATGCTAGTGG CAGTATCGTG GGTGTCTTTT TGGCTAGACA AAGATTCTGT
HG53'( 1 0 )  ATGCTAGTCG CAGTATCGTG GGTGTCTTTT TGGCTAGACA AAGATTCTGT
HG53'( 1 5 )  ATGTTGGTCG CAGTATCATG GGTGTCATTT TGGCTAGACA AAGATTCTGT
C o n se n su s  ATGYTRGT8G CAGTATCRTG GGTGTCWTTT TGGCTAGACA AAGATTCTGT
801 850
HG 53' ( 4 )  CCCGGCTCGT GTAACGCTAG GAGTAACCAC CTTACT&ACT ATGACTACAC
HG 53' ( 1 0 )  CCCGGCTCGG GTTACGCTAG GAGTAACTAC CTTACT|ACT ATGACCACAC
H g 5 3 ' ( 1 5 )  CCCGGCTCGG GTTACGCTAG GAGTAACQAC CTTACTfACT ATGACCAC^C
C o n se n su s  CCCGGCTCG* GTAACGCTAG GAGTAACSEAC CTTACTMACT ATGACYACRC
851 900
H G53' ( 4 )  AAGCATCAGG TGTAAATGCG AATTTGCC|C CAGTCAGCTA TACQAAGGCA
H G53' ( 1 0 )  AAGCATCGGG TGTAAATGCG AATTTGCCfC CAGTCAGTTA CACAAAGGCA
H G53' ( 1 5 )  AAGCATCGGG TGTAAA©GCG AATTTGCCTC CAGTCAGCTA |A C J a AGGCA
C o n se n su s  AAGCATCRGG TGTAAATGCG AATTTGCCKC CAGTCAGXTA YACMAAGGCA
901 950
H G 53' ( 4 )  ATTGACATAT GGATTGGTGT CTGTCTAGCA TTTATTTTTG GTGCTCTTTT
H G 53'( 1 0 )  ATTGACATAT GGATTGGTGT CTGTCTAGCA TTTATTTTTG GTGCTCTTTT
H g 5 3 ' ( 1 5 )  ATTGACATAT GGATTGGTGT CTGTCTAGCA TTTATTTTTG GTGCTCTTTT
C o n se n su s  ATTGACATAT GGATYGGTGT CTGTCTAGCA TTTATTTTTG GTGCTCTTTT
951 1000
HG53' ( 4 )  GGAATTTGCA TTAGTGAATT GGGCAGCACG GCAGGATCTC GTAGCCCACA
HG53' ( 1 0 )  GGAATTTGCA TTAGTGAATT GGGCAGCACG GCAGGATCTC GTAGCCCACA
HG53' ( 1 5 )  GGAATTTGCA TTAGTGAATT GGGCAGCACG GCAGGATCTC GTAGCCCACA
C o n se n su s  GGAATTTGCA TTAGTGAATT GGGCAGCACG GCAGGATCTC GTAGOgCACA
1001 1050
H G 53' ( 4 )  GTCGGGCCCG ATATCGACAA TCACCTTTGT TCTTTAGGAA |C C |G A TTC A
H G 53'( 1 0 )  GTCGGGCCCG ATATCGACAG CTACCTTTGT TCTTTAGGAA TCCfcGATTCA
H G53' ( 1 5 )  GTCGGGCCCG ATATCGACAG YCACCTTTGT TCTTTAGGAA CCCfGATTCA
C o n s e n s u s  GTCGGGCCCG ATATCGACAR YYACCTTTGT TCTTTAGGAA YCCHGATTCA
1051 1100
H G53' ( 4 )  CGACAAGAAA ACTCCCATCA TTTCTATGCA CCTATACAAC AAGAGGTTAC
H G53' ( 1 0 )  CGACAAGAAA ACTCCCATCA TTTCTATGCA CCTATACAAC AAGAGGTTAC
HG53'( 1 5 )  AGACAAGGAA ACTCCCATCA TTTCTATGCA CCTATACAAC AAGAGGTTAC
C o n s e n s u s  MGACAAGRAA ACTCCCATCA TTTCTATGCA CCTATACAAC AAGAGGTTAC
Figure 58, See legend on next page.
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1101  1150
H G 53' ( 4 )  GTTGGAAGAT TTGCC0TTCA GTTGGTGGGA TAAAATATGG AAAATACGCT
H G 53'( 1 0 )  GTTGGAAGAT TTACCGTTCA GTTGGTGGGA TAAAATATGG AAAATACGCT
H G 53'( 1 5 )  GTTAGAAGAT TTGCCATTCA GTTGGTGGGA TAAAATATGG AAAATACGCT
C o n s e n s u s  GTTRGAAGAT TTRCC§TTCA GTTGGTGGGA TAAAATATGG AAAATACGCT
1151  1200
H G 53' ( 4 )  ATAAGGAACG GAGTCG||AGS ATAGATCTTA TATCGAGAGT GATGTTfCCG
H G 5 3 '(1 0 ) ATAAGGAACG GAGTCGGAGG ATAGATCTTA TATCGAGAGT GATGTT|CCG
HG53 ' (1 5 ) ATAAGGAACG GAGTCGAAGA ATTGATCTTA TATCGAGAGT GATGTT|CCG
C o n s e n s u s  ATAAGGAACG GAGTCGRAGR ATWGATCTTA TATCGAGAGT GATGTTYCCG
1201 1250
H G 53' ( 4 )  CTGTGCTTCA TTATTTTCAA TATfATGTAC TGGTGGCGAT ATCTGATACC
H G 53'( 1 0 )  CTGTGCTTCA TTATTTTCAA TAT|ATGTAC TGGTGGCGAT ATCTGATACC
H G 53'( 1 5 )  CTGTGCTTCA TTATTTTCAA TATAATGTAC TGGTGGCGAT ATCTGATACC
C o n s e n s u s  CTGTGCTTCA TTATTTTCAA TATjCATGTAC TGGTGGCGAT ATCTGATACC
1251  1300
H G 53' ( 4 )  GTACATGGCA GTACA^GCftC AGTTGGAATG A tg a g g c c t t  g c a i t A t g g a
H G 53' ( 1 0 )  GTACATGGCA GTCCAGGCAC AGTTGGAGTG A tg a jg g c t j j t  $ c a £ tg tg g a
H G 53' (1 5 ) GTACATGGCA GTGCAAGCGC AGTTGGAATG A tg a g S c tg t  | c a § t | t g g a
C o n se n su s  GTACATGGCA GTHCARGCRC AGTTGGAlTG A t g a ® c t j§ t  y c a lk ty tg g a
1301 1350
H G53' ( 4 )  g g c t t g t c t t  t t t a c g g a a a  a a t t c t a t t t  a t g t g a t a c a  a a a a c tc g g g
H G 53' ( 1 0 )  g g c t t g t c t t  t c ta c g g j .a a  a a t t c t a t t g  a t g t g a t a c g  a a a a c tc g g g
H G 53' (1 5 ) g g c t t g t c t t  t c ta c g f f i t a a  a a t t c t a t c g  a t g t g a t a c g  a a a a fc tc g g g
C o n se n su s  g g c t t g t c t t  t c t a c g i |> a a  a a t t c t a t y k  a t g t g a t a c g  a a a a y tc g g g
1351 1400
H G 53' ( 4 )  g a t t t g a t a c  a g t a t t g t t g  t a g a t g c c t t  | ^ a t a t t f a t |  t t g t a a t g t g
H G 53' (1 0 ) g g t t t g a t a c  a g t a t t g t t g  t a g a t g c c t t  | a t a t t | a t |  t t g t a a g a t g
H G 53' ( 1 5 )  g l t t t g a t a c  a g t a t t g t t g  t a g a t g c c t t  | a t a t t ^ a t |  t t g t a a t a t g
C o n s e n s u s  g r t t t g a t a c  a g t a t t g t t g  t a g a t g c c t t  y a t a t t y a t y  t t g t a a w a t g
1401  1450
H G 53' ( 4 )  a c c a a t t g a t  t c t c a a a a a g  t g c t g a t c t c  a a a a g a a a a g  t a t a a a c t g t
H G 53' ( 1 0 )  a c c a a t t g a t  t c t c a a a a a g  t g c t g a t c t c  a a a a g a a t t j  t a t a a a c t g t
H G 53' ( 1 5 )  a c c a a t t g a t  t c t c a a a a a g  t g c t g a t c t  c a a a a g a a a a n  t a t a a a c t g t
C o n s e n s u s  a c c a a t t g a t  t c t c a a a a a g  t g c t g a t c t  c a a a a g a a a a r  t a t a a a c t g t
1451 1500
H G 53' (4 ) g a a a t c ...........................................................................................................................
H G 53' ( 1 0 )  g a a a t c a t t c  ..............................................................................................................
H G 53' ( 1 5 )  g g a a t c a t t c  a t t t g t g c g t  t t a c g g a c c a  a t t t a a t c c a  t t g t a g t a t g
C o n s e n s u s  g g a a t c a t t c  a t t t g t g c g t  t t a c g g a c c a  a t t t a a t c c a  t t g t a g t a t g
Figure 58, See legend on next page for details.
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1501 1536
H G53' ( 1 5 )  t c a c a t t t t g  a a a g a c g a a t a a a tg tc a g g  g t c a t t  
C o n s e n s u s  t c a c a t t t t g  a a a g a c g a a t a a a tg tc a g g  g t c a t t
B
HG53'(4) LHFTRSEGFG YEKLLDEQKI
HG53'(10) LHFTRSEGFG YEKLLDEQKI 
HG53'(15) LHFTRSEGFG YEKLLDEQKI 
Consensus LHFTRSEGFG YEKLLDEQKI
50
IKHLLESPYS DYDWRVRPRG RLGPADDDDY 
IKHLLESPYS DYDWRVRPRG RLGPADDDDY 
IKHLLESPYS DYDWRVRPRG RLGPADDDDY 
IKHLLESPYS DYDWRVRPRG RLGPADDDDY
51 100
HG53'(4) DSEPVFITVN MYLRSISKVD DVNMEYSLHF TFREEWIDER LYFNSPTLKH
HG53'(10) DSEPVFITVN MYLRSISKVD DVNMEYSLHF TFREEWIDER LYFNSPTLKH
HG53'(15) DSEPVFITVN MYLRSISKVD DVNMEYSLHF TFREEWIDER LYFNSPTLKH
Consensus DSEPVFITVN MYLRSISKVD DVNMEYSLHF TFREEWIDER LYFNSPTLKH
101 150
HG53'(4) IVLSPGQRIW VPDTFFQNEK DGKKHDIDTP NILIRIHNGT GKILYSCRLT
HG53 ' (10) IVLSPGQRIW VPDTFFQNEK DGKKHDIDTP NILIRIHNGT GKILYSCRLT
HG53'(15) IVLSPGQRIW VPDTFFQNEK DGKKHDIDTP NILIRIHNGT GKILYSCRLT



























2 0 1 250
HG53'(4) QSLPSFLLSN VKTGNCTSVT NTGAYSCLRT IIELKREFSY YLLQLYIPSF
HG53'(10) QSLPSFLLSN VKTGNCTSVT NTGAYSCLRT IIELKREFSY YLLQLYIPSF
HG53'(15) QSLPSFLLSN VKTGNCTSVT NTGAYSCLRT IIELKREFSY YLLQLYIPSF
Consensus QSLPSFLLSN VKTGNCTSVT NTGAYSCLRT IIELKREFSY YLLQLYIPSF
251 300
HG53' (4) MLVAVSWVSF WLDKDSVPAR VTLGVTTLLT MTTQASGVNA NLPPVSYTKA
HG53'(10) MLVAVSWVSF WLDKDSVPAR VTLGVTTLLT MTTQASGVNA NLPPVSYTKA
HG53'(15) MLVAVSWVSF WLDKDSVPAR VTLGVTTLLT MTTQASGVNA NLPPVSYTKA
Consensus MLVAVSWVSF WLDKDSVPAR VTLGVTTLLT MTTQASGVNA NLPPVSYTKA
301 350
HG53'(4) IDIWIGVCLA FIFGALLEFA LVNWAARQDL VAHSRARYRQ iPLFFRNPDS
HG53'(10) IDIWIGVCLA FIFGALLEFA LVNWAARQDL VAHSRARYRQ LPLFFRNPDS
HG53'(15) IDIWIGVCLA FIFGALLEFA LVNWAARQDL VAHSRARYRQ SPLFFRNPDS
Consensus IDIWIGVCLA FIFGALLEFA LVNWAARQDL VAHSRARYRQ #PLFFRNPDS
351 400
HG53'(4) RQENSHHFYA PIQQEVTLED LPFSWWDKIW KIRYKERSRR IDLISRVMFP
HG53 ' (10) RQENSHHFYA PIQQEVTLED LPFSWWDKIW KIRYKERSRR IDLISRVMFP
HG53'(15) RQGNSHHFYA PIQQEVTLED LPFSWWDKIW KIRYKERSRR IDLISRVMFP
Consensus RQGNSHHFYA PIQQEVTLED LPFSWWDKIW KIRYKERSRR IDLISRVMFP
401 426
HG53'(4) LCFIIFNIMY WWRYLIPYMA VQAQLE
HG53'(10) LCFIIFNIMY WWRYLIPYMA VQAQLE
HG53'(15) LCFIIFNIMY WWRYLIPYMA VQAQLE
Consensus LCFIIFNIMY WWRYLIPYMA VQAQLE
Figure 58, Alignment of three individually amplified 3’ RACE-PCR products a] 
nucleotide sequence: Variation between the different clones is shaded in grey. A 
consensus sequence is also displayed with a summary of possible nts highlighted in bold. 
For part a] only Y codes either a C or a T, M codes either an A or a C, R: an A or a G, S: a G 
or a C, K: a G or a T, W: an A or a T and H: an A, C or T. Nucleotides in uppercase are 
coding sequence whilst lower case nucleotides represent the UTRs. b] peptide sequence: 
Variation between the amino acid sequence is indicated with grey shading.
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Table 13, Percentage variation between the HG5 3’ RACE cDNA clones. This has been 
calculated at both the nucleotide and amino acid levels with clones amplified from an 
avermectin susceptible isolate.
HG5 3’ ends isolated from avermectin susceptible H. 
contortus
Clone 4 Clone 10
Variation at the 
nucleotide level, 
over a length of 
1281 bp
Clone 10 4.45% (57/1281 nt)
Clone 15 5.31% (68/1281 nt) 4.45% (57/1281 nt)
Variation at the 
amino acid level, 
over a length of 426 
residues
Clone 10 0.23% (1/426aa)
Clone 15 0.00% (0/426aa) 0.23% (1/426aa)
6.2.5 HG5 Sequence from Avermectin Susceptible H. contortus
The consensus full-length sequence for HG5 was transferred to the GCG package on the 
gnome workstation and was compared with known sequences present in the EMBL 
database. The identity of HG5 with related sequences has been summarised in Table 14.
Figure 59 illustrates an alignment of HG5 with the two most similar full-length protein 
sequences GBR2A (U40573) and GluClal (U142524), both isolated from C. elegans. The 
four transmembrane regions (denoted TM1-4) have been highlighted and the signal 
cleavage site is indicated by the arrow. Two N-linked glycosylation sites exist at residues 
148-150 (NGT) and residues 225-227 (NCT). The two cysteines at positions 165 and 179 
are believed to form the cys-loop, which is the signature of TGICs. The two conserved 
cysteines (C2226 & C237) situated further downstream from the loop are a common feature 
of glycine receptor subunits. Several predicted phosphorylation sites have been identified 
along the intracellular loop spanning between transmembrane domain 3 and 4 of HG5. 
These include 2 casein kinase II phosphorylation motifs, TLED (residues 377-380) and 
SWWD (residues 384-387), and a phosphorylation site specific to protein kinase C, SKR 
(residues 398-900).
Predicted ligand binding sites are also present including residues YAXT and TGXY at 
positions 186-189 and 232-235 respectively. Phenlyalanine (residue 91) and glutamine 
(residue 177) are also thought to play a role in agonist binding. Finally the tyrosine residue at 
position 185 appears to be highly conserved in a-like subunits compared to (3-like subunits 









Gamma, y-like subunit y « -
like
Alpha, a-like subunits
HG1 Giya HG4 HG2 HG3 GluCIX HG5 GluCIa
GABAa 28% 38% 31% 31% 36% 35% 33% 35% 42% 40% 33% 33% 27% 31% 32% 32% 31%
HG1 - 33% 26% 27% 26% 28% 25% 27% 32% 29% 28% 29% 24% 28% 30% 29% 28%
Giya 40% 41% 43% 42% 42% 42% 47% 47% 42% 43% 36% 40% 41% 41% 46%
80% 48% 47% 46% 48% 57% 57% 43% 49% 39% 45% 47% 47% 44%
HG4 48% 47% 45% 48% 53% 57% 43% 47% 38% 47% 46% 46% 42%
79% 79% 74% 81% 91% 62% 60% 41% 57% 57% 57% 52%
72% 87% 88% 86% 67% 58% 40% 54% 54% 55% 50%
HG2 75% 81% 89% 66% 55% 37% 52% 53% 54% 45%
HG3 88% 85% 56% 59% 40% 54% 55% 55% 49%
GluCIX 91% 66% 68% 55% 63% 63% 68% 55%
71% 72% 53% 72% 72% 72% 59%
HG5 63% 44% 56% -'-V. S5%
55% 48%
40% 61% 67% 67% 50%





R. norvegicus Partial sequence
Table 14, Comparison of Amino Acid Identities of HG5 with related receptor subunits.
HG5 .MFA LILPFLLHFT RSEGFGYEKL LDEQKIIKHL LESPYSDYDW RVRPRGRLGP 53
GBR2A  MWHY RLTTILLIIS IIHSIRAKRK LKEQEIIQRI L  KDYDW RVRPRGMNAT 50
G lu C la l MATWIVGKLI IASLILG IQA GQARTKSQDI FEDDNDNGTT TLESLARLTS PIHIPIEQPQ TSDSKILAHL FTSGYDFRVR PPT DNG 86
+
HG5 ADDDDYDSEP VFITVNMYLR SISKVDDVNM EYSLHFTFRE EWIDERLYFN........SPTL KHIVLSPG........ QRIWV PDTFFQNEKD 131
GBR2A WPDTG...GP VLVTVNIYLR SISKIDDVNM EYSAQFTFRE EWTDQRLAYE RYEESGDTEV PPFWLATSE NADQSQQIWM PDTFFQNEKE 137
G lu C la   GP VWSVNMLLR TISKIDWNM EYSAQLTLRE SWIDKRLSYG VKGDGQ. . . . PDFVILTVG HQIWM PDTFFPNEKQ 158
HG5
GBR2A
G lu C la
HG5
GBR2A
G lu C la
GKKHDIDTPN ILIRIHNGTG KILYSCRLTL TLS 
ARRHLIDKPN VLIRIHKN.G QILYSVRLSL VLS
AYKHTIDKPN VLIRIHND.G TVLYSVRISL VLS
PMRLAD Y P L D V Q T Z 
?MSLEF Y P L D R Q N :
PMYLQY YPMDVQC
++++
rv DFASYAYTTK DIEYGWKEEK PIQIKDGLRQ SLPSFLLSNV 221
,1 DLASYAYTTQ DIKYEWKEKK PIQQKDGLRQ SLPSFELQDV 226
51 DLASYAYTTK DIEYLWKEHS PLQLKVGLSS SLPSFQLTNT 247







jR T I  IELKREFS] 
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T L G V T T L L T M
[AN LPPVSYTK* 311 
NAN VPPVSYTK* 316
NSQ LPPVSYIkH  337
HG5 j | |W IG V C L A F  IF G A L L E F A L  VNWAARQDLV AHSRARYRQS PLFFRNPDSR QENSHHFYAP IQQEVTLEDL PFS^WDKIWK IRYKERSRRI 401
GBR2A D V W IG V C LA F  IF G A L L E F A L  VNYAARKDMT OVSORIROMK QLPTEGYRP LSASQG RSSFCCRIFV RRYKERSKRI 391
G lu C la  ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ V N H I A N K Q G V  ERK ARTEREK AEIPLLQNLH . . NDVPTKVF NQEEKVRTVP LNRRQMNSFL NLLETKTEWN 425
HG5
GBR2A
G lu C la
WuM m
R VM FPLC EII I P'i74AVQAQL E . . . 4 3 6 (
R L V F P IG Y A C  FNVLYW AVYL M ......................................... 4 1 6 1
illl 4 61
Figure 59 Alignment of HG5 with GBR2A and GluCla receptor subunits
K E Y : Predicted signal cleavage sites are between the residues GF (indicated by ^ ) for HG5- A K fo r GBR2A, QQfor GluCla, N X  ( T / S )  are predicted N-linked Glycosylation sites 
MHHBTransmembrane domains (TM1-4). + marks the residues belie^gdto be involved in ligand binding. T L E D  SWWD are predicted casein kinase II phosphorylation sites, S R R .
SQR, SKR and TER are predicted protein kinase C phosphorylation site, I C I cysteines forming the cysteine loopj  C | cysteine characteristic of glycine receptors.
6.2.6 Isolation of the 5’ end of avermectin resistant HG5
The mRNA from avermectin resistant Haemonchus contortus eggs was extracted for cDNA 
synthesis. The resulting cDNA was used in RACE-PCR to amplify two individual copies of 
the 5’ end of HG5. The exact conditions required to amplify the 5’ end of HG5 from 
avermectin susceptible worms were used. The alignment of the two 5’ end, HG5 sequences, 
from resistant nematodes and the consensus 5’ sequence from susceptible worms can be 
seen in figure 60. Variation of sequence between the clones is shaded in grey and has been 
summarised in table 15. The 5’ consensus sequence for HG5 from avermectin susceptible 
and resistant H. contortus was identical. It can therefore be concluded that avermectin 
resistance has not resulted from a genetic mutation coded within the N-terminal domain of 
HG5.
1 25
S C onsen sus  r t y a g t a t c t a t g t g a t c g a c a c t a  ATGTTCGCCT TjRATTCTGCC ATTTC
RHG55' ( 1 )  g t c a g t a t c t a t g t g a t c g a c a c t a  ATGTTCGCCT Tj|ATTCTGCC ATTTC
RHG55' (2 ) a a t t C g a t c t a t g t g a t c g a c a c t a  ATGTTCGCCT TjfjjATTCTGCC ATTTC
26 85
S C o n se n su s  TGTTGCATTT CACRCGGTCC GAAGGTTTTG GTTACGAGAA GCTATTGGAT GAGCAGAAAA 
RHG55' ( 1 )  TGTTGCATTT CACRCGGTCC GAAGGTTTTG GTTACGAGAA GCTATTGGAT GAGCAGAAAA 
RHG55' ( 2 )  TGTTGCATTT CACRCGGTCC GAAGGTTTTG GTTACGAGAA GCTATTGGAT GAGCAGAAAA
86 145
S C o n se n su s  TTATCAARCA TCTATTGGAA AGTCCCTATA GCGAfTACGA TTGGCGjgGTT CGTCCCCGTG 
RHG55' ( 1 )  TTATCAAftCA TCTATTGGAA AGTCCCTATA GCGAfTACGA TTGGCGQGTT CGTCCCCGTG 
RHG55' ( 2 )  TTATCAARCA TCTATTGGAA AGTCCCTATA GCGAFTACGA TTGGCGAGTT CGTCCCCGTG
146 205
S C o n se n su s  GTCGTCTfGG TCCCGCTGAC GACGACGATT ACGATAGTGA ACCAGTATTC ATTACAGTCA 
RHG55' ( 1 )  GTCGTCTfGG TCCCGCTGAC GACGACGATT ACGATAGTGA ACCAGTATTC ATTACAGTCA 
RHG55' ( 2 )  GTCGTCTGGG TCCCGCTGAC GACGACGATT ACGATAGCGA ACCAGTATTC ATTACAGTCA
206 265
S C o n se n su s  ACATGTACTT GAGGAGTATW TCTAAAGTCG AYGATGTTAA TATGGARTAT TCRTTGCAYT 
RHG55' ( 1 )  ACATGTACTT QAGGAGTATT TCTAAAGTCG ACGATGTTAA TATGGARTAT TCRTTGCAfT 
RHG55' ( 2 )  ACATGTACCT AAGGAGTATA TCAAAAGTCG ACGATGTTAA TATGGAGTAT TCATTGCACT
266 325
S C o n se n su s  TYACATTTCG AGAAGARTGG ATTGACGARA GGCYRTATTT CAAYAGCCCG ACGTTGAAAC 
RHG55' ( 1 )  TTACATTTCG AGAAGAGTGG ATTGACGAGA GGCTATATTT CAAYAGCCCG ACGTTGAAAC 
RHG55' ( 2 )  TTACATTTCG AGAAGARTGG ATTGACGAGA GGCTGTATTT CAAfAGCCCG ACGTTGAAAC
326 385
S C o n se n su s  ATATYGTRCT GTCACCTGGA CAACGAATgT GGGTGCCCGA CACMTTCTTC CARAAYGAGA 
RHG55' (1 ) ATATCGTTCT GTCACCTGGA CAACGAATGT GGGTGCCCGA CACATTCTTC CARAACGAGA 
RHG55' (2 ) ATATCGTGCT GTCACCTGGA CAACGAATAT GGGTGCCCGA CACfTTCTTC CAGAACGAGA
Figure 60, See legend on next page.
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386 445
S C onsen sus  AARATGGCRA GAAACATGAC ATCGATACTC CGAAXATTTfT RATTCGGATA CATAAXGGYA
RHG55' ( 1 )  AAGATGGCAA GAAACATGAC ATCGATACTC CGAACATTTT RATTCGGATA CATAACGGTA
RHG55' ( 2 )  AAGATGGCGA GAAACATGAC ATCGATACTC CGAACATTCT RATTCGGATA CATAACGGGA
446 505
S C onsen sus  CAGGAAAGAT WCTKTATTCM TGTCGGCTTA CTYTGACCCT GAGCTGTCCR ATGAGGTTGG
RHG55' ( 1 )  CAGGAAAGAT ACTRTATTC|i TGTCGGCTTA CTCTRACCCT GAGCTGTCCR ATGAGGTTGG
RHG55' ( 2 )  CAGGAAAGAT ACTGTATTCG TGTCGGCTTA CTCTAACCCT GAGCTGTCCA ATGAGGTTGG
506 565
S C onsen sus  CCGATTATCC GCTTGATGTA CAGACATGTG TWGTGGATTT TGCTTCATAC GCCTATACTA
RHG55' ( 1 )  CCGATTATCC GCTTGATGTA CAGACATGTG TfGTGGATTT TGCTTCATAC GCCTATACTA
RHG55' ( 2 )  CCGATTATCC GCTTGATGTA CAGACATGTG TAGTGGATTT TGCTTCATAC GCCTATACTA
566 597
S C onsen sus  COAAAGACAT MGAATACGGA TGGAARRAGG AR
R H G 5 5 '(1 ) COAAAGACAT AGAATACGGA TGGAAGGAGG AA
RHG55' ( 2 )  CAAAAGACAT CGAATACGGA TGGAAGGAGG AA
Figure 60, Alignment of HG5 5’-RACE products from avermectin-resistant H. 
contortus. The sequence of two individually amplified HG5 5’ RACE products, from an 
avermectin-resistant population of H. contortus, were aligned together with the consensus 
sequence from an avermectin susceptible population. Key: Y codes either a C or a T, M 
codes either an A or a C, R: an A or a G, S: a G or a C, K: a G or a T and W: an A or a T. 
Nucleotides in uppercase are coding sequence whilst lower case nucleotides represent the 
5’ UTR.
Table 15, Variation between the 5’ end RACE products amplified from avermectin
HG5 5’ ends isolated from avermectin resistant H. contortus
Clone 1 Clone 2




Clone 3 1.0 % (6/597) 0.50% 1/199 4.7 % (28/597) 1.51% 3/199
Clone 8 5.2 % (31/597) 0.50% 1/199 4.5 % (27/597) 0.00% 0/199




Clone 1 " “ “ "
Clone 2 4.5 % (27/597) 0.50% 1/199
6.3 Discussion
The derivation of a consensus sequence for HG5 came from six individual HG5 cDNAs. 
This was achieved by amplifying three 5’- and three 3’-ends using a RACE-PCR technique. 
Comparison of sequences revealed as high as 5.86 % and 5.53 % nucleotide variation 
existed between 5’ and 3’ termini respectively. These values are slightly higher than the 
4.49 % variation observed for the different HG4 amplified cDNAs (Chapter 3). The
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translated 5’ end HG5 sequence encoded by clones 8 & 3 each have one amino acid 
differing from the consensus whilst clone 12 has two. These may either represent 
polymorphic sites or PCR induced artefacts.
Similarly, the translated 3’ end sequence is identical for two of the amplified clones with the 
third clone (seen in lane 10 of figure 57) conferring one amino acid mismatch with the 
consensus sequence. It may also be noted that even though clones 4 and 15 differ by 
having 68 nt mismatches across a sequence of 1281 nts, none of the variation is carried 
over to the translated sequence. Since the majority of variation is present at the nucleotide 
level it is likely that they are a result of polymorphism existing between the individual 
nematodes used to synthesis the cDNA.
The HG5 consensus sequence was found to be most similar to the C. elegans full-length 
glutamate-gated chloride channel subunits GBR-2A (62 % identical at the amino acid level), 
GBR-2B (57 %) and GluClal (56 %) (Laughton et al., 1997b & Cully et al., 1994). Two 
partial sequences, catalogued in the EMBL database, also show similarity to HG5, they have 
each been denoted GluCIX and are believed to be filarial orthologues of GBR-2. GluCIX 
from D. immitis is 71 % identical to HG5 across a 98 amino acid overlap. Likewise, the partial 
sequence from O. volvulus has 66 % identity with HG5 covering a 352 amino acid overlap. 
These percentage identities have been summarised in table 14.
The next objective will be to amplify a full-length cDNA of HG5 by designing gene specific 
primers and using PCR. If the sequence obtained is consistent with the consensus 
sequence, it can then be expressed in Xenopus oocytes. If HG5 is an a-like subunit, it is 
expected to form homomeric channels that are selectively responsive to avermectin at pM 
concentrations and co-expression with GluCip should result in heteromeric channels gated 
by glutamate and potentiated by avermectin at nM values (Cully et a/.,1994).
To date GluCla2s and GBR-2A have been localised to the pm4 and pm5 muscle cells of the 
pharynx (Horrovitz, pers. comm., Dent et al., 1997). The spatial expression of HG5 will need 
to be determined. From C. elegans expression studies it can be predicted that HG5 may 
localise to the surface of the pm4 and pm5 cells in the pharynx. However, studies of HG4 
expression, accomplished for this thesis, do not match the findings found in C. elegans. 
Therefore, it will be interesting to determine whether HG5 is co-expressed with HG4 on the 
surface on commissures present in the nervous system of the agriculturally important 
parasite.
GluClal subunits bind avermectin when expressed as homomeric channels in Xenopus 
oocytes (Cully et al., 1994). Avermectin resistance may have developed due to a mutation in 
GluCla’s ligand binding site. A number of residues encoded by the N-terminal extracellular 
domain of this protein have been predicted to participate in the formation of a binding site 
(Wolstenholme, 1997). It is possible that an alteration of these predicted residues may 
prevent the binding of avermectin to the receptor. Resistance may also have developed due
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to a point mutation, converting an in-frame codon into a stop codon, as is the case seen for 
the C. elegans arv-15 mutant. If HG5 is an a-like subunit it may possess the ability to 
avermectin. Comparison of these predicted sites from avermectin susceptible and resistant 
HG5 genes will establish any differences, which may prevent the drug binding.
The 5’ end of HG5 from an avermectin resistant isolate was successfully amplified from two 
individual cDNAs. Comparison of these sequences with the HG5 consensus sequence from 
avermectin susceptible worms was accomplished unveiling that no difference exists at the 
amino acid level. Therefore the N-terminal extracellular domain of HG5 from avermectin 
resistant nematodes does not prevent the drug binding to the receptor.
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7 Discussion
The work described in this thesis provides the first report of full-length cDNA 
sequences/clones of the glutamate-gated chloride channel subunits from parasitic 
nematodes. Interesting and provocative differences have been revealed between C. elegans 
and H. contortus, the latter being the parasitic worm most closely related to C. elegans 
(Blaxter et al., 1998). These findings call into question the validity of extrapolating data 
obtained from C. elegans to parasites. The knowledge obtained in this study is a vital first 
step in the understanding of the structure and function of these channels as important drug 
targets.
The proteins coded by HG4 and HG5 share typical features with members of the TGIC 
superfamily. Each subunit possesses 4 hydrophobic transmembrane domains (denoted 
TM1 to TM4) and 2 highly conserved extracellular cysteines, which form a disulphide-bonded 
cys-loop. A second pair of cysteine residues is present further downstream of the cys-loop 
but upstream from TM1. These features are characteristic of inhibitory glutamate-gated 
chloride channel and glycine receptor subunits. Both cDNAs have been amplified with the 
knowledge that a splice leader sequence of 22 nucleotides, known as SL1, is present 
upstream of the initiation codon. Two N-linked glycosylation sites are coded by each subunit 
as well as potential phosphorylayion sites for either protein kinase C or casein kinase II 
existing along the intracellular loop between TM3 and TM4.
The HG4 cDNA is composed of 1756 base pairs, of which the first 29 nucleotides make up 
the 5’ utr region including the SL1 sequence whilst the last 431 nt constitute the 3’ utr. The 
remaining 1296 base pairs code a polypeptide of 432 amino acid residues. This translated 
product is 80.25 % identical to the glutamate-gated chloride channel beta subunit, GluClp. 
Such a high identity suggests that HG4 is the parasitic orthologue. In contrast, the HG5 
cDNA varies in size due to the different lengths of 3’ utr following the stop codon. Consistent 
between each of the amplified clones, a 25 nt 5’ utr precedes a 1308 bp coding frame which 
when translated yields a 436 amino acid polypeptide chain. Depending on the clone, the 
length of the 3’ utr may be 175, 177 or 253 nucleotides. Comparison of the HG5 polypeptide 
with related proteins catalogued in the database reveal that it is most similar to the glutamate 
gated chloride channel subunits being both a- and y-like in nature. Highest full-length amino 
acid identities are with GBR-2A (62 %), GBR-2B (57 %) and GluClal (56 %).
The degree of polymorphism between each of the amplified cDNAs has been estimated by 
aligning the open reading frames. A high variation of 4.49 % has been calculated for HG4 
clones and up to 5.86 % has been recorded between HG5 clones. For the former value, 3(5 
nucleotides differ along a stretch of 579 nts. Upon translation only 1 out of the 26 differences 
confer an amino acid alteration. Similarly, for the HG5 clone, 35 nucleotides differed over a 
stretch of 597 nts, but only three of these confer an alteration at the amino acid level.
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Amplification of full-length HG4 cDNAs from an avermectin-resistant isolate of H. contortus 
has been achieved. Comparison of sequence from the two populations establishes that no 
alteration exists at the translated level, possibly interfering with avermectin binding. 
Likewise, amplification of the 5’ terminus of HG5 from a resistant isolate exhibits no variation 
at the amino acid level to the consensus sequence derived from susceptible nematodes. 
This confirms that the N-terminal domain, including the predicted determinants of the ligand- 
binding site, remained unaltered in HG5 amplified from a resistant population. To 
summarise, avermectin resistance developed by the isolate used in this study has not 
resulted from amino acid variation in either the HG4 subunit or the N-terminal extracellular 
domain of HG5. However, HG4 and HG5 may still play a role in the development of 
avermectin resistance. Further work needs to be done to amplify a full-length clone of HG5 
from the resistant population to determine whether a point mutation exists, preventing drug 
binding. Also, corresponding genomic sequences should be isolated to compare promoter 
and intronic regions. Resistance may be a result of the up-regulation of subunit expression; 
this can be determined by Northern blots comparing HG4 or HG5 mRNA levels from 
avermectin-susceptible and -resistant populations.
If HG4 is the parasitic orthologue of GluCip it is be predicted that expression in Xenopus 
oocytes as homomeric channels will respond to glutamate at equivalent mM concentrations 
in a reversible manner (Cully et al., 1994). The consensus sequence of HG4 is in the 
process of being expressed in oocytes. As HG5 is a GluCla-like subunit, it is believed that 
expression of homomeric channels will respond irreversibly to avermectin at pM levels (Cully 
et al., 1994). A full-length consensus sequence of HG5 needs to be cloned in future 
experiments for expression work to be possible. This will also enable examination of co­
expressed HG4/HG5 heteromeric channels, which are predicted to form glutamate-gated 
chloride channels that are potentiated by avermectin at nanomolar concentrations.
In C. elegans, GluClp has been localised to the to pm4 pharyngeal muscle cells where they 
form receptors with related subunits (Laughton et al., 1997a). As HG4 is predicted to be the 
parasitic orthologue, it is expected that it will also be expressed at identical sites in H. 
contortus. This theory has been tested, as detailed in Chapter 4 and 5, by synthesising 
antibodies to a peptide designed to a site along the N-terminal domain of HG4, which 
displays high heterogeneity with related proteins.
Purified antibodies are able to specifically recognise the N-terminal domain of HG4 when 
expressed in a prokaryotic expression system. ELISA results corroborate these findings with 
purified anti-HG4 antibodies binding to the peptide antigen: RSTGGTQEQEILNELLSN. In 
contradiction to the expected localisation of HG4, exposure of collagenase treated H. 
contortus to a 1:10 dilution of anti-HG4 antibody does not result in specific binding to the 
pm4 and pm5 cells. Instead immunostaining of commissures and ventral & dorsal nerve 
cords are observed. More specifically commissures spanning the anterior of the worm to the 
mid-body region, above the vulva in female nematodes are recognised by anti-HG4 
antibody.
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The neuronal network for C. elegans, defined by White et al. (1989), enables the prediction 
of the neurones in H. contortus, which express HG4. These include the motor neurones 
DA1-DA4, VA1-VA3, AS1-AS3, VD1-VD7 and DD1-DD4. The former three classes are 
excitatory in nature releasing acetylcholine whilst the latter two classes are inhibitory, 
releasing GABA. DA, VA and AS motor neurones all receive synaptic input from the AVE 
interneurone which spans the ventral cord originating in the nerve ring and terminating 
immediately anterior to the vulva. From the observations described in this report it is 
proposed that the AVE interneurone releases glutamate at its synapses with the above 
mentioned motor neurones which in turn cross-communicate utilising the same 
neurotransmitter. It may be questioned why this network is only seen in the nervous system 
above the vulva in females and equivalent regions in the male. Commissures, spanning this 
region, cross talk with the sublateral cords. It is therefore possible that the presence of 
glutamate-gated chloride channels on motor neurones innervating these cords provide an 
additional form of regulation. This functionality may fine-tune the resulting potential that 
reaches the synapses.
According to Blaxter et al., (1998) phylogenetic calculations suggest that H. contortus is the 
parasitic worm most closely related to C. elegans. However the expression pattern observed 
for HG4 questions whether C. elegans is an ideal model in which to study the drug targeting 
associated with parasitic nematodes. GluCip is expressed in the C. elegans pharynx with 
related subunits forming the avermectin target of inhibitory glutamate-gated receptors. 
Based solely on C. elegans findings, it has previously been proposed that avermectin causes 
starvation of the nematode (Geary et al., 1993). The localisation in H. contortus of HG4, 
reveals a set of glutamate-gated chloride channels that may regulate locomotion of the 
anterior portion of the body via the sublateral cords. Avermectin may therefore target these 
receptors inducing paralysis of the worm leading to a rapid expulsion of worms from the host. 
It is postulated that the difference in spatial expression between HG4 and GluCip is a 
consequence of different promoters regulating the expression of the two subunits. Isolation 
of the genomic sequence of HG4 therefore needs to be accomplished for comparison with 
the GluCip genomic sequence. An investigation into HG4 expression in C. elegans using a 
lac-z reporter construct is recommended. Expression of this construct, comprising the HG4 
promoter, in the presence of X-gal will determine whether the difference in expression 
patterns is directly related to promoter regulation.
With the spatial expression of GluCla2A confined to pm4 and pm5 cells in the pharynx (Dent 
et al., 1997), HG5 is also expected to be expressed in an equivalent locality in H. contortus. 
However, as HG4 expression is restricted to certain commissures and ventral & dorsal 
cords, it is possible that HG5 is co-expressed with HG4.
Future work should include the amplification of a full-length HG5 sequence from a resistant 
population of Haemonchus contortus, as there may be a genetic mutation situated down 
stream of the 5’ end that may confer a non-functional subunit. Expression of both HG4 and 
HG5 subunits, as homomeric and heteromeric receptors in Xenopus oocytes should be done
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to corroborate that these subunits form glutamate-gated chloride channels. Co-expression 
using HG2 and HG3 should also be addressed, including the effect of avermectin potency on 
each of the receptors formed from the various subunit combinations used.
Antisera raised against HG5, HG2 and HG3 will be useful for co-localisation studies. Results 
from these experiments is expected to determine whether the subunits associate together as 
glutamate-gated chloride channels along commissures. These results may also indicate 
whether there is a second population of channels existing on pm4 and pm5 pharyngeal 
muscles.
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Appendix 1, Plasmid Maps N a e 1131
Ssp I 442
Ssp I 2850 SsP. n 9
Nae I 330
Xmn I 2645
Sea I 2526 Pvu I 500 
,Pvu  II 529
Pvu I 2416
SssH II 619 
Kpn I 657
pBluescript II SK (+/-)
2961 bp
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Appendix 2 Genetic Markers in E. coli strains
Marker Description
Amy Amylase
ara Mutation destroys ability to catabolise arabinose
Camr Chloramphenicol resistance due to inactivation by chloramphenicol 
acetyltransferase
endA1 Mutation in DNA-specific endonuclease 1 improves the quality of plasmid 
DNA isolations.
F Plasmid that carries a lacZ gene bearing deletions at its 5’ end resulting in 
the synthesis of an inactive C-terminal co-fragment of the p-galactosidase. 
Ideal for alpha-complementation.
gyrA46 Mutation in DNA gyrase subunit A, confers resistance to nalidixic acid.
hsdR17
(rk',mk+)
Host specific restriction minus and modification positive; prevents cleavage 
of transformed DNA by the endogenous restriction endonuclease EcoK 
however modification by methylation can still occur.
lac Unable to utilise lactose
LacP Overproduces the lac repressor protein, inhibiting transcription from the lac 
promoter
LacZ (3-galactosidase
lacZAM15 (3-galactosidase carries a deletion of the 3’ end of lacZ transcribes an 
inactive N-terminal fragment called an a-fragment, required for a- 
complementation
ProAB Defective in proline metabolism, requires proline in minimal media in order 
to survive.
recA1 Recombination defective.
relA1 Allows RNA synthesis in the absence of protein synthesis.
rpsL Bears a mutation in the S12 subunit of the 30S ribosome conferring 
resistance to streptomycin.
SupE44 Nonsense supression of the amber termination codon (UAG) where 
translation of message does not always stop when the ribosome 
encounters an amber codon. A mutant tRNA gene causes the substitution 
of a glutamine at this position allowing translation to continue.
thi Unable to biosynthesis thiamine, requires thiamine (vitamin B1) in minimal 
media for growth
TnlO(tetR) Contains the TN10 transposon, confering tetracycline resistance by active 
efflux of drug from the cell
traD36 Mutation of the Transfer factor prevents the tranfer of F’ episome other 




RoRi 28 mer 5' QAC TAC QTT AGC ATC TAG AAT TCT CGA G 3'
SL1 22 mer 5 / GGT TTA ATT ACC CAA GTT TGA G 3'
HG4 GSSP1 21 mer 5 ' ATG CAG CTC ACC CTA AAA AGG 3 '
HG4 GSSP2 24 mer 5 ' TAC TAC CTG GTC CAG TTG TAC GGT 3 '
HG4 GSSP3 21 mer 5 ' GAC ACC TTT TTC CCG ACC GAA 3 '
HG4 GSAP1 22 mer 5 ' ACC GGT GGC AGT TTA GCA TTG A 3 '
HG4 GSAP2 22 mer 5 ' GCA TGT GAC AGG AGC TGG TAA T 3 '
HG4-CSP1 35 mer 5’ GTC ATA GCG GCC GCG ATC TTG AAT GTC ACA GTA TA 3’
HG4-CAP1 32 mer 5’ TGC ACT TCT AGA AAA TAC TGT TGT GTG ATG ATG GC 3’
HG4MUTS 17 mer 5' GGC GAT CCA CTG GTG GC 3'
HG4pMALS 24 mer 5' GAC GCA GTC GAC ATG TCA CAG TAT 3'
HG4pMALA 26 mer 5' TGC ACT CTG CAG TTA ATT GGT ATG GC 3'
HG5 GSSP1 20 mer 5 ' GAT ATC GAT ACT CCG AAC A T 3 '
HG5 GSSP2 28 mer 5 , t t c  T G T  t q c  ATT TCA CGC GGT CCG AAG G 3 '
HG5 GSSP3 22 mer 5 ' ACC GAT CCA GAA CAA AGA TGG C 3 '
HG5 GSAP1 20 mer 5 ' CTG ACG TGC AAT TAC CGG TT  3 '
HG5 GSAP2 21 mer 5 ' CTC CGT TCC TTA  TAG CGT A TT 3 '
KS 17 mer 5 '  TCG AGG TCG ACG GTA TC 3 '
T3 20 mer 5 '  AAT TAA CCC TCA CTA AAG GG 3 '
T7 22 mer 5 '  GTA ATA CGA CTC ACT ATA GGG C 3 '
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Appendix 4, Avermectin Resistant H. contortus
An avermectin resistant field isolate of Haemonchus contortus was selected for RNA 
extraction. This particular isolate originated from the White River in South Africa (van Wyk & 
Malan, 1988). Van Wyk & Malan reported the effect of infecting 5 helminth-free sheep each 
with a single dose of 5000 larvae. Thirty days after infection, 0.2 mg/kg body weight of 
Ivermectin, was administered orally. The five sheep were slaughtered 7 to 10 days after 
treatment and worm counts were performed. A 33% reduction in Haemonchus contortus 
numbers was calculated thus showing some degree of resistance to ivermectin. The same 
isolate was used to infect a Dorset lamb followed by administration of 200 pg/kg ivermectin. 
In accordance this treatment did not significantly affect egg counts (Coles, pers. comm).
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